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Virulence determinants of M tuberculosis remain largely unknown. Of key 
interest has been the ability of the bacterium to survive intracellularly within its host cell, 
the macrophage, and its ability to cause extensive tissue necrosis. Exported proteases are 
commonly associated with virulence in bacterial pathogens, yet their role in 
Mycobacterium tuberculosis has virtually not been studied. Preliminary experiments 
showed M tuberculosis culture filtrates contained a proteolytic activity inhibited by 
mixed serine/cysteine protease inhibitors and activated by ca2+, features typical of some 
serine proteases, notably subtilisins, and possibly metalloproteases. Purification attempts 
were unsuccessful. A family of five genes that encode putative, secreted, serine 
proteases has recently been described in M tuberculosis. These proteases share 36-47% 
sequence identity and are all encoded with putative signal peptides, suggesting that they 
are translocated across the cytoplasmic membrane. One member, mycP I, was selected 
for further study. The gene product, mycosin-1, was 30-35% identical to bacterial 
subtilisin-like serine proteases and contained the classic catalytic triad and oxyanion 
hole. Mycosin-1 also contained a typical signal peptide, a likely propeptide, and a C-
terminal hydrophobic sequence with a high transmembrane potential. Topology analyses 
predicted mycosin-1 to be a type I ectoprotein. Consistent with this, expression of 
mycosin-1 in M tuberculosis and in Mycobacterium smegmatis transformed with mycP I 
(M smegmatis-PI) was limited strictly to the cell envelope, as seen by Western blotting, 
and immunogold electron microscopy. Only full-length, 50-kDa mycosin-1 was 
observed by Western blotting in broth-grown M tuberculosis and M smegmatis-PI 
lysates, whereas a 40-kDa species was detected in 6-week M. tuberculosis culture 
filtrates. A similar 40-kDa immunoreactive band was also observed in lysates of 
macrophages infected with M tuberculosis, consistent with robust transcription of the 
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mycP 1 gene during growth in macrophages. Since putative mature mycosin-1 has a 
molecular weight of 38.6 kDa, the 40-kDa protein may represent activated mycosin-1 
after propeptide cleavage. In conclusion, mycosin-1 is an exported, cell envelope-
associated subtilisin homolog that is expressed during growth of M tuberculosis in vitro 
and in macrophages. 
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INTRODUCTION 
As the 21 st century approaches, Mycobacterium tuberculosis, the causative agent of 
tuberculosis, remains the scourge of mankind, accounting for 8 million new cases of 
tuberculosis and 2.9 million deaths from the disease annually (Bloom et al. , 1992). It is 
estimated that one third of the world's population harbors M tuberculosis, placing them at 
risk of developing· the disease. Despite the significant morbidity and mortality rate caused 
by this disease, research into the pathogenesis of tuberculosis has been slow. This was 
partly due to the initial successes of First World countries in controlling this disease, and 
partly due to the difficulty in culturing and manipulating M tuberculosis. The lack of 
research directed towards M tuberculosis infection ensured that, in the mid to late 1980's, 
when there was an increasing incidence of tuberculosis worldwide, the numerous theories 
regarding the pathogenesis of tuberculosis remained unproven. 
In response to the increasing global incidence of tuberculosis, new research 
programmes and international collaborations were established to study the physiology, 
biochemistry and molecular biology of M tuberculosis, with the ultimate aim of identifying 
novel drug targets and developing an effective vaccine. Of key interest have been the ability 
of the M tuberculosis bacillus to survive the microbicidal mechanisms of its host cell, the 
macrophage, and the ability of the bacillus to cause tissue pathology, characterised by cavity 
formation. However, despite the upsurge in tuberculosis research, mycobacterial virulence 
determinants remain largely unknown (virulence is defined as the competence of an 
infectious agent to produce pathological effects). 
Proteases are produced by an array of pathogenic microorganisms. Many of these 
proteases are actively involved in the ability of the microorganism to establish disease, and 
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are especially prevalent in microorganisms that cause tissue destruction. At the outset of this 
study, little was known about protease activities in M tuberculosis and, apart from a few 
preliminary reports, the subject received sparse attention. The hypothesis that 
M tuberculosis produces proteases that actively contribute to the pathogenesis of 
tuberculosis formed the basis of the present work, and to that end, several approaches were 
taken to identify and characterise protease-encoding genes and proteolytic activities in this 
organism. In addition to increasing our knowledge of M tuberculosis biochemistry and 
physiology, the discovery of proteases may provide novel drug targets that could facilitate 
the development of new therapies. 
This thesis begins with two literature review chapters detailing essential aspects of 
M tuberculosis (Chapter 1) and the roles of proteases in infectious diseases (Chapter 2). 
These chapters are followed by experimental chapters that describe the identification of 
proteolytic activity in M tuberculosis culture filtrates (Chapter 3), as well as the initial 
characterization of mycosin-1 , the first member of a novel family of putative subtilisin-like 
serine proteases (Chapters 4-7). The characterization of mycosin-1 includes an analysis of 
its predicted sequence (Chapter 4); PCR amplification of the mycP I gene, cloning and 
expression of mycP I in E. coli and M smegmatis, and detection of mycosin-1 in 
M tuberculosis (Chapter 5); localisation of mycosin-1 (Chapter 6); and, finally, detection of 
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The origin of M tuberculosis has been hotly debated for many years. The 
favoured view is that M tuberculosis originated from a mutant of M bovis, the causative 
agent of tuberculosis in cattle, other animals, and occasionally humans. Therefore, the 
first humans with tuberculosis likely contracted the disease through the consumption of 
infected beef or milk. This probably occurred in the Neolithic period ( 4000-7000 BC) 
when cattle first became domesticated (Manchester, 1984). Interestingly, this period 
corresponds with the earliest evidence of human tuberculosis (Sager et al., 1972). Most 
reports suggesting the presence of tuberculosis are based on the identification of 
tuberculous-like lesions in human skeletal remains. However, these reports should be 
cautiously interpreted as several other afflictions (for example, bacterial and fungal 
infections, trauma, and bone tumors) cause bone lesions resembling those of tuberculosis. 
Although there are reports indicating tuberculosis in humans dating back to 5000 BC, the 
earliest definitive evidence dates back to the Dynastic period (which started about 3500 
BC), where evidence of pulmonary and vertebral tuberculosis has been found in Egyptian 
mummies (Zimmerman, 1979). In addition, microscopic examination of vertebral 
lesions in these mummies revealed the presence of acid-fast bacilli, presumed to be 
M tuberculosis and M bovis. 
With the advent of the first chemotherapeutic agents for tuberculosis control in 
1952, the incidence of tuberculosis began to steadily decline in First World Countries. 
However, since 1985, First World Countries have experienced a steady increase in the 
incidence of tuberculosis (Murray, 1989; Cantwell et al., 1994). It has been suggested 
that this increase is linked to the burgeoning HIV epidemic and the emergence of multi-
drug resistant strains of M tuberculosis (Selwyn et al., 1989; Bloch et al., 1994). 
Developing countries, however, have not enjoyed any respite from this disease and 
continue to be plagued by the pathogenic effects of M tuberculosis infection. 
In 1991, in response to the increasing world incidence of tuberculosis, the World 
Health Organisation (WHO) recommended that each National Tuberculosis Programme 
institute tuberculosis control measures that work towards attaining two objectives by the 
year 2000. Firstly, to treat successfully 85% of detected smear-positive cases, and 
secondly, to detect 70% of all such cases. The vast increase in the global incidence of 
tuberculosis further prompted the WHO in March 1993 to declare tuberculosis a global 
emergency. In the same year, the WHO established a worldwide surveillance and 
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monitoring project and adopted a programme of directly observed treatment, short-course 
(DOTS) as its strategy for global tuberculosis control. The need to take 4 drugs 
(isoniazid, rifampicin, ethambutol, and pyrazinamide) for a period of 6 months has 
fostered a large amount of non-compliance with this medication in afflicted communities. 
Furthermore, non-compliance has resulted in the devlopment of partially treated 
tuberculosis and the emergence of drug-resistant M tuberculosis strains. The DOTS 
strategy seeks to bypass the non-compliance problem by ensuring that trained personnel 
directly observe tuberculosis patients to be taking their medication. Initial success ( cure 
rates of 80-90%) was achieved with using DOTS in areas of China and Africa (Murray et 
al., 1991 ; China Tuberculosis Control Collaboration, 1996). However, implementation 
of DOTS by national programmes has been slow, and in those countries where DOTS has 
been used, only a small proportion of tuberculosis patients have access to the programme. 
Despite these initial problems, DOTS has achieved a measure of success (summarised in 
Table 1.1). 
Table 1.1. Key findings of the 1999 WHO Tuberculosis Report 
1) 76% of the global population, encompassing an estimated 85% of tuberculosis patients, were living 
in countries that had adopted DOTS. However, only 35% of the global population (2.1 out of 5.8 
billion), and 35% of tuberculosis cases, lived in areas where DOTS was available. 
2) 12% of all estimated tuberculosis cases, and 16% (I 0% in 1995) of all smear-positive cases, were 
detected under DOTS. Despite these low detection rates, the detection of smear-positive cases 
using DOTS has been increasing at about I 00 000/year since 1994. At this rate the global target of 
70% case detection would be reached by 2015. However, by adding 250 000 extra cases/year 
(10% of the unnotified cases living in DOTS countries), this target could be reached by 2005. 
3) Treatment success rates under DOTS varied from 58% in the African region to over 80% in the 
American, Eastern Mediterranean and Western Pacific regions. Overall success rates (1994-1997) 
were 77-79% under DOTS and 54-57% worldwide. 
Although the benefits of DOTS are beginning to be appreciated, an 
epidemiological model of tuberculosis projects that even with optimal uptake and 
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implementation of DOTS the morbidity and mortality from tuberculosis in the next three 
decades will be enormous (Murray et al., 1998). This model predicts a total of 225 
million new cases and 79 million deaths from tuberculosis between 1998 and 2030. In 
addition, Murray et al. (1998) suggest that active case-finding by mass miniature 
radiography could save 23 million lives in the same time period. This is in direct contrast 
to the WHO recommendation of passive case-finding as the primary strategy for 
detecting tuberculosis. 
In 1908 Calmette and Guerin began work on a virulent bovine strain of 
M tuberculosis. After 13 years and 230 subcultures this strain [termed the bacillus of 
Calmette and Guerin (BCG)] lost its virulence for animals (Grange et al., 1983). The 
resulting vaccine was first used to immunise a child in 1921 and subsequently has been 
used to immunise more than 1 billion children in more than 182 countries (Huebner 
1996). There has been much speculation on the BCG vaccine as the many clinical trials 
set up to evaluate its efficacy have provided variable results (Fine & Rodrigues, 1990; 
Bloom & Fine, 1994; Colditz et al., 1994; Huebner 1996). However, there is general 
consensus that BCG vaccination protects children from disseminated disease and from 
tuberculous meningitis (Bloom et al., 1992; Rodrigues et al., 1993). With increasing age 
the degree of protection wanes resulting in little or no protection after 10-15 years 
(Styblo & Meijer, 1976; Rodrigues et al., 1993). Most clinical trials show a wide 
variation in efficacy of the BCG vaccine in adults (i.e., 0-77%), suggesting that 
childhood vaccination may be ineffective in the prevention of tuberculosis in adults 
(Bloom et al., 1992; Huebner, 1996). Murray et al. 1998 suggest that a new vaccine with 
50% efficacy could lower the incidence of tuberculosis by 36 million cases and mortality 
by 9 million cases over the next 30 years. Thus, extensions to the DOTS programme are 
required if the morbidity and mortality produced by M tuberculosis are to be curtailed 
over the next 30 years. 
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Clearly, the predicted morbidity and mortality figures resulting from 
M tuberculosis infection indicate that a cohesive and co-ordinated world collaboration 
directed towards the eradication of tuberculosis from all communities is urgently 
required. 
In this chapter, the essential features of the M tuberculosis bacillus are reviewed, 
focusing on the mechanisms used to overcome host defenses and how it establishes 
disease. In addition, recent advances in the understanding of various aspects of 
M tuberculosis biochemistry, physiology and molecular biology are discussed. 
1.2. INCIDENCE 
In the past, data reflecting the world-wide incidence of tuberculosis has been inaccurate 
and notification rates poor. Therefore, National Programmes and the scientific 
community relied on estimates. Now, through the endeavours of the WHO Tuberculosis 
Programme, accurate data and increasing notification rates are emerging that paint a 
gloomy picture, particularly in the Developing World. History has proven that the brunt 
of the tuberculosis burden falls on the disadvantaged communities of the world, and 
some suggest that it has become a useful barometer of the standard of living and equity in 
any society (Coovadia & Benatar, 1991). This is confirmed by the data recently released 
by the WHO Tuberculosis Programme that indicates a higher incidence of tuberculosis in 
Third World Countries and countries in which a significant proportion of the population 
are disadvantaged. Those countries most affected by the tuberculosis epidemic are to be 
found in Africa (including South Africa, Tanazania, Kenya, and Uganda), Asia 
(including Vietnam, Cambodia, India, and China), South America (including Peru), the 
Phillipines, and Indonesia (Figure l. lA). The highest rates of HIV /TB co-infection are 
found in sub-Saharan Africa, with significant co-infection rates also present in the rest of 
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Figure I.I. Global incidence of tuberculosis. A) Global incidence of tuberculosis and B) Global 
incidence of HIV/tuberculosis co-infection. Both maps were constructed with data from 1997 and are 










experienced a steady increase in the number of tuberculosis patients and M tuberculosis 
is now a significant player in the pathogenic microbial world of these countries. 
Amongst the reasons suggested for the increase of tuberculosis in First World 
Countries are unemployment, increasing numbers of immigrants from Third World 
Countries, the global increase in HIV infection, drug abuse, and the emergence of drug-
resistant strains (Bloom & Murray, 1992). 
The global increase in HIV infection has had a major influence on the rise of 
tuberculosis, especially in the Developed World (Bloom et al. , 1992). Since 
cell-mediated immunity is essential for controlling M tuberculosis infection, tuberculosis 
is frequently the first indication of HIV infection which characteristically has a lowered 
CD4 count resulting in a dampened cell mediated immune response (Barnes et al. , 1991; 
Jones et al., 1999). HIV-infected tuberculosis patients are more likely to present with 
extrapulmonary disease (i .e. , miliary TB, meningitis, and lymphadenitis) (Bloom et al. , 
1992) and are more likely to develop life-threatening manifestations of tuberculosis 
(Barnes et al., 1991 ). Furthermore, evidence is accumulating suggesting that tuberculosis 
may accelerate the course of HIV infection (Barnes & Modlin, 1996). With the rampant 
spread of HIV infection through the Developing World it becomes evident that to prevent 
a logarithmic increase in the number of deaths from HIV and/or tuberculosis strict 
control measures as well as novel therapies are urgently required. 
1.3. THE MYCOBACTERIAL CELL ENVELOPE 
Traditionally the mycobacterial cell envelope has generated much interest and 
excitement as it was thought to be unique and appeared to have immunogenic 
components. Accordingly, over many years, the mycobacterial cell envelope has been 
the target of enthusiastic research as investigators were hoping it contained the secret to 
the pathogenic success of M tuberculosis. However, the true contribution of the 
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mycobacterial envelope to the virulence of these pathogens remains uncertain despite 
enormous efforts to understand its structure and function. Although most of the core 
components are not unique to mycobacteria, the arrangement nevertheless is such that it 
forms a structure that is unusual and characteristic for its genus. The cell envelope 
consists of the plasma membrane, cell wall and an outer loosely attached 'capsule'. To 
date, the capsule has only been demonstrated in pathogenic mycobacterial species, 
however it is unknown whether or not the capsule is restricted to pathogenic 
mycobacteria (Daffi:~ & Etienne, 1999). 
1.3.1. Molecular composition 
I. 3.1.1. Plasma membrane 
The plasma membrane is a typical bacterial cytoplasmic membrane and within the 
mycobacteria genus all are similar (Akamatsu et al., 1966; Kumar et al., 1979; Silva & 
Faccioli, 1983). It consists of polar lipids that are assembled, in association with 
proteins, into a lipid bilayer. The main lipids are phospholipids, of which 
phosphatidylinositol mannoside (PIM), phosphatidylglycerol, cardiolipin and 
phosphatidylethanolamine predominate. Small amounts of phosphatidylinositol and 
menaquinones (2-methyl-polyprenol-1,4-naphthoquinone) are also present (Goodfellow 
& Minnikin, 1984). Ornithine lipids and the carotenoid, leprotene, have been found in 
M tuberculosis cultures, but, there appears to be uncertainty about their precise location 
(David, 1984; Laneelle et al., 1990). The fatty acid components of the phospholipids 
consist mainly of octadecenoic (stearic), octadecenoic (oleic), and tuberculostearic (10-
methyl stearic) fatty acids (Okuyama et al., 1967). The glycosylphosphopolyprenols, 
phosphodecaprenol, and phosphooctahydroheptaprenol, are thought to be plasma 
membrane associated (Takayama & Goldman, 1970; Besra & Chatterjee, 1994). 
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Another molecule thought to be plasma membrane associated 1s 
lipoarabinomanan (LAM). LAM, a polysaccharide with broad immunological activity, is 
composed of arabinose and , mannose units and is covalently linked to a 
phosphatidylinositol group (Hunter & Brennan, 1990). Although its location is unknown 
it is presumed that the phosphatidylinositol group anchors it in the plasma membrane. 
Two recently suggested models show LAM spanning the cell wall skeleton or linking the 
plasma membrane and cell wall skeleton (Daffe & Draper, 1998). Most of the arabinan 
termini are capped with oligomannosyl units (ManLAMs) in the slow growers (for 
example, M tuberculosis and M bovis) and inositolphosphate groups in the fast growers 
(for example, M smegmatis) (Chatterjee et al. , 1992; Venisse et al. , 1993; Khoo et al. , 
1995). Lipomannan, structurally related to LAM but lacking the arabinan segment, is 
probably also anchored in the cell membrane (Hunter & Brennan, 1990). 
To date, few proteins have been found associated with the plasma membrane. 
Compounding this has been the difficulty in subfractionating M tuberculosis envelope 
components and separating out contaminating polysaccharides. Lee et al. (1992) have 
shown a 16-kDa protein with some similarity to low-molecular-weight heat shock 
proteins to be the major membrane protein in M tuberculosis Erdman. The recent 
completion of the M tuberculosis genome sequence has indicated the presence of 
numerous putative membrane proteins that await experimental study. 
1.3.1.2. Cell wall 
The cell wall consists of a covalently linked cell-wall skeleton that is non-
covalently associated with a variety of glycolipids (Table 1.2), glycopeptidolipids and 
proteins. The cell-wall skeleton consists of peptidoglycan, arabinogalactan and mycolic 
acids that are all covalently linked. 
9 
The peptidoglycan layer (made up of alternating glucosamine and muramic acid 
units) forms the backbone and although similar to the commonest bacterial peptidoglycan 
(i.e., Aly), it differs in that the muramic acid is N-glycolylated instead of N-acetylated 
and the crosslinks include bonds between two diaminopimelic acid residues as well as 
between diaminopimelic acid and D-alanine (Adam et al., 1969; Wietzerbin et al., 1974). 
The next layer is comprised of arabinogalactan (AG) which is attached to the 
peptidoglycan layer by an oligosaccharide linker, galactofuranosyl, that is in turn 
attached through a phosphodiester bond to a muramic acid residue of peptidoglycan 
(McNeil et al., 1990). AG is a polysaccharide consisting of a backbone of galactose 
units with three chains of arabinose units branching off from near its reducing end (Daffe 
et al., 1990, 1993). The non-reducing termini of the arabinan chains consist of 
pentaarabinosyl residues to which the mycolic acids are attached by an ester link to 
arabinose (Azuma et al., 1968; Kanetsuna et al., 1969). These mycolic acids are 
clustered in groups of four and are present on two thirds of the pentaarabinosyl units in 
M tuberculosis (McNeil et al., 1991). The pentaarabinosyl units in other mycobacterial 
species are less mycoloylated. The mycolic acids (long-chain a-branched ~-hydroxy 
fatty acids) make up the final layer of the cell wall skeleton and have long carbon chain 
lengths (50 to 60 carbon atoms with a branched a-side chain containing another 24 
carbon atoms). This confers wax-like properties, hence contributing to the 
hydrophobicity and impermeability of the envelope. 
1.3.1.3. Capsule 
The presence of a mycobacterial capsule has been a topic of debate for some time 
(reviewed in Daffe & Etienne, 1999). Technical artefacts cast doubt over the 
electronmicroscopic detection of an electron transparent zone (ETZ) outside the bacterial 
wall but surrounded by the phagosomal membrane. However, as electron microscopic 
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techniques have been improved, the existence of a capsule now has greater credibility. 
This has been mainly due to improved electron microscopy sample preparation afforded 
by embedding mycobacteria using the freeze-substitution technique (Graham & 
Beveridge, 1990; Paul & Beveridge, 1992, 1994). This technique has improved the 
ultrastructural visualisation of the outer layer of the envelope, by maintaining the 
integrity of hydrated structures and minimising lipid extraction, thereby stabilising cell 
structures. 
Using both physical (glass-bead agitation) and detergent extraction techniques, 
the components of the capsule have been recently characterised and demonstrated to 
consist mainly of polysaccharides and protein (Ortalo-Magne et al. , 1995). There is 
inter-species variation in the ratio of these 2 components with polysaccharides the 
predominant constituent m pathogenic species (M tuberculosis, M kansasii, and 
M gastri) and protein m non-pathogenic species (M smegmatis and M phlei) 
(Ortalo-Magne et al. , 1995; Lemassu et al., 1996). The major polysaccharides are a 
100-kDa D-glucan (the major capsular polysaccharide in M tuberculosis), 13-kDa 
D-arabino-D-mannan (in slow-growing mycobacteria the D-arabinan segment is capped 
on the non-reducing ends by oligomannosides), and a 4-kDa D-mannan. Small amounts 
of uncharacterised oligo- and polysaccharides are also present. 
There appears to be a mixture of secreted, cell envelope-associated, or 
cytoplasmic membrane-anchored proteins. Examples, in M tuberculosis, of the many 
surface-exposed proteins are alanine dehydrogenase (Andersen et al. , 1992), the 19-kDa 
and 38-kDa lipoproteins (Garbe et al., 1993), and the 30/31-kDa fibronectin-binding 
proteins (Wiker & Harboe, 1992). Raynaud et al. (1998) demonstrated the presence of 8 
enzymes in the culture filtrates and/or cell surfaces of pathogenic mycobacteria 
(M tuberculosis and M bovis). In non-pathogenic mycobacteria (M smegmatis and 
M phlei) these enzymes were present deeper in the cell envelope. 
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Ortalo-Magne et al. (1995) have argued against the common belief that the 
capsule is predominantly made up of lipid. They have shown that lipid only comprises 2-
5% of outer capsular constituents. Most lipid (Table 1.2) is in the inner part of the 
capsule with the acyl trehaloses [dimycolyl trehalose (cord factor), sulfatides] 
predominating. Some phospholipids (e.g., PIM), species-specific lipids (e.g., 
dimycocerosate of phthiocerol), type-specific lipids [ e.g., phenolic glycolipids (PGL ), 
lipooligosaccharides (LOS)] and glycopeptidolipids (glycoconjugates unique to 
mycobacteria and not found in PGL-containing species) are present in the outer layer of 
the capsule (Ortalo-Magne' et al., 1996b). 
Table 1.2. Distribution of glycolipids in mycobacteria 
Compound Pathogenic species Non-pathogenic species 
Trehalose dimycolate M. tuberculosis, M. bovis, M. avium, M. smegmatis, M. phlei, 
(TDM) M. kansasii, M. parafortuitum, and others 
others 
Sulfatides M. tuberculosis 
Polyphthienoyl trehalose M. tuberculosis 
Polyphleoyl trehalose M. smegmatis, M. phlei 
2,3 diacyltrehalose M. tuberculosis, M. africanum, 
(DAT) M. bovis, M. fortuitum 
Lipooligosaccharides M. tuberculosis, M. kansasii, M. smegmatis, M. gastri 
M. malmoense, M. szulgai, M. 
gordonae, M. paratuberculosis, 
M. fortuitum, M. mucogenicum, and 
others 
Glycopeptidolipids M. paratuberculosis, M. simiae, M. smegmatis 
(GPL) M. fortuitum, M. lepraemurium, 
M. chelonae, M. peregrinun, M. 
porcinum, M. senegalense, M. 
abscessus, MAIS complex 
Phenolic glycolipids M. tuberculosis, M. leprae, M. bovis, M. gastri 
(PGL) M. marinum, M. kansasii, M. ulcerans, 
M. haemophilum 
Phosphotidylinositol All mycobacterial species 
mannosides (PIM) 
Adapted from Vergne & Daffi\ (1998) 
Most of the polysaccharides and proteins present on the cell surface were also 
detected in M tuberculosis culture filtrates. This suggests that in vitro the capsule is 
shed into the medium (Ortalo-Magne' et al., 1995). Therefore, Daffe & Draper (1998) 
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suggest that in an intracellular environment this shed material (predominantly 
polysaccharides and proteins) could be retained by the phagosomal membrane and may 
contribute to the 'electron transparent zone' seen on EM sections of pathogenic 
mycobacteria within host cells. 
1.3.2. Ultrastructure 
The three components of the cell wall skeleton are covalently linked forming a 
semi-rigid supramolecular structure (Figure 1.2). 








Figure 1.2: Ultrastructure of the M. tuberculosis cell envelope. Schematic representation of the 
structural components making up the cell envelope, i.e. , cell membrane, cell wall skeleton (CWS), and 
capsule. Key: ff , phospholipids; tll , protein; e , glucose, glucosamine, and muramic acid; o , galactose; 
e, arabinose; ? , galactofuranosyl linker; fJ , pentaarabinosyl units; • , mannose; t , glycolipids; o , 
polysccharide. 
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The hydrophobic mycolic acids are thought to be arranged perpendicular to the 
arabinogalactan-peptidoglycan layer and are covered by an outer leaflet of free wall 
lipids interdigitating between them (Minnikin, 1982). Hence, the whole structure forms 
an asymmetric lipid bilayer. The presence of this lipid bilayer is consistent with X-ray 
diffraction studies (Nikaido et al., 1993) and electron microscopy (Draper, 1982). In 
addition, by freeze-fracture microscopy, Rastogi et al. (1991) revealed the presence of 
two distinct cleavage planes. The inner cleavage plane incorporates the cell membrane 
and it is presumed that the outer cleavage plane incorporates the mycolic acids and free 
wall-lipids. The outer lipid bilayer is covered, in turn, by the capsule composed of 
polysaccharides, protein, and some lipid. The mycolic acid layer and the outer leaflet of 
glycolipids are together responsible for the extreme lipophilicity and waxiness of the 
envelope. 
1.3.3. Envelope components and virulence 
Although there are no definitive data yet, it is likely that the mycobacterial cell 
envelope contributes to the pathogenicity of the bacterium. The structure of the envelope 
ensures that there is an impermeable barrier between the bacillus and the host, and the 
envelope contains components that are resistant to host defence mechanisms (Daffe & 
Etienne, 1999). In addition to affording passive protection, some envelope components 
have been implicated in active processes. Many believe that the tissue pathology 
characteristic of advanced tuberculous disease is the consequence of a maladjusted 
immune system. In this regard some envelope components have been implicated in 
immune system modulation. LAM, cord factor, and sulpholipid 1 can stimulate tumor 
necrosis factor (TNF)-a release from macrophages (Silva & Faccioli, 1988; Moreno et 
al., 1989; Brozna et al., 1991 ); LAM and sulpholipid 1 are able to inhibit activation by 
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interferon (IFN)-y (Pabst et al., 1988; Hunter et al., 1988); phenolic glycolipids and 
arabinomannan are immunosuppressive (Ellner et al., 1979; Fournie et al., 1989); and 
PIM is able to inhibit proliferation of peripheral blood monocytes. Furthermore, LAM 
can induce IL-1, IL-6 and IL-10 production (Barnes et al., 1992); inhibit induction of 
MHC Class 2 genes (Chan et al., 1991 ); inhibit T-cell proliferation (Moreno et al., 1989); 
and inhibit IL-2, IL-5, and GM-CSF gene transcription (Chujor et al., 1992). Apart from 
immunomodulation, sulpholipid 1 has been implicated in inhibition of phagosome-
lysosome fusion (Goren et al., 1976), and suppression of protein kinase C and the 
oxidative activity of phagocytes (Brozna et al., 1991 ). 
The spectrum of potentially pathogenic effects of LAM extend to the scavenging 
of reactive oxygen intermediates (Chan et al., 1991 ), stimulation of nitric oxide (Adams 
et al., 1993), induction of macrophage early response genes (Roach et al., 1994), and 
inhibition of protein kinase C (Adams et al., 1993). The multitude of potentially 
pathogenic effects of LAM have ensured it much attention as the prime candidate for a 
virulence factor. However, the debate regarding the location of LAM and the fact that 
LAM is present in both pathogenic and non-pathogenic strains have made the 
interpretation of this data, in the context of it as a virulence factor, confusing. In 
advanced mycobacterial disease, envelope components from dead or dying bacilli have 
been shown to be toxic and highly antigenic (Goren, 1982; Bloch, 1995). This may be 
responsible for the intense cell-mediated reaction that is characteristic of advanced 
disease and which may be partly responsible for the observed tissue destruction. 
The contribution by the cell envelope to intracellular survival of M tuberculosis 
is discussed further in section 1.6.2. 
The evidence reviewed here and in the literature is probably sufficient to 
implicate the mycobacterial cell envelope in the pathogenicity of M tuberculosis. 
However, it is not sufficient to completely explain the difference in virulence between 
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the pathogenic and non-pathogenic mycobacterial species, whose cell envelopes 
essentially share the same structure and maJor components. Thus, by itself, the 
mycobacterial cell envelope cannot account for all the differences in virulence between 
pathogenic and non-pathogenic mycobacteria, and additional factors must play a 
significant role. 
1.4. METABOLISM AND NUTRITION 
The hallmark of M tuberculosis growth is its slow doubling time of 12-20 hours 
compared to the 20 min of E. coli and the 1-2 hours of fast-growing members of the 
mycobacterium genus (M smegmatis, M fortuitum , M chelonei) (Wheeler & Ratledge, 
1988). This difference in growth rate incited researchers to suggest a vastly different 
metabolism in M tuberculosis and a possible association with virulence. However, no 
fundamental difference in the metabolism of M tuberculosis and other bacteria has been 
uncovered and no explanation for this phenomenon was given (Ratledge, 1982; Wheeler 
& Ratledge, 1988). In addition, slow growth does not correlate with virulence as 
M tuberculosis shares this characteristic with avirulent M bovis BCG and low-virulence 
mycobacteria such as M avium, M intracellulare, M scrofulaceum and M kansasii 
(Pascopella et al. , 1992). Attempts to explain the phenomenon of exceptionally slow 
growth rate on the basis of substrate limitation imposed by the thick cell wall and/or the 
scarcity of ribosomal RNA genes (1 in M tuberculosis vs 7 in E. coli) are not convincing 
in the face of large variations of growth rates among mycobacterial species that share 
these properties (Hiriyanna & Ramakrishnan, 1986; Wheeler & Ratledge, 1988). 
Although the in vitro nutritional requirements of M tuberculosis are rather simple 
[simple carbon source (e.g. , glycerol), inorganic nitrogen (NH/), inorganic elements and 
trace elements] the in vivo scenario is likely to be quite different. Residence inside a 
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macrophage or a granuloma is likley to impose some nutritional restrictions on
 the 
bacillus. It is noteworthy then that the recent completion of the M tuberculosis gen
ome 
sequence has revealed the presence of a diverse array of genes potentially involved in
 the 
M tuberculosis metabolic machinery (Cole et al., 1998). Genes required for
 the 
synthesis of all the essential amino acids, vitamins and enzyme co-factors have 
been 
identified, as well as the enzymes necessary for glycolysis, the pentose phosp
hate 
pathway, and the tricarboxylic acid and glyoxylate cylces. Furthermore, sequ
ence 
information suggests that M tuberculosis can metabolise carbohydrates, hydrocarb
ons, 
alcohols, ketones, and carboxylic acids. 
Due to the variety and quantity of lipids available in mammalian cells and the 
tubercle, it has been suggested that in vivo M tuberculosis is likely to be lipolytic 
(splitting up of fat) rather than lipogenic (forming fat) (Wheeler & Ratledge, 19
94). 
Indeed the genome sequence has indicated the presence of - 250 distinct enzy
mes 
involved in fatty acid metabolism ( compared to the - 50 enzymes in E. co
li) 
(Cole et al. , 1998). Furthermore, fatty acid transporter proteins have recently been fo
und 
in M tuberculosis (Hirsch et al. , 1998). 
Another source of carbon could be the degradation of proteins and in this regard 
proteases may play a significant role. Although not much is known a
bout 
M tuberculosis proteases, the M tuberculosis genome sequence has indicated
 the 
presence of in excess of 20 putative protease genes, some of them encoding secr
eted 
proteases. In addition, a gelatinase has been detected in pathogenic mycobact
erial 
species but not in nonpathogenic members (Kannan et al., 1987) and a Ca
2+-dependent 
protease with elastolytic (splitting up of elastin) activity has been detected in statio
nary 
phase M tuberculosis culture filtrates (Rowland et al., 1997). Further evid
ence 
favouring the ability of M tuberculosis to degrade macromolecules has been
 the 
demonstration of 22 extracellular enzyme activities in the culture filtrates and/or surf
ace-
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located material of M tuberculosis (Raynaud et al., 1998). Of these, the location of 8 
was unique to pathogenic strains whereas in nonpathogenic strains these 8 enzymes were 
located more deeply in the cell envelopes. The ability to break down macromolecules 
extracellularly would necessitate the ability to transport the breakdown products into the 
bacterium. In this regard a number of transport proteins and putative transport proteins 
have been identified. Apart from the fatty acid transporter protein already mentioned, 
M tuberculosis possesses a 3 8 kDa phosphate-binding protein [present in the cell 
envelope and its expression is increased by phosphate-starvation (Espitia et al., 1992)] 
and iron-transport proteins. In addition, scrutiny of the M tuberculosis genome reveales 
the presence of a number of putative transport proteins. 
An intracellular residence may also limit the bacterium's access to a nitrogen 
source. Again, M tuberculosis appears to possess an array of enzymes (for example, 
alanine dehydrogenase, glutamine synthetase, urease, aminopeptidases, and amidases) 
potentially involved in nitrogen acquisition. At least two of these enzymes, alanine 
dehydrogenase and glutamine synthetase, are located on the surface and present in higher 
quantities in the culture supernatants of pathogenic mycobacteria than their 
nonpathogenic counterparts (Andersen et al., 1992; Harth et al., 1994; Raynaud et al., 
1998). The M tuberculosis urease was shown to be active over a wide pH range and 
expression of this enzyme was increased 10-fold upon nitrogen-deprivation (Clemens et 
al., 1995b ). This would suggest that urease plays an important role in nitrogen 
acquisition, possibly also under adverse conditions. 
Iron acquisition is deemed essential for in vivo growth of bacteria and 
M tuberculosis is again able to meet the challenge by producing two high-affinity iron 
binding molecules (siderophores), mycobactin (cell-associated) and exochelin (secreted). 
These proteins are also present in other members of the mycobacteriaceae family and, 
although there is substantial inter-species variation in the amount of siderophore 
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production, it cannot be correlated with virulence (Barclay & Ratledge, 1988). 
M tuberculosis has 4 mycobactins which are present in both virulent and avirulent 
strains but no structural analysis has been published on these proteins (Barclay & 
Ratledge, 1988). The exochelins bind iron in the extracellular environment, transfer it to 
the mycobactins which then facilitate the transport of iron through the plasma membrane 
to the interior of the bacterium. Although structural information on the exochelins is 
sparse, the preliminary data suggest that those from slow-growing mycobacteria are 
structurally distinct from those of rapidly growing mycobacteria (Gordon & Andrew, 
1996). Furthermore, M tuberculosis exochelins are able to remove iron from the human 
iron-binding proteins, transferrin and lactoferrin (Gobin & Horwitz, 1996), suggesting 
that the ability of M tuberculosis to acquire iron from various sources may be related to 
virulence. However, definitive evidence linking iron acquisition to virulence is lacking 
and will require generation of the appropriate mutants . 
In addition to the presence of numerous metabolic pathways, the metabolic 
versatility of M tuberculosis is highlighted further by its ability to survive starvation. 
This bacterium has been shown to be able to remain viable without any access to 
nutrients, suggesting that, in some unknown way, it is able to shut down its metabolism 
(Nyka, 1974). This "starved-state" is, however, associated with some morphological 
changes in that the starved bacillus loses its acid fastness and is resistant to any form of 
staining (chromophobicity) (Nyka, 1974; Barclay & Ratledge, 1989). Chromophobic 
bacilli have been isolated from chronic, caseous lesions (Nyka, 197 4 ). 
In summary, the above data describe a highly adaptable organism, one that grows 
in a metabolically active, acid-fast form when conditions are favourable, and rapidly 
switches to an inactive chromophobic state under adverse conditions of starvation and 
hypoxia. The latter state would be consistent with its predicted in vivo behaviour where 
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it appears to be able to remain dormant for many years only to reactivate and cause 
disease. 
1.5. MACROPHAGE RECEPTORS USED BY M TUBERCULOSIS 
The ability of M tuberculosis to establish disease appears to be critically 
dependant on its ability to invade and survive within host mononuclear phagocytic cells 
(namely, macrophages). M tuberculosis gains entry via a number of receptors present on 
the surface of the macrophage. Some investigators have proposed that the intracellular 
fate of the bacillus may be determined, in part, by the receptor to which it binds. 
Consequently, this has become an area of active research. In vitro the bacillus is able to 
bind opsonically to a wide range of receptors that includes complement receptor (CR) 
types 1, 3 and 4, the mannose receptor (MR), surfactant protein A receptor (SFA-r), 
CD 14 ( on microglial cells), macrophage scavenger receptors, and the F c receptor. In 
addition, M tuberculosis can bind directly (non-opsonically) to CR3, CR4, the mannose 
receptor, and CD14. The preferred receptor/sin vivo are unknown. 
CR3 , a prinicipal phagocytic receptor on monocytes and neutrophils, has been the 
focus of avid research as it is used by a diverse group of intracellular pathogens (Falkow 
et al. , 1992; Isberg & Tran Van Nhieu, 1994). Furthermore, as a member of the 
P2-integrin family, it is likely to be involved in signal transduction pathways and 
cytoskeletal rearrangements. It expresses a broad ligand specificity that includes 
complement component C3bi (the best documented ligand), various extracellular 
proteins, bacterial proteins, and microbial oligo- and polysaccharides (Ehlers & Daffo, 
1998). In vitro , M tuberculosis is able to bind opsonically (CR3 is the dominant receptor 
for complement-opsonised particles) and non-opsonically to CR3 (Schlesinger et al. , 
1990; Hirsch et al. , 1994a; Cywes et al. , 1996). The former is usually to the C3bi 
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binding site while the latter is to the lectin site (Cywes et al. , 1997). Binding to the lectin 
site is probably mediated by envelope polysaccharides, including a D-glucan. 
The ability of M tuberculosis to bind opsonically depends on the availability of 
C3bi. Apart from activating the alternative pathway of complement activation, 
M tuberculosis is able to generate C3 bi by recruiting complement component C2a to 
form a C3 convertase on the surface (Schorey et al. , 1997). This results in cleavage of 
C3 to C3b, which is then deposited on the bacterial surface. Although C3b binds to CRl, 
cleavage of C3b by factor I (synthesised in the lung) generates C3bi, thus promoting 
binding to CR3. Furthermore, this C2a-mediated C3 cleavage is only present in 
pathogenic mycobacteria, suggesting that it may be a virulence factor. Direct binding to 
the p-glucan lectin site results in rapid phagocytosis by unactivated mononuclear 
phagocytes. This is in direct contrast to C3bi-opsonised particles that are able to bind, 
but without the presence of inflammatory mediators no internalisation occurs (Sampson 
et al., 1991 ). Thus, direct binding may provide an efficient way of promoting bacillus 
uptake by mononuclear phagocytes in the uninflamed lung. In addition, entry via this 
receptor may be beneficial for intracellular survival as it has been shown to result in a 
diminished or absent respiratory burst (Wright & Silverstein, 1983; Berton et al., 1992). 
However, direct proof that CR3-mediated entry is beneficial for intracellular survival is 
still needed. 
CR4 is also a member of the P2-integrin family and has been shown to be the 
predominant integrin receptor on the macrophage (Zaffran et al., 1998). M tuberculosis 
can bind both directly and opsonically to this receptor (Schlesinger et al. , 1990; Hirsch et 
al., 1994a; Zaffran et al., 1998; Schlesinger et al. , 1990). In addition, binding to this 
receptor resulted in rapid tyrosine phosphorylation of a major 60 k.Da macrophage 
protein, presumed to play a role in M tuberculosis phagocytosis. The ligand and 
binding-site involved in direct binding are unknown. 
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The mannose receptor (MR) is a C-type lectin that is only present on mature 
macrophages. It mediates attachment to glycoconjugates terminating in mannose, fucose 
and N-acetylglucosamine. This receptor is able to promote the uptake of virulent M 
tuberculosis (for example, Erdman and H37Rv), but not avirulent M tuberculosis 
H37Ra, by human monocyte-derived macrophages (Schlesinger, 1993). Since it is 
strongly downregulated by inflammatory mediators, including mycobacterial antigens, 
the MR probably plays an important part in promoting uptake of M tuberculosis by 
alveolar macrophages in the uninflamed lung (Mokoena & Gordon, 1985; Schreiber et 
al., 1993). Its role after the initial infection is probably minor. Although its ligand is 
unknown, some researchers consider mannose-capped LAM to be a leading candidate 
(Schlesinger et al., 1996). The problem with this is that the location of LAM is unknown 
and may not be on the bacterial surface (Ortalo-Magne et al., 1995; Ortalo-Magne et al. , 
1996a). Hence, it may not be available for binding to MR. There are other possible 
candidates, including neutral, nonacylated arabinomannan and phosphatidylinositol 
mannoside (PIM). 
Surfactant protein A (SP-A), present in alveolar fluid, may play a role in the 
pathogenesis of tuberculosis as it is present at the site of initial inoculation. This protein, 
together with the mannose binding protein (MBP) and complement component Clq, is a 
member of the collectin family (C-type lectins with an added collagenous region). These 
molecules are able to bind to cell surface receptors, probably mediated by the collagen-
like domain. SP-A has been shown to bind to at least two distinct receptors: a) ClqRp - a 
126-kDa protein that is expressed on monocytes, macrophages, neutrophils and 
endothelial cells (Nepomuceno et al. , 1997); and b) SPR210 - a 210-kDa that is 
expressed on type II pneumocytes and macrophages (Chroneos et al., 1996). CRl is able 
to bind Clq with high affinity, and therefore, although it remains to be demonstrated, it 
may be an additional receptor for SP-A (Klickstein et al., 1997). Opsonisation with SP-
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A enhances macrophage binding and uptake of M tuberculosis (Downing et al., 1995), 
and opsonisation with MBP enhances binding of M tuberculosis to endothelial cells, 
fibroblasts, and type II pneumocytes (Hoppe et al., 1997). Thus this may be a 
mechanism utilised by the bacterium to enter both phagocytic and non-phagocytic cells. 
The advantage conferred on the organism by using this mode of entry remains to be 
elucidated. 
CD14 (a phosphatidylinositol glycan-linked membrane protein) can bind LAM of 
M tuberculosis H37Ra and induce the production of interleukin (IL)-8 (Pugin et al. , 
1994). In addition, microglial cells have been shown to be able to bind M tuberculosis 
using CD 14 (Peterson et al., 1995). Although this is followed by internalisation, it is 
unclear whether CD 14 is assisted by another protein. 
Scavenger receptors ( class A) on human mononuclear phagocytes have been 
shown to bind M tuberculosis Erdman (Zimmerli et al., 1996). The likely ligands may 
be sulfatides as they have been demonstrated to compete with other ligands for class A 
scavenger receptor binding (Ernst, 1998). Whether these receptors are able to activate 
the cytoskeleton or whether they achieve internalisation through the use of other 
receptors remains to be elucidated. 
1.6. PATHOGENESIS 
1.6.1. Overview 
The ability of M tuberculosis to establish disease appears to be critically 
dependant on its ability to invade and survive in host mononuclear phagocytes, primarily 
macrophages. The extent to which this is possible is a consequence of the balance 
between the inherent microbicidal power of the host macrophage and the dose and 
virulence of the invading bacilli (Dannenberg, 1991; Dannenberg & Rook, 1994). The 
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degree of damage appears to be a direct result of the interplay between a vigorous tissue-
damaging cell-mediated immune response and ill-defined bacterial virulence factors. 
M tuberculosis commonly enters the body via the inhalation of small aerosol 
droplets (1-2 µm) that pass into the lower respiratory tract. In humans, the inhalation of 
M tuberculosis is followed by one of four potential outcomes: 1) all bacilli are killed by 
the host's immune response with no potential for tuberculosis in the future; 2) the bacilli 
may grow, multiply and cause clinical disease (referred to as primary infection); 3) the 
bacilli may become dormant and never cause disease (referred to as latent infection), in 
which case the only sign of exposure is a positive tuberculin skin test; and 4) the latent 
organisms may replicate again and cause clinical disease (referred to as reactivation). 
Although M tuberculosis has been shown to invade non-phagocytic cells in vitro, 
no evidence has yet been presented that this happens in vivo (Hoppe et al. , 1997; 
Birkness et al. , 1999) . Thus, the contribution of epithelial and other non-phagocytic 
cells lining the respiratory tract is unknown. It has been universally accepted that the 
alveolar macrophage represents the first line of the host defense in the airway. These 
cells are constitutively phagocytic, and are able to rapidly phagocytose the inhaled 
bacilli. M tuberculosis gains entry into alveolar macrophages via a number of receptors 
present on the surface of the macrophage (reviewed in section 1.5). It has been suggested 
that receptor choice may determine the intracellular fate of the phagocytosed bacilli, 
however this remains to be conclusively demonstrated. 
The microbicidal activity of the macrophage ensures that the majority of 
tuberculosis infections are arrested at this initial stage. Only 10% of individuals exposed 
to M tuberculosis will develop clinical disease and those with latent infection have a 5-
10% lifetime risk of developing disease, indicating how effective the host' s defense 
mechanisms are in preventing disease (Israel et al. , 1994). In these individuals the only 
signs of infection may be a positive tuberculin skin test or a small, calcified lung lesion 
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seen on a chest X-ray. In some instances, however, the bacilli are able to resist the 
microbicidal activity of the alveolar macrophage and survive. 
The intracellular survival strategies utilised by M tuberculosis (reviewed in 
section 1.6.2) are incompletely understood at this time but have been suggested to hinge 
on the ability of the bacillus to avoid a respiratory burst upon phagocytosis, to effectively 
neutralise toxic oxygen and nitrogen intermediates, and to avoid phagolysosome fusion 
(Wright & Silverstein, 1983; Berton et al., 1992; Chan et al., 1992; Armstrong & 
Hart, 1971). The bacilli that are not killed by the alveolar macrophage multiply, cause 
lysis of the cell and are released. The released bacilli are then further phagocytosed by 
alveolar macrophages and nonactivated macrophages (Dannenberg, 1991). The latter 
cells are blood monocytes that have been attracted by released bacilli, cellular debris and 
chemotactic factors (C5a, cytokines, etc). As this lesion develops, the incoming 
immature macrophages begin to play a more dominant role as they are able to get to the 
center of the lesion where the bacilli reside, whereas the alveolar macrophages tend to be 
more peripheral. Dannenberg (1991) refers to this as the symbiotic stage ( occuring 7-21 
days postinfection) as neither bacillus nor macrophage is able to inflict any damage to 
one another. During this time logarithmic growth of the bacilli occurs unhindered, as the 
macrophages are not activated and are therefore unable to kill the multiplying bacilli. 
Thus, increasing numbers of macrophages and bacilli accumulate in the lesion. 
The cytoplasm of unactivated macrophages appears to be a good growth medium for 
M tuberculosis and active growth occurs (Danenberd & Rook, 1994). The host attempts 
to remove this favourable environment by destroying the cells in which the multiplying 
bacilli reside. This is evident by the development of caseous necrosis. Removal of the 
favourable intracellular environment results in exposure of the bacilli to the unfavourable 
conditions of solid caseous material (low pH, anoxia, nutrient depletion), inhibition of 
growth and phagocytosis of bacilli by activated macrophages with antimycobacterial 
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activity (Poole et al., 1970). The development of caseous necrosis stops logarithmic 
growth of intracellular bacilli, suggesting a potential benefit to the host. However, the 
host achieves this through the sacrifice of some of its tissue (Canetti, 1955; Poole et al., 
1970). 
The cause of caseous necrosis has become an area of contention. Dannenberg 
(1991) suggests that necrosis is a consequence of the development of delayed-type 
hypersensitivity to bacillus components that are released upon macrophage lysis. Orme 
(1998), however, disagrees and postulates that the centers necrose because the 
concentration of cytokines reaching these cells is too low or absent, thus allowing 
subsequent degeneration. He bases this on the observation that, after several weeks, 
epithelioid cells in the center of granulomas in rabbits and guinea-pigs begin to 
degenerate and become necrotic whereas in mice this does not occur. The granulomas in 
rabbits and guinea-pigs are surrounded by a mantle of lymphocytes whereas mice have 
rafts or wedges of lymphocytes that penetrate through extensive sections. Thus, in rabbit 
and guinea-pig granulomas, it is likely that insufficient cytokines will reach the central 
cells, these cells will not become activated and will eventually degenerate. In contrast, 
the presence of lymphocytes through large sections of mice granulomas ensures 
sufficient cytokines reaching cells, thus preventing degeneration. Keane et al. (1997) 
propose that apoptosis of M tuberculosis-infected macrophages also plays a role in the 
development of caseous necrosis. They showed that M tuberculosis infection of 
macrophages in vitro induced apoptosis and that this appeared to be mediated by TNF-a. 
In addition, there was evidence of apoptosis in sections from active tuberculous 
granulomas, but not quiescent lesions. 
Whatever the cause of caseous necrosis, it appears that the host attempts to kill 
the invading pathogens at the expense of its own cells and tissues. The purpose of the 
tissue-damaging component of the immune response is to localise the bacilli to the 
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caseous center thus preventing disease progression. It is usually achieved when there are 
a small number of bacilli; however, when large numbers are present extension of the 
caseous focus is possible. Many unactivated macrophages and lymphocytes accumulate 
around the caseous center. Only activated macrophages have mycobactericidal activity, 
so the host's ability to prevent disease progression now rests on its ability to activate the 
surrounding macrophages. This is usually accomplished by T-lymphocytes, attracted and 
activated by macrophage-produced cytokines, that, in turn, produce lymphokines that 
activate macrophages. There is evidence that the cytokines interleukin (IL)-8, tumor 
necrosis factor (TNF)-a and IL-IP play a role in attracting and activating T-lymphocytes. 
Alveolar macrophages obtained by bronchoalveolar lavage (BAL) in patients with 
tuberculosis have been shown to release elevated levels ofIL-8 (Law et al., 1996a), TNF-
a and IL-1 p (Law et al. , 1996b ). In addition, intact mycobacteria, their cell wall 
components (e.g. , LAM) and secreted proteins (e.g. , 20 kDa and 46 kDa proteins) 
stimulate the release of these compounds from macrophages (Zhang et al. , 1995). 
TNF-a plays a central role in the host's ability to restrict M tuberculosis 
infection. Experimental data (from both animals and humans) have revealed the 
importance of TNF-a in the following: inducing granuloma formation in BCG infection 
(Kindler et al., 1989); enhancing the antimycobacterial activity of macrophages (Flesch 
& Kaufmann, 1990); mouse survival of M tuberculosis infection (Flynn et al. , 1995); 
and growth inhibition of M tuberculosis in human alveolar macrophages (Hirsch et al., 
1994a). In addition, Silver et al. (1998) showed that production of TNF-a by 
mononuclear phagocytes is greater with increasing strain virulence. However, apart from 
its potential protective function, TNF-a (and IL-IP) has also been implicated in the 
weight loss, night sweats and tissue necrosis characteristic of active tuberculosis 
(Takashima et al. , 1990). Macrophages infected with virulent M tuberculosis are more 
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susceptible to TNF-a-induced cytotoxicity than those infected with attenuated or 
avirulent strains (Filley et al. , 1999), prompting some investigators to question whether 
the ability of M tuberculosis to stimulate TNF-a production serves primarily to promote 
pathogenesis rather than protection. These cytokines, however, probably play a critical 
role in attracting and activating T-lymphocytes, essential for protection against 
M tuberculosis. 
The importance of the CD4+ helper T cell subset has now become well-
established; however, evidence is mounting implicating CD4+ and CD8+ cytotoxic T cells 
(CTLs), y'6 T cells and CD4-CD8- T cells in the host's immune response (reviewed in 
section 1. 7). The immune system networks involved in host defense against 
M tuberculosis are complex and, as such, the literature contains conflicting experimental 
data. This is likely a result of different experimental methodologies and the difficulties 
experienced in attempting to approximate in vivo conditions. Despite these difficulties, 
the greater body of work supports a TH 1 response (T1-11/T H2 cells are subsets of T helper 
cells differentiated in vitro according to the blends of cytokines they produce) to 
M tuberculosis infection (Schluger et al., 1998; Ellner, 1999). Therefore, in the context 
of M tuberculosis infection, it appears that the CD4+ helper T cells amplify the immune 
response by activating macrophages (helped by CD8+ T cells, and also y'6 T cells and 
CD4-CD8- T cells) and recruiting new immune cells to the site of the lesion (Stenger & 
Modlin, 1999). The CD4+ and CD8+ CTL's lyse unactivated macrophages laden with 
M tuberculosis bacilli releasing them for uptake by activated macrophages that have 
antimycobacterial activity. In addition, lysis by CD8+ CTL's can result in direct killing 
of M tuberculosis (Stenger et al., 1998). The y'6 T cells and CD4-CD8- T cells control 
inflammation by lysing T cells, thereby dampening the immune response and preventing 
extensive tissue injury. 
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The extent of disease depends on the balance between an exuberant tissue-
damaging immune response and a more focussed antimycobacterial cell-mediated 
immune (CMI) response in inhibiting M tuberculosis multiplication. In sensitive hosts 
the bacilli that are released at the edge of the caseous center are taken up by unactivated 
macrophages and the tissue-damaging response is continued in order to stop intracellular 
bacillary multiplication (Lurie, 1964; Dannenberg, 1991 ). Thus the caseous center 
enlarges and, as more and more local lung tissue is destroyed, there is increased potential 
to erode into the lymphatics and bloodstream with dissemination to extrapulmonary sites. 
In the resistant host, the strong CMI ensures that there are enough activated macrophages 
surrounding the caseous center to phagocytose and destroy released bacilli. With time 
the primary tubercle becomes walled off, the caseous center is resorbed, fibrous tissue is 
deposited and the disease is arrested. Dystrophic calcification may occur at the site of 
caseous necrosis. The bacilli that were able to disseminate are either destroyed at their 
metastatic site or reside there in a dormant state (Dannenberg & Rook, 1994). 
Sometimes, even with a strong CMI response, progressive disease occurs 
resulting in liquefaction of the caseous center and ultimately cavity formation (Canetti, 
1955; Lurie, 1964; Dannenberg & Rook, 1994). The factors that cause liquefaction are 
unknown. The liquefied material is a good growth medium for M tuberculosis and 
unhindered extracellular growth occurs (Dannenberg, 1991; Dannenberg & Rook, 1994). 
This material can drain into neighbouring bronchi and alveoli, causing a broncho- or 
lobar pneumonia and/or allowing a large number of bacilli to be spread with coughing to 
the outside (Bloom & Murray, 1992). Erosion into blood vessels can result in 
haemoptysis and/or haematogenous dissemination to extrapulmonary sites. 
An effective chemotherapeutic regimen comprising at least 3-4 antibiotics usually 
results in clinical improvement and cure of active disease. However, the prolonged 
duration of such chemotherapy (usually a minimum of 6 months) fosters non-
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compliance, making relapse of active disease a common feature, especially in Third 
World Countries. Clearly, an effective vaccine would be optimum for the control of 
tuberculosis in these communities. Since the concept of dormant bacilli encompasses a 
bacterium in which the metabolism has been down-regulated, it is likely then that these 
bacteria will not be affected by current chemotherapeutic agents, whose modes of action 
are directed at various metabolic pathways. Thus, dormant bacilli remain resident in 
human tissues for many years and retain the ability to cause active disease. The 
conditions required to reactivate these bacilli are unknown but may include various 
clinical states that involve some degree of immunosuppression. Clinicians suggest that 
most adult tuberculous disease is a consequence of reactivation rather than new or 
re-infection (Coovadia & Benatar, 1991). 
1.6.2. Intracellular survival 
Intracellular survival strategies have been an area of active research, generating 
data which have yielded some insights into the possible mechanisms, but no definitive 
conclusions have been reached. 
1.6.2.1. Barrier 
The unique structure of the mycobacterial cell envelope may promote 
intracellular survival by presenting a barrier that is impermeable and impervious to 
microbicidal macromolecules (for example, degradative enzymes and bactericidal 
peptides) and contains structures that are resistant to degradation by host enzymes (Daffe 
& Draper, 1998). 
1.6.2.2. Respiratory burst 
An important part of the microbicidal activity of the macrophage is the 
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respiratory burst, which generates reactive oxygen intermediates (Off, H202, 02-) that 
kill invading bacteria and other pathogens. It is in this context that envelope/capsular 
components may play an important role. Entry into a macrophage via the CR3 receptor 
does not elicit a respiratory burst. Therefore, by expressing a surface ligand for CR3, 
M tuberculosis may be able to enter the alveolar macrophage without precipitating a 
respiratory burst (Wright & Silverstein, 1983; Berton et al., 1992). In addition, some 
envelope components have been shown to either inhibit the production of reactive 
oxygen intermediates [e.g., sulfatides (Pabst et al., 1988; Brozna et al. , 1991) ] or 
inactivate them [(e.g. , LAM (Chan et al., 1991)]. 
Superoxide dismutase (SOD) and catalase/peroxidase (katG) are both able to 
inactivate reactive oxygen intermediates and are present in mycobacteria (Middlebrook 
& Cohn, 1953; Andersen et al., 1991; Balaji & Boom, 1998). In pathogenic strains these 
enzymes are surface-exposed but are cytosolic in non-pathogenic strains (Escuyer et al., 
1996; Raynaud et al., 1998). A similar distribution of SOD in other bacteria has been 
associated with virulence in those strains containing surface-exposed enzymes (Beaman 
et al., 1983; Beaman & Beaman, 1990). Presumably, surface-exposed enzymes have 
direct access to and can neutralise reactive oxygen intermediates before significant 
damage to the bacterium can occur. The presence of catalase/peroxidase in M bovis and 
M tuberculosis species has been associated with enhanced virulence of these bacteria in 
the guinea-pig (Wilson et al., 1995; Li et al., 1998). 
1.6.2.3. Nitrogen intermediates 
Despite the data presented above, a sizeable amount of work is accumulating 
suggesting that reactive oxygen intermediates have a limited role to play in host defense. 
Investigators now support the idea that reactive nitrogen intermediates (NO, N02, HN02) 
may play a more significant role (Denis, 1991; Chan et al. , 1992). This has been 
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relatively well studied in the murme model, where invesigators have shown that 
M tuberculosis is able to replicate much faster in a mouse lacking the ability to produce 
inducible nitrogen oxide synthase (iNOS) than in the wild-type mouse (MacMicking et 
al. , 1997). In other experiments, an interferon regulatory factor-I (transcription enhancer 
of the iNOS gene) knockout mouse, whose macrophages are unable to release NO, was 
unable to clear infection with BCG and succumbed (Kamijo et al., 1994); similarly, mice 
treated with iNOS inhibitors succumb to infection with M tuberculosis (Chan et al. , 
1995). However, the involvement of reactive nitrogen intermediates in host defense in 
humans remains a contentious issue. This initially rested on the inability to demonstrate 
iNOS in human macrophages and the finding by Kuo et al. (l 996) that alveolar 
macrophages from patients with tuberculosis have a higher capacity for the generation of 
reactive oxygen intermediates compared with cells obtained from normal control 
subjects. However, since then, Nicholson et al. (1996) have demonstrated upregulation 
of iNOS in alveolar macrophages from patients with tuberculosis, and Rockett et al. 
(1998) showed that 1,25-dihydroxyvitamin D3 can induce iNOS and inhibit 
M tuberculosis growth in a human macrophage-like cell line. 
Reactive nitrogen intermediates induce the production of a set of proteins, termed 
Nox (Garbe et al., 1996). Recently, Nox16 was found to be the major protein induced 
upon exposure of M tuberculosis to reactive nitrogen intermediates (Garbe et al., 1999). 
This protein was found to be identical to the a-crystallin homolog, sHsp16 (16 kDa small 
heat shock protein), which has been implicated in biologic states associated with low 
metabolic rates and dormant conditions in other organisms (Liang et al. , 1997). The role 
ofNox16 in the M tuberculosis infectious process remains to be elucidated. 
1.6.2.4. Inhibition of phagosome-lysosome fusion 
Phagosome-lysosome fusion with the release of lysosomal hydrolases that digest 
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and kill ingested microbes is an integral part of the macrophage defense against invading 
pathogens. Not only is it possible that the M tuberculosis envelope may protect it from 
these hydrolases, but it is now well documented that M tuberculosis is able to inhibit 
phagosome-lysosome fusion (Armstrong & Hart, 1971). This appears to be linked to the 
exclusion of the proton ATPase from the phagosomal membrane (Sturgill-Koszycki et 
al. , 1994), thereby preventing phagosome acidification and arresting maturation of the 
phagosome at an early endosome stage (Clemens & Horwitz, 1995) [this occurs at the 
rab7 stage, a small OTP-binding protein specific for late endosomes (Via et al., 1997)]. 
In contrast, cytokine-activated macrophages, when stimulated with interferon (IFN)-y 
and lipopolysaccharide, are able to acidify mycobacterial phagosomes more readily 
(Schaible et al., 1998; Via et al., 1998). 
Although inhibition of phagosome-lysosome fusion 1s not umque to 
M tuberculosis - Legionella pneumophila, Toxoplasma gondii and Chlamydia psitacci 
also reside in phagosomes that do not fuse with lysosomes - it does appear that the 
M tuberculosis phagosome reacts very differently with the endosomal-lysosomal 
pathway. The L. pneumophila phagosome does not contain any endosomal or lysosomal 
markers, suggesting that its interaction with the endosomal-lysosomal pathway is 
minimal (Clemens, 1996). This is in direct contrast to the M tuberculosis phagosome 
that contains endosomal markers (MHC class II and transferrin receptor molecules) 
(Clemens & Horwitz, 1995) and modest amounts of lysosomal membrane glycoproteins 
(CD63, LAMP-I) (Xu et al., 1994; Clemens & Horwitz, 1995). By retaining interactions 
with endosomes, M tuberculosis resides in a phagosome in which the intracellular 
contents are constantly restored, presenting one way in which the bacterium may obtain 
nutrients for intracellular growth and multiplication. Thus, phagosome manipulation 
may be intimately linked to the intracellular growth of virulent mycobacteria. Although 
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the molecular mechanisms underlying this process are unknown some researchers have 
suggested the following: 
1) The size and surface characteristics of viable mycobacteria can promote close 
phagosome membrane apposition and hence preclude membrane tubule formation 
required for vesicular trafficking and maturation (De Chastellier & Thilo, 1997). 
2) Receptor choice my dictate the subsequent phagosomal development, as uptake 
via the Fe receptor does not support phagosome manipulation and results in an acidified 
phagosome (Armstrong & Hart, 1975). Furthermore, nonopsonic FimH-mediated 
binding and uptake of E. coli into macrophages produces tight-fitting phagosomes 
whereas antibody-mediated uptake produces loose, spacious phagosomes (Baorto et al., 
1997). 
3) Intracellular growth of M tuberculosis results in the specific induction of an array 
of proteins that may interfere with host cell signalling events (Lee & Horwitz, 1995). 
Recently, a phagosomal coat protein, tryptophane aspartate-containing coat protein 
(TACO), has been implicated in the inhibition of M bovis- and M bovis BCG-containing 
phagosomes fusing with lysosomes (Ferrari et al. , 1999). This protein prevented 
phagosomes containing live organisms, but not dead organisms, from fusing to 
lysosomes. In macrophages lacking TACO, the mycobacterial-containing phagosomes 
fused with lysosomes resulting in degradation of the organisms. Moreover, expression of 
TACO in nonphagocytic cells prevented lysosomal delivery of mycobacteria and 
prolonged their intracellular survival. TACO was shown to belong to the Trp-Asp (WD) 
repeat protein family whose members are involved in a variety of processes, including 
signal transduction and cytoskeletal organisation. Ferrari et al. (1999) suggest that 
TACO may be involved in influencing the actin/tubulin cytoskeleton and/or micro-tubule 
regulation, although this remains to be elucidated. 
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Although the inhibition of phagosome-lysosome fusion may be significant, 
occasionally fusion has been noticed (Armstrong & Hart, 1975; McDonough et al., 1993; 
Bloom et al., 1994). When phagosome-lysosome fusion does occur, M tuberculosis is 
able to bud off from the phagolysosome and multiply in a newly formed vesicle 
(McDonough et al., 1993). Although the avirulent H37Ra strain behaves in a similar 
manner, it is not able to multiply in this vesicle. These observations are in direct contrast 
to those of Armstrong & Hart (1975) and Clemens & Horwitz (1995) who found no 
evidence that live M tuberculosis can enter a lysosomal compartment. Instead, they 
found that only dead bacilli enter a lysosomal compartment, suggesting that active 
processes exerted by the mycobacteria are required to prevent transport to 
endosomal/lysosomal organelles. 
1.6.2.5. Escape into the cytoplasm 
Shigella flexneri and Listeria monocytogenes escape into the cytoplasm to 
successfully evade the microbicidal mechanisms of the macrophage (Sansonetti et al., 
1986; Bielecki et al. , 1990). Conflicting data regarding the ability of M tuberculosis to 
escape into the cytoplasm have been published, making this concept an area of 
contention. Myrvick et al. (1984) and McDonnough et al. (1993) have observed 
M tuberculosis H37Rv in the cytoplasm. In addition, they noted that avirulent 
M tuberculosis H3 7Ra and M bovis BCG could not escape into the cytoplasm, 
suggesting that this process was related to virulence. However, Clemens & Horwitz 
(1995) did not find any evidence for M tuberculosis Erdman in the cytoplasm. Despite 
these conflicting observations, a contact-dependant cytolysin expressed by 
M tuberculosis (King et al., 1993) has been identified, suggesting that M tuberculosis 
has the ability to form pores in membranes, possibly allowing escape into the cytoplasm. 
This cytolysin was not present in avirulent M bovis BCG and was expressed at a lower 
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level in avirulent M tuberculosis H37Ra. Membrane-bound cytolysins play an important 
role in the ability of intracellular bacteria (for example, L. monocytogenes and S. jlexneri) 
to enter and exit host cells (Welch, 1991 ; Sansonetti, 1993). 
1.6.2.6. Secreted proteins 
M tuberculosis bacilli are likely to induce or suppress genes in response to the 
changing intracellular milieu. Furthermore, growth within macrophages leads to a 
marked induction in the activity of the mtrA gene, which is part of an M tuberculosis 
two-component regulator system that may transduce signals relating to environmental 
changes accompanying intracellular growth (Via et al., 1996). Investigators have 
confirmed the presence in vivo of proteins that are not present in vitro (Lee & Horwitz, 
1995). These proteins are presumed to be required for intracellular survival and are 
likely to include various cell-surface and secreted proteins, although the identities of 
these are unknown. Some of these cell-surface and secreted proteins may be proteases. 
Furthermore, these proteases may be part of the M tuberculosis arsenal that helps the 
bacillus survive intracellularly within a hostile phagocytic cell ( discussed in detail in 
Chapter 2). Thus, the intracellular phenotype of M tuberculosis may be quite different. 
1.6.3. T cell immune response 
There is compelling clinical evidence that a vigorous and controlled host immune 
response is essential for the elimination of M tuberculosis bacilli from an infected host. 
Furthermore, the successful elimination of M tuberculosis depends mainly on the 
efficient interaction between infected macrophages and antigen-specific T cells. This 
part of the chapter reviews current evidence on the contribution of the various T cell 
subsets to protection from M tuberculosis. 
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1.6.3.1. CD4+ helper T cells 
Involvement of the CD4+ helper T cell subset has now become well-established. 
This is a result of experiments that revealed an aggravation of disease in CD4-depleted 
mice (Podrazzini et al. , 1987), the ability of CD4+ T cells from immunised mice to 
protect nonimmune mice against M tuberculosis (Orme, 1987), and a dramatically 
increased susceptibility of AIDS patients to tuberculosis (Barnes et al., 1991; Jones et al. , 
1999) . . The CD4+ T cells are thought to protect against M tuberculosis infection by the 
antigen-specific production of cytokines which activate infected macrophages to kill their 
intracellular bacillary load. CD4+ T cells recognise antigen that is derived from the 
phagocytic pathway and which is presented by an antigen presenting cell (primarily 
macrophages and dendritic cells) in the context of major histocompatibility (MHC) class 
II molecules. 
The CD4+ helper T cells are further differentiated into two phenotypes, T1-1l and 
T 1-12. The driving force behind this differentiation is unknown but may include a specific 
cytokine/lymphokine milieu or some endocrine factors. T 1-11 cells produce IFN-y and IL-
2 which activate inflammatory and phagocytic cells. T 1-12 cells predominantly secrete IL-
4, but also IL-5 and IL-10, which not only drives the immune system to a humeral 
response but also inhibits the cell mediated response. IL-3, lymphotoxin and 
granulocyte-macrophage-colony stimulating factor (GM-CSF) are secreted by both T 1-11 
and T H2 cells. Evidence to date points to a T 1-1 I-type response to M tuberculosis 
infection. Perhaps the most convincing data were obtained by Barnes et al. (1993) who 
demonstrated higher levels of the T 1-11 cytokines IFN-y and IL-2 in pleural fluid than in 
blood, in patients with tuberculous pleuritis. In addition, there was a lower level of the 
T H2 cytokine IL-4 in pleural fluid than in blood, and lymphocytes from pleural fluid 
produced more IFN-y and IL-2 when stimulated with M tuberculosis than did peripheral 
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blood lymphocytes. From these data it was concluded that there is a T 1-il-type response 
at the actual site of disease. Further supporting a T1-1 l response is the finding of increased 
levels of IL-12 in pleural fluid and BAL cells from patients with tuberculosis (Zhang et 
al. , 1994), and that IL-12 is released by macrophages upon phagocytosis of 
M tuberculosis (Fulton et al. , 1996; Ladel et al. , 1997). Since IL-12 is known to 
produce a T 1-11-type response it may be a possible regulator of T cell phenotypes in 
tuberculosis. 
1.6.3.2. y8Tcells 
M tuberculosis antigens are also able to activate human y3 T cells ( especially 
Vy9+ and V32+) which recognise mycobacterial antigens in a non-MHC-restricted 
manner, distinct from CD4+ T cells, and have been shown to respond to small phosphate-
containing antigens (Balaji & Boom, 1998). A role for these cells has been demonstrated 
in murine models (Ladel et al., 199?; Li et al., 1996) and y3 T cells from healthy 
tuberculin-positive individuals produce a T 1-1 l-type cytokine profile and have cytolytic 
activity for M tuberculosis-infected macrophages (Tsukaguchi et al. , 1995). However, 
in humans, there is no evidence for the accumulation of these cells at the site of 
tuberculous disease, and it has been suggested that they may be involved in the early 
immune response (Tazi et al. , 1991). Recent studies have shown that engagement of a 
mycobacterial antigen with a y3 T cell receptor induces the upregulation of FasL on 
chronically infected y3 T cells (Manfredi et al., 1998). Interaction with Fas on 
immigrating monocytes results in activation-induced cell death of the y3 T cells. 
Therefore, the envisioned role for y3 T cells is that they participate in the early 
containment of disease and, as the disease progresses, Fas-FasL apoptosis removes the 
majority of M tuberculosis-reactive y3 T cells (Li et al., 1998). Stenger & Modlin 
(1999) suggest that the reduction in y3 T cells may limit inflammation and inhibit tissue 
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damage, but perhaps at the expense of the development of chronic infection (Boom et al., 
1992; Gately et al., 1992). 
1.6.3.3. CD4+ and CD8+ cytolytic T cells (CTLs) 
It is becoming increasingly recognised that a cytotoxic T cell response also plays 
a significant role in protection against M tuberculosis. There is evidence implicating 
both CD4+ and CD8+ CTLs (Kaufmann, 1988; Ottenhof & Mutis, 1990; Tan et al., 
1997). CD4+ CTL activity is greatly enhanced at the site of disease compared to that of 
peripheral blood cells, suggesting that they play a role in the local immune response. 
However, Tan et al. (1997) demonstrated that alveolar macrophages are more resistant to 
CD4+ CTL-mediated cytolysis than are blood monocytes. It is unknown whether the 
reduced cytolysis is mediated by M tuberculosis thereby shielding itself from host 
microbicidal mechanisms, or whether this is a host mechanism that prevents the spread of 
released bacilli. 
As the major cytolytic pathway used by CD4+ CTLs is FasL-induced apoptosis, 
Oddo et al. (1998) assessed the effect of adding recombinant FasL to M tuberculosis-
infected macropahges. This induced apoptosis and also led to a decrease in 
M tuberculosis viability. TNF-a-induced apoptosis produced similar results; however, 
nonapoptotic complement-induced cell death had no effect on the viability of 
M tuberculosis. Furthermore, M tuberculosis-infected macrophages were more resistant 
to FasL-induced apoptosis and this correlated with reduced levels of surface Fas 
expression. Thus, the ability of M tuberculosis to modulate surface molecules may be 
yet another dimension of its ability to escape host defense mechanisms. However, 
Stenger & Modlin (1999) caution that the above experiment reflects the effects of 
endogenously added FasL, and whether this is the contact-dependent pathway utilised by 
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CD4+ CTLs to effect cytolysis remains to be determined. Lewinsohn et al. (1998) show 
that CD4+ CTL clones can also induce apoptosis in a FasL-independent manner. 
The contribution by CD8+ cytotoxic T cells is uncertain. Although there is strong 
evidence implicating these cells in protective immunity in animal models (Flynn et al. , 
1992), there is, unfortunately, conflicting data from human studies. Confusion arose 
from earlier studies that revealed human M tuberculosis-specific cytolytic T cells to be 
CD4+ not CD8+ (Ottenhof & Mutis, 1990), CD8+ T cells in tuberculosis patients are not 
concentrated at the site of disease (Barnes et al., 1989), and that the severity of 
tuberculosis in HIV-infected individuals is unaffected by the CD8+ T cell count (Jones et 
al., 1999). Nevertheless, more recent studies indicate involvement of CD8+ T cells in the 
human immune response to tuberculosis. CD8+ T cells recognise antigen that has been 
processed in the cytosol and that is presented in the context of MHC class I molecules. 
Tan et al. (1997) showed CD8+ M tuberculosis-reactive CTLs in the lungs of 
tuberculosis patients and Lalvani et al. (1998) found IFN-y secreting CD8+ T cells in the 
peripheral blood of tuberculosis patients. In addition, cloning of peripheral blood 
mononuclear cells from these patients yielded T cells which recognized ESAT6, an early 
secretory antigen of M tuberculosis (Mohagheghpour et al., 1998). CD 8+ T cells are 
potent producers of IFN-y and probably afford protection from M tuberculosis infection 
by complementing CD4+ T cells as a source ofIFN-y. Tascon et al. (1998) have shown 
that, in their mouse model, IFN-y production by CD8+ T cells was the method of 
protection against M tuberculosis infection and not the ability of CD8+ T cells to lyse 
M tuberculosis-infected cells. 
Recently, a subset of CD8+ T cells have been shown to recognise nonpeptide 
antigens of M tuberculosis presented in the context of human CD 1 molecules, further 
adding to the complexity (Gong et al. , 1998). This subset is able to recognise and lyse 
M tuberculosis-infected macrophages. In addition, some M tuberculosis-specific human 
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CD8+ T cells can recognise antigen not restricted by MHC class I molecules or CD 1. 
This suggests a novel nonpolymorphic MHC class lb antigen presenting pathway 
involved in immunity to tuberculosis (Lewinsohn et al., 1998). Recent studies have 
demonstrated that CD8+ T cells lyse infected cells via the granule-exocytosis pathway 
and, in so doing, can stimulate the release of molecules that can directly destroy the 
intracellular microbe (Stenger et al., 1998). One of the candidate molecules, granulysin, 
can directly kill extracellular M tuberculosis. Furthermore, experiments using infected 
cells in the presence of granulysin and perforin (a pore forming molecule that colocalises 
with granulysin in cytotoxic granules) revealed that granulysin was able to kill 
intracellular M tuberculosis only in the presence of perforin (Stenger et al., 1998). In 
addition to its cytolytic role, CD8+ T cells can also produce large amounts of IFN-y, 
contributing to the role played by CD4+ T cells in activating macrophages. 
1.6.3.4. CD4- CD8- T cells 
Double-negative (CD4- CD8) T cells recogmse antigen m a CDl-restricted 
manner (Porcelli, 1995) and have been demonstrated to be able to lyse cells pulsed with 
my co bacterial lipids (Beckman et al., 1994) and glycolipids (Sieling et al., 1995). In 
addition they can also release IFN-y. More recently they have been shown to be able to 
lyse M tuberculosis-infected macrophages via the Fas-FasL pathway but this does not 
result in killing of the bacteria (Stenger et al. , 1997; Gong et al. , 1998). This is in direct 
contrast to CD4+ and CD8+ CTLs, and the role of these CDl-restricted double-negative T 
cells has been suggested to be related to controlling inflammation by dampening the 
host's immune response and preventing extensive tissue injury (Stenger & Modlin, 
1999). 
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1.6.3.5. T cell hyporesponsiveness 
Newly diagnosed tuberculosis patients have hyporesponsive T cells, emphasising 
the importance of an effective T cell response for protection from M tuberculosis 
infection (Onwubalili et al., 1985; Toossi et al., 1986; Torres et al., 1994). There is 
evidence that the immunosuppressive cytokines, TGF-P and IL-10, play a role in T cell 
hyporesponsiveness (Zhang et al., 1995). In addition, Hirsch et al. (1999) have recently 
shown that T-cell apoptosis may also be involved. 
TGF-P, produced mainly by monocytes and macrophages, has profound anti-
inflammatory effects, part of which is the deactivation of macrophages and the 
downregulation of IFN-y, TNF-a and IL-1 (Ruscetti et al., 1993). Experimental data 
supporting the involvement of TGF-P has shown that this cytokine is able to block 
phagocytosis and growth inl1ibition of M tuberculosis by mononuclear phagocytes 
(Hirsch et al., 1994b; Hirsch et al., 1997). Furthermore, TGF-P is increased in 
mononuclear phagocytes and lung granulomas from patients with pulmonary tuberculosis 
(Toossi et al. , 1995). 
IL-10 has been shown to be increased by M tuberculosis infection of human and 
murine macrophages (Orme et al., 1993). In addition, IL-10 transgenic mice are more 
susceptible to disseminated M bovis BCG infection whereas wild-type mice are able to 
restrict the infection (Murray et al., 1997). 
Hirsch et al. (1999) have shown an increased propensity for apoptosis of T cells 
(CD4 and non-CD4) from tuberculosis patients when stimulated with M tuberculosis. In 
addition, they also showed that there is a higher percentage of spontaneous apoptosis in 
tuberculin-positive healthy individuals and in patients with active pulmonary tuberculosis 
than in tuberculin-negative individuals. Data suggesting that activated T cells are 
predisposed to apoptosis (Ju et al., 1995; Munn et al., 1999) led the authors to suggest 
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that the increased susceptibility of T cells from patients with active tuberculosis to 
apoptotic cell death is a consequence of activation in vivo. The mechanism of T-cell 
hyporesponsiveness appears to be an interplay between immunosuppressive cytokines 
and apoptosis. Since TGF-P has been shown to induce B-cell apoptosis (Chaouchi et al., 
1995) and arrest the growth of activated T cells (Ahuja et al., 1992), it is posssible that 
this cytokine is involved in T cell apoptosis. 
1.7. CONCLUSION 
M tuberculosis is a complex and insidious organism that for centuries has baffled 
and bewildered clinicians and scientists alike. In this introductory review, an attempt 
was made to highlight the enormous progress achieved in the past decade to understand 
the mechanisms used by M tuberculosis to establish disease. Despite recent advances, 
however, few virulence factors of M tuberculosis have been clearly defined. The 
increasing global incidence of tuberculosis, and in particular of multi-drug resistant 
strains of M tuberculosis, necessitates the discovery of novel drug targets and an 
effective vaccine. Global collaboration in the implementation of TB control programmes 
is required if we are to stem the tide. The potential for 60-80 million lives to be lost from 
tuberculosis during the next 2-3 decades clearly justifies intensive research directed 
towards the identification of potential virulence determinants of M tuberculosis. The 
rising tide of tuberculosis ensures that M tuberculosis will enter, yet again, a new 
millennium as "The Captain of All These Men of Death" 1 - this presents a challenge to 
all scientists to guarantee that this will be the last millennium in which the 
M tuberculosis bacillus enjoys the privilege. 
1 "The captain of all these men of death that came against him to take him away, was the consumption, for 
it was that brought him down to the grave." John Bunyan (1680), In The Life and Death of Mr Badman 
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Proteases are enzymes that catalyse the hydrolysis of peptide bonds in proteins 
and/or peptides. They are distributed throughout all living organisms, where they 
participate in many physiological functions. These enzymes are increasingly implicated 
in the pathophysiology of a number of diseases, including infectious, neoplastic and 
inflammatory diseases, justifying the enormous amount of research that has focused on 
them. Notably, proteases are emerging as potential candidates in the pathogenesis of a 
number of infectious (and non-infectious) diseases and drugs designed to inhibit them 
have been associated with an improved clinical outcome (Travis et al., 1995). For 
example, the four separate HIV-1 protease inhibitors (saquinavir, ritonavir, indinavir, and 
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nelfinavir) that inhibit proteases involved in processing the human immunodeficiency 
virus gag-pol polyprotein are responsible for a decrease incidence in clinical progression 
and mortality (Deeks et al., 1997), and angiotensin-converting enzyme inhibitors 
(designed to inhibit the metalloprotease angiotensin-converting enzyme) heralded a 
major breakthrough in the treatment of hypertension and congestive cardiac failure 
(Opie, 1999). Thus, proteases are emerging as novel drug targets in pathologically 
diverse diseases. 
2.2 CLASSIFICATION 
Over 300 proteases have been discovered and are currently classified according to 
the reaction catalysed, the chemical nature of the catalytic site, and their evolutionary 
relationships (Barrett & Rawlings, 1991; Barrett, 1994 ). 
a) Reaction catalysed 
This is the mechanism by which the International Union of Biochemistry and 
Molecular Biology has classified enzymes. According to the Enzyme Nomenclature 
199 2, class 3 contains hydro lases, and subclass 3 .4 contains the peptide hydro lases or 
peptidases (also referred to as proteases or proteinases). Using the principle of reaction 
catalysed, subclass 3.4 is divided into the exopeptidases (their action is restricted to the 
amino or carboxyl termini of proteins) and endopeptidases (cleave internal peptide 
bonds) (Table 2.1). 
The exopeptidases are subdivided into: those acting at a free N-terminus and 
liberating a single amino acid residue, a dipeptide or a tripeptide (aminopeptidases, 
dipeptidyl-peptidases and tripeptidyl-peptidases, respectively), and those acting at a free 
C-terminus and liberating a single amino acid (carboxypeptidase) or a dipeptide 
(peptidyl-dipeptidase); those that are specific for dipeptides (dipeptidases); and those that 
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remove terminal residues that are substituted, cyclized, or linked by isopeptide bonds 
(peptide linkages other than those of a-carboxyl to a-amino groups) (omega peptidases). 
Endopeptidases preferentially hyrolyse peptide bonds in the inner regions of 
proteins. A subclass of these, termed oligopeptidases, act on oligopeptide or polypeptide 
chains smaller than proteins. 
Table 2.1. Classification of peptidases by type of reaction catalysed and catalytic type 
Reaction catalysed Catalytic type Action EC subsection 
Exopeptidases 
,.....,.. 








Serine-type carboxypeptidases 3.4.16 
Metallocarboxypeptidases 3.4.17 
Cysteine-type carboxypeptidases 3.4.18 
Peptidyl-dipeptidases ~ 3.4.15 
Di peptidases .. 3.4.13 
Omega peptidases -oo-o--e--<111 3.4.19 
~
Endo peptidases -OOobo-
Serine endopeptidases 3.4.21 
Cysteine endopeptidases 3.4.22 
Aspartic endopeptidases 3.4.23 
Metalloendopeptidases 3.4.24 
Endopeptidases of unknown 3.4.99 
catalytic mechanism 
Adapted from Barrett, (1994) 
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b) Catalytic type 
There are 4 distinct types of catalytic mechanisms used by proteases that serve as 
the basis for another classification system (Hartley, 1960). Proteases are assigned to 5 
different sub-groups according to the functional residue in the active site (Barrett, 1979; 
Barrett, 1994). These subgroups are: serine proteases, cysteine proteases, aspartic 
proteases, metalloproteases, threonine proteases, and proteases of unknown catalytic 
mechanism. Both the carboxypeptidases and endopeptidases are sub-classified in this 
way (Table 2.1 ). Inhibitors provide the most reliable way of establishing the catalytic 
mechanism (Table 2.2). 
Table 2.2. Inhibitors used for the determination of protease catalytic type 
Serine Cysteine Metallo Aspartic 
APMSF' Cystatin Bestatin Pepstatin 
Antithrombin III E-64i EDTA 
al-Protease inhibitor EGTA 
Aprotinini Phosphoram idon 









armacroglobu I in' 
;irreversible inhibitors 
Abbreviations: APMSF, 4-(amidinophenyl)methanesulphonyl fluoride; E-64, L-trans-
epoxysuccinyl-leucylamide-( 4-guanidino )-butane; EDT A, ethylenediaminetetraacetic acid; 
EGTA, ethylene glycol-bis(~-aminoethyl ether)N,N,N',N'-tetraacetic acid; PMSF, 
phenylmethanesulphonyl fluoride; TLCK, L-1-chloro-3-[4-tosylamido]-7-amino-2 
heptanonehydrocloride; TPCK, L-1-ch loro-3-[ 4-tosylam ido )-4-phenyl-2-butanone; ALLM, 
N-acetyl-Leu-Leu-methional; ALLN, N-acetyl-Leu-Leu-norleucinal 
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Unfortunately, there is some cross-reactivity of group inhibitors. For example, 
EDTA inhibits proteases that are dependent on Ca2+ for optimal activity. Although the 
majority of Ca2+-dependent proteases are metalloproteases, the subtilisin family (serine 
proteases) and cal pain family ( cysteine proteases) also show augmented activity in the 
presence of Ca2+ and are inhibited by EDT A. Some serine proteases contain a cysteine 
residue close to the active site aspartate residue, consequently these proteases are 
activated by thiol-containing compounds and inhibited, to some degree, by cysteine 
protease inhibitors. 
C) Evolutionary relationship 
Based on their amino acid sequences, proteases in each subgroup are divided into 
different families ( a group of proteases that are shown by their primary structures to be 
evolutionarily related) (Rawlings & Rawlings, 1993). All the members of a family are 
believed to have diverged from a common ancestral protein. Within each family there 
are occasionally sets of families that, although diverging from a common ancestral 
protein, have diverged so far that their relationship can no longer be proven. These sets 
of families are termed "clans". The clans are distinguished by the linear order of 
catalytic site residues, clusters of conserved amino acids around the catalytic residues, 
and the tertiary structures of the proteins (Barrett, 1994). 
2.3 CATALYTIC TYPES 
2.3.1 Serine proteases 
These proteases are dependent on an active site serine residue for activity. The 
many proteases requiring a serine residue for activity are derived from separate 
evolutionary origins, consequently there are fundamental differences among them 
(Barrett & Rawlings, 1995). Amino acid sequence analysis indicates that there are about 
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Chymotrypsin (Homo sapiens) 
glutamyl endopeptidase (S. aureus) 
protease Do (E. coli) 
lysy l endopept idase (Achromobacter lyticus) 
streptogrisin A (Streptomyces griseus) 
togavirin (Sindbis virus) 
IgA I-specific serine-type prolyl endopeptidase (N. 
gonorrhoeae) 
flavivirin (yellow fever virus) 
hepacivirin (hepatitis C virus) 
Pl proteinase (plum pox potyvirus) 
NS3 polyprotein peptidase (cattle viral diarrhea 
virus) 
serine endopeptidase (equine arteritis virus) 
36 kDa protease (apple stem grooving virus) 
porin D (Pseudomonas aeruginosa) 
subtilisin (Bacillus licheniformis) 
kexin (Saccharomyces cerevisiae) 
tripeptidyl-peptidase II (Homo sapiens) 
prolyl oligopeptidase (Sus scrofa) 
dipeptidyl-peptidase IV (Homo sapiens) 
acylaminoacyl-peptidase (Homo sapiens) 
carboxypeptidase C (S. cerevisiae) 
prolyl aminopeptidase (N. gonorrhoeae 
Proly l oligopeptidase 
X-Pro dipeptidyl-peptidase (L. lactis) 
lysosomal Pro-X carboxypeptidase (Homo 
sapiens) 
PS-10 peptidase (S. lividans) 
D-Ala-D-Ala carboxypeptidase A (B. 
stearothermophilus) 
D-Ala-D-Ala carboxypeptidase B (Streptomyces 
sp.) 
D-Ala-D-Ala peptidase C (E. coli) 
repressor LexA (E. coli) 
signal peptidase I (E. coli) 
signalase (Saccharomyces cerevisiae) 
Tsp protease (E. coli) 
tricorn core protease (Su lfolobus solfataricus) 
assemblin (human cytomegalovirus) 
endopeptidase Clp (£. coli) 
protease [V (£. coli) 
endopeptidase La (Escherichia coli) 
omptin (E. coli) 
chymotrypsin-like protease (Coccidioides immitis) 
chymotrypsin-like protease PrtB (Treponema 
denticola) 
Known catalytic residues 
.. ... H . .. .. .. .. D ......... .... S .. . . .. . 
. .... . . .. .. ... H ....... . D . ........ S .. . 
.. ... . ............ H .... D .... ... S .. . . 
.. ... . . .. .. .. . . ... ........ H .... D .. S .. 
..... . .... H ........ .. D .. . .... S ....... . 
........ H ........ D .......... S ....... . . 
............... S ....................... . 
...... HD . . . . S . . . . .. . . . . . . . . .......... . 
.. . . .. ... H ... D ... S ... . .. .. .. . .... . ... . 
.. . ..... . .... .. .. .... ... .. H .. D .. . S .. .. . 
. . . . ..... ....... . .. S ...... .. .. . . .. . .. . .. . 
. .... . . .. . .. . ......... . . H .. D . .. .. . S .. . 
........... . ..... H ..... D .... S . ... . . . .. . 
... . D ... H .. .. . . . .... .. ....... S ... .. ... . . 
. . . .... . D . . . . . . . H .......... S . .. . . . . . .. . . 
.. . D . .. .. .. . . . .. H .. .. .. ..... .. .. ... S .. . 
..... .. S .. D ... H ...... .. .. ... .. .. . ... ... . 
.... . . S .. .. .... D ..... H ..... . .. . . .. .. . . . . 
. .. .. . S .. . ..... D ..... H ........ . ..... . .. . 
............. . S ... . ........... D ... H ... . 
. .. .. . . .. ............... . ... . S .. . D .. H .. . 
.. . ... .. . .. .. . . . ... . S .. ......... . ....... . . 
. . .. . SXXK .. .................. . . . .... . 
. . . . . . . . .. SXXK ................. . . ... . 
. ... SXXK ............ . ...... . .. . ..... . 
. .. .... . ..... S .. . . ....... K .......... ... . 
....... . S ........ K ......... .. ... . .. .. . .. . 
........ S .. . . . ... K ............ .. . .. . .. .. . 
.. .... H ......... S . ....... H .......... . . 
. . ..... . . . .. . S ....... H ..... . . ... ...... . 
Adapted from the MEROPS web site (http://www.b i.bbsrc.ac.uk/Merops/Merops.htm) and Barrett & 
Rawlings, (1 995). 
D, aspartate ; H, histidine; S, serine; K, lysine 
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37 evolutionary families (Rawlings & Barrett, 1993; Rawlings & Barrett, 1994), most of 
which can be further assigned to a specific clan (Table 2.3), making 8 different clans. 
Three-dimensional structures of members from four of the clans reveal that they are 
completely unrelated, suggesting that serine proteases have at least 4 separate 
evolutionary origins (Rawlings & Barrett, 1994). The classic catalytic triad containing 
serine (nucleophile), aspartate (electrophile), and histidine (base) is present only in clan 
A (chymotrypsin), clan B (subtilisin), and clan C (carboxypeptidase C). However, the 
order of these residues in the primary sequence is different for each of the 3 clans. 
In contrast, the catalytic mechanism of clan E and clan F is different and includes 
catalytic residues -Ser-Xaa-Xaa-Lys- and a Ser / base dyad, respectively (Rawlings & 
Barrett, 1994). So far, only members of clan A and B have been demonstrated to be 
produced as inactive zymogens, requiring propeptide cleavage for activity. 
2.3.2 Cysteine proteases 
The activity of cysteine proteases is dependent upon a catalytic dyad of cysteine 
and histidine. These proteases are widely spread in nature from viruses to mammals. 
The primary sequence order of these residues differs among the 4 7 families that are 
incorporated into this group (Rawlings, 1994). Some families show identity, especially 
around the catalytic site residues, making it possible to further subdivide them into 6 
clans (PA, CA, CD, CE, CF, and CH). Those families not yet assigned to any clan are 
grouped into clan CX. Cysteine proteases are usually active only (or optimally) in the 
presence of reducing agents, for example, dithiothreitol and/or cysteine. 
2. 3. 3 Aspartic proteases 
This group depends on aspartic acid residues for their catalytic activity. Initially 
it was thought that these proteases were confined to eukaryotes, but several examples 
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have now been found in microorganisms. This group incorporates 19 families, and some 
of these families can be attributed to a clan, making two clans (AA and AB). Those 
families that cannot be attributed to any specific clan are placed into clan AX. The 
microbial aspartic proteases are divided into pepsin-like enzymes (produced by 
Aspergillus, Penicillium, Rhizopus and Neurospora) and rennin-like enzymes (produced 
by Endothia and Mucor spp.) (Rao et al. , 1998). Most aspartic proteases show optimal 
activity at an acidic pH (pH 3 to 4) hence they are sometimes referred to as acidic 
proteases. 
2.3.4 Metalloproteases 
This group contains a diverse array of proteases that are united by their 
requirement for a divalent metal ion for activity, usually zinc. The amino acid signature, 
HEXXH, constituting the core of one of the two zinc binding sites has been identified as 
being highly conserved in most metalloproteases (Jongeneel et al. , 1989). However, this 
motif is also common in a variety of protein sequences that are not metalloproteases. 
Rawlings & Barrett (1995a) warn that only 20 % of protein sequences in the SwissProt 
database that share the HEXXH motif are metalloproteases. To increase specificity for 
metalloproteases, Jongeneel et al. (1989) have redefined the signature to a-a-H-E-a-a-H-
a-b, where a represents an uncharged residue and b a hydrophobic residue. The two 
histidines participate in the co-ordination of the zinc atom, while the conserved glutamic 
acid is catalytic. About 57 families have been recognised and can be assigned to 10 
different clans (Rawlings & Barrett, 1999). Clan MA contains proteases in which a 
glutamic acid residue (HEXXH + E) or a histidine residue (HEXXH + H) completes the 
Zn-binding site. The histidine residue is usually 8 residues after the HEXXH motif 
(Figure 2.1) (Rawlings & Barrett, 1995a, 1999). The other clans contain proteases that 
have the HEXXH motif but additional metal ligands are as yet unidentified (some in clan 
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MA and MX); proteases in which the metal atoms are bound at motifs other than the 
HEXXH consensus sequence ( clans MC, ME and MJ); single zinc ion ligated to His, 
Asp and His (clan MD); two zinc ions ligated by Lys, Asp, Asp, Asp, Glu (clan MF); 
two cobalt or manganese ions ligated by Asp, Asp, His, Glu, Glu (clan MG); two zinc 
ions ligated by His ( or Asp), Asp, Glu, Asp ( or Glu), His ( clan MH); and 
metalloprotease families not yet assigned to any clan ( clan MX). 
Family Representative sequence 
Ml 01 I • QWFGNLVTIEW-WNDLWLNEGFASYVEYLGA 
M2 02 VQYYLQYKDLHRGANPGFHEAIGDVLALSVS 
M4 03 VTDYTAGLIYQNESGAINEAISDIFGTLVE 
MS 04 SLMGKLYNGWWSSTTCGWTEDFADAVAFHTF 
M13 05 GFDDNGRNFNKDGDLVDWWTQQSASNFKESQ 
M30 06 • MVNANQKLLKEQKEDGMDVWLDEAFAMASEH 
M6 07 DLGLPDEYDTDYTGHGEPIQAWSVMSGGTWA 
M7 08 VLGLPDHYSGPCSELMSGGGPGPSCTNPYPN 
MB 09 LGFSGPFFEDARIVANVPNVRGKNFDVPVI 
M9A 10 YLDGRFDLYGGFSHPTEKIVWWSEGIAEYVA 
M9B 11 YLQGRYVVPGMWGQGEFYQEGVLTWYEEGTA 
MlOA 12 SLGLGHSSDPKA------VMFPTYK-YV 
MlOB 13 LGLSHPGDYNADTRQFSLMSYWSETNT 
Mll 14 NYGLEHAGRGTLYGDATDVMGDFNKAGK 
M12A 15 IGFYHEHTRMDDYQYYSIMHYGKYSFS 
M12B 16 NLGMEHDGKDCLRGASLCIMRPGLTPGR 
M12C 17 NFGSPHDSGTECTPGESKNLGQKENGNY 
M36 18 GLSNRLTGGPANSNSLYALESGGMGEGW 
M48 19 WQKNHIVNMVIFSQLHTFLIFSLFTSIY 
Figure 2.1. Clan MA of metalloproteases. Families are represented by one typical member. The HEXXH motif is demonstrated 
by white letters on a black background. The residue that is known to represent the third metal binding site is indicated by black letters 
on a grey background . Key to sequences : I, human membrane al any I aminopeptidase (P 15144); 2, germinal dipeptidyl-dipeptidase 
A (P22966); 3, Bacillus sp. thermolysin (P06874); 4, Streptomyces cacaoi mycolysin (P20910); 5, human neprilysin (P08473); 6, 
Staphylococcus hyicus hyicolysin (Q08002); 7, Bacillus. thuringiensis immune inhibitor A (P23382); 8, Streptomyces. lividans 
snapalysin (P43 l 62); 9, Leishmania major leishmanolysin (P08148); I 0, Vinbrio alginolyticus microbial collagenase (P43 l 54); 11 , 
Clostridium perfringens microbial collagenase, class I (P43153); 12, human macrophage elastase (P39900); 13, Serratia marcescens 
serralysin (P23694); 14, Chlamydomonas reinhardtii gametolysin (P3 l l 78); 15, Astacus jluviatilis astacin (P07584); 16, Crotalus 
adamanteus adamalysin; 17, Bos taurus ADAMIO (Q10741); 18, Aspergillus fumigatus fungalysin (P46074); 19, Streptomyces 
cervisiae Ste24p endopeptidase (P47154). Adapted from Rawlings & Barrett (1999). 
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2.4 PHYSIOLOGICAL FUNCTIONS OF PROTEASES 
Proteases are ubiquitous enzymes present in all organisms and play a critical role in 
essential metabolic and regulatory functions. The diverse array of essential processes in 
which they are involved are critical for fundamental cellular activities. An in-depth 
review of protease functions is beyond the scope of this chapter, but some essential 
functions will be highlighted. 
Proteases are involved in the continuous, balanced degradation of proteins, which 
is essential for the maintenance of the amino acid pool, ensuring adequate nutrition and 
the synthesis of vital proteins. In mammalian hosts there are several 
protease/antiprotease systems that regulate the turnover of essential connective tissue 
proteins. Attention has focused on one of these systems, the elastase/antielastase system, 
which may contribute to the etiology of inflarnn1atory or degradative diseases, such as 
emphysema, atherosclerosis, arthritis and bacterial lung infections (Werb et al., 1982; 
Stockley, 1983; Umeki et al., 1988). Endogenous host elastases - neutrophil elastase, 
macrophage elastase and tissue elastase - are regulated by serum protease inhibitors, most 
notably al-protease inhibitor. An imbalance in the elastase/elastase inhibitor ratio 
results in increased elastolysis and possible pathology. Although the turnover of elastin 
fibres in adult mammals is very slow, some degradation does occur under physiologic 
circumstances, which includes growth, wound healing, tissue remodelling, and pregnancy 
(Werb et al., 1982). 
Proteases, and more specifically, lysosomal proteases, are an integral part of 
mammalian host defense against invading microbes. Phagocytic cells (for example, 
monocytes, tissue macrophages, and Kupffer cells) ingest foreign molecules, including 
invading microbes, by phagocytosis. The resulting phagocytic vacuole (phagosome) 
fuses with lysosomes, forming a phagolysosome, in which the entrapped foreign 
molecules are destroyed by a variety of lysosomal hydrolases (including lysozyme, 
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phospholipase A2, ribonuclease, deoxyribonuclease, and proteases). Inhibition of 
phagosome-lysosome fusion, thereby avoiding the potentially toxic effects of lysosomal 
enzymes, forms part of the repertoire of strategies used by intracellular pathogens to 
survive within macrophages. 
Additional homeostatic mechanisms in which proteases are involved include the 
regulation of gene expression (Roberts et al. , 1977; Kalisz, 1988); the regulation of many 
rate-controlling processes by activating the enzyme zymogens involved (generation of 
protein hormones, assembly of fibrils and viruses, blood coagulation, and fertilisation of 
ova by sperm) (Van de Ven et al. , 1990; Hutton, 1990); and the degradation of a variety 
of regulatory proteins (e.g., the heat shock response, the SOS response to DNA damage, 
and programmed cell death) (Gottesman Maurizi, 1992; Visser et al., 1996). 
Loss of homeostatic balance in the control of key proteolytic systems can lead to 
severe pathological consequences, including diseases such as emphysema, Alzheimer' s 
disease, and rheumatoid arthritis (Stockley, 1983; Tetley, 1993; Koo et al. , 1999). 
2.5 SECRETION MECHANISMS OF EXTRACELLULAR BACTERIAL 
PROTEASES 
Although microorganisms elaborate proteases from all four catalytic types, 
bacterial extracellular proteases are most commonly of the serine or metallo catalytic 
type, and are involved in a wide spectrum of processes. These range from general 
"house-keeping functions" that are responsible for the homeostatic stability of the 
bacterium to pathogenic functions that in one or more ways contribute to the pathogenic 
success of the bacterium ( discussed further in section 2.6). Secreted or membrane-bound 
bacterial proteases are more likely to be involved in disease pathogenesis, as these 
proteases have direct access to host tissues, inflammatory mediators, and immune 
molecules. 
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Gram-positive and Gram-negative bacteria secrete proteases into the extracellular 
medium. To prevent unwanted proteolysis, most extracellular bacterial proteases are first 
synthesised as inactive precursors that are then processed to the mature active protease 
(Wandersman, 1989). 
In Gram-positive bacteria, secreted proteases are synthesised as preproenzymes 
containing an amino-terminal signal peptide followed by a propeptide and then the 
mature protein (Pugsley & Schwartz 1985; Wandersman, 1989). The signal peptide is 
usually required for translocation of the protease across the cytoplasmic membrane, 
where it is cleaved off by a signal peptidase, a component of the sec-dependent general 
export pathway; this generates the proenzyme form. The lengths of propeptides vary 
from protease to protease [for example, 8 amino acids in the B. licheniformis 
penicillinase (Chang et al., 1982), 77 amino acid residues in the B. amyloliquifaciens 
subtilisin BPN' (Eder et al., 1993), and 190 amino acid residues in the B. subtilis neutral 
protease (Yang et al. , 1984)], and the propeptide can be located anywhere in the 
precursor form. The commonest location is between the signal peptide and the mature 
protein; however, it can also be located as a carboxy-terminal extension of the mature 
protein. The function of the bacterial propeptide has not been completely elucidated, but 
it has been implicated in promoting the correct folding of the protease (Eder et al., 1995), 
altering protease specificity (Wandersman, 1989), serving as a membrane anchor 
(Wandersman, 1989), playing a role in the secretion process (Pugsley & Schwartz, 1985); 
(Fujishige et al., 1992; Braun & Tommassen, 1998), and inhibiting the premature 
intracellular activation of the protease (maintaining the zymogen in an inactive form to 
prevent unwanted proteolysis) (Baker et al., 1992; Braun & Tommassen, 1998). 
Apart from a signal peptide-dependent secretory pathway, Gram-negative bacteria 
are also able to secrete proteins in a signal peptide-independent manner (Pugsley, 1993). 
The signal peptide-dependent pathway is similar to that in Gram-positive bacteria and 
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examples of Gram-negative bacterial proteases secreted via this pathway are the IgA 
proteases (Neisseria spp., Haemophilus influenzae, and Streptococcus sanguis), 
Pseudomonas aeruginosa elastase (Kessler & Safrin, 1999), and the Serratia marcesens 
serine protease. Interestingly, most of these proteases have propeptides situated at the 
C-terminus of the mature protease. The Erwinia chrysanthemi proteases B and C are 
secreted via the signal peptide-independent pathway. These proteases are dependent on 
specific secretion functions that are encoded by genes adjacent to the protease structural 
genes (Delepelaire & Wandersman, 1989, 1991). 
2.6 PATHOGENIC POTENTIAL OF BACTERIAL PROTEASES 
It is becoming increasingly apparent that bacterial proteases have a far greater 
potential to contribute to pathogenesis than was generally recognised, and consequently 
they are now receiving greater attention. A review of the literature reveals the presence 
of virulence-associated proteases among diverse microbial pathogens, including 
Gram-positive and Gram-negative bacteria, viruses, parasites, fungi , and yeasts. In these 
microbes, proteases are involved in numerous processes, including potentially pathogenic 
functions (Travis et al., 1995; Goguen et al., 1995; Maeda & Yamamoto, 1996; 
Harrington, 1996). A number of areas in which microbial proteases are known to exert 
their pathological effects are discussed below. 
2. 6.1 Tissue destruction 
a) Direct 
Bacterial proteases can directly degrade proteins that are essential to tissue 
architecture, namely collagen, fibronectin and elastin, resulting m massive tissue 
destruction. Many bacterial diseases associated with tissue destruction have been linked 
to the ability of the bacterium to express proteases that degrade one or more essential 
57 
tissue proteins (Table 2.4). Prime examples are: corneal keratitis caused by 
Serratia marcesens (Molla et al., 1986) and Pseudomonas aeruginosa (protease-negative 
strains of this species do not cause the disease) (Fisher & Allen, 1958); periodontitis 
caused by Porphyromonas gingivalis (Potempa et al., 1995); gangrene caused by 
Clostridium perfringens (Rood & Cole, 1991; Matsushita et al., 1994 ); and pneumonia 
caused by Legionella pneumophila (Baskerville et al., 1986), Aspergillus fumigatus 
(Kolattukudy et al., 1993; Kothary et al., 1999), and P. aeruginosa (Galloway, 1991) 
(Table 2.4 contains a partial list of bacterial proteases involved in direct tissue 
destruction). Tissue degradation can benefit the bacterium by providing a source of 
amino acids that are essential for growth, breaking down tissue planes facilitating 
bacterial spread, and providing an environment suitable for growth, as is the case with 
anaerobic bacteria. 
Table 2.4. Tissue destructive enzymes of bacterial pathogens 
Organism Disease Substrate Reference 
Porphyromonas spp. Periodontal disease Co llagen Potempa et al. , ( 1995) 
Serratia spp. Corneal keratitis Collagen Molla et al. , 1986 
Clostridium spp. Necrotising diseases Collagen Bond et al., (1984) 
Pregnancy complications Matsushita et al. , (1994) 
E. coli Pregnancy complications Collagen McGregor et al., (1987) 
Peptostreptococcus spp. Breast abscess, diabetic foot Coll agen Krepel et al., (1991) 
necrotic pulp chambers 
Enterococcus faecal is Infections (wound, urinary tract, Co ll agen Su et al. , (1991) 
biliary tract), endocarditis, septicaemia 
intra-abdominal abscesses 
Legionella pneumophila Legionnaire ' s disease Collagen Baskerville el al., (1986) 
Pseudomonas aeruginosa Corneal keratitis, Emphysema Coll agen Galloway et al., (1991) 
Cystic fibrosis infections Elastin 
Aspergillus fumigatus aspergi llosis Elastin Kothary et al., (1984); 
Kolattukudy et al. , ( 1993) 
Staphylococcus aureus pneumonia Elastin Potempa et al., (1988) 
Staphlococcus epidermidis Perifollicular or macular atrophy Elastin Sloot et al., ( 1992) 
Vibrio spp. Elastin Smith et al. , ( 1982) 
Fibronectin 
Serratia spp. Fibronectin Molla et al. , 1986 
b) Indirect 
Fibroblasts, neutrophils, and macrophages secrete proenzymes including latent 
connective tissue-degrading metalloproteinases. Microbial proteases acting on these 
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enzymes can activate collagenases and tissue plasminogen activator, both of which can 
cause tissue destruction and facilitate bacterial translocation (for example, the cysteine 
protease of P. gingivalis activates the complement system, neutrophils are attracted to the 
sight of inflammation, the dying neutrophils release elastase, Cathepsin G, proteinase 3, 
collagenase and gelatinase which then degrade connective tissue) (Uitto et al., 1989; 
Matsumoto et al. , 1992; Sorsa et al. , 1992; Travis et al., 1995). 
2.6.2 Immune evasion 
The complement system is an integral part of the host's defense against invading 
microbes. Part of the complement system's function is the recruitment of phagocytic 
cells (by generating chemotactic factors) and opsonisation ( enabling recognition by 
phagocytic cells). Bacteria avoid this process by producing proteases that degrade 
complement components and immunoglobulins. This renders the host's immune system 
"blind" to infecting pathogens, contributing to both extracellular and intracellular 
survival. The Serratia 56 K protease and Group B Streptococcus C5a protease can both 
inactivate complement chemotactic component C5a (Hill et al. , 1988; Molla et al. , 1989), 
and the Candida albicans proteinase and Yersinia pestis Pla protease can degrade 
complement component C3 (Sodeinde et al., 1992; Kaminishi et al. , 1995). In addition, 
proteases from a number of bacteria (for example, P. aeruginosa, S. epidermidis, 
C. albicans, and Neisseria spp) can degrade immunoglobulins, notably IgA and IgG, 
thereby disrupting opsonisation and evading phagocytosis (Plaut et al., 1975; Galloway, 
1991 ; Sloot et al., 1992; Kaminishi et al. , 1995). 
Bacterial metabolic products that act as chemotactic factors, for example formyl-
Met-Leu-Phe peptide, are also substrates for some bacterial proteases. Pseudomonas 
elastase is able to degrade this peptide and destroy its receptor present on the surface of 
neutrophils (I j iri et al., 1994). 
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Some bacteria escape the host's immune response by interfering with T-cell 
activation and function. A Legionella pneumophila protease can degrade IL-2 and cleave 
CD4 on human T cells, suggesting a contribution by this protease to the ability of the 
bacterium to evade the host's immune mechanisms (Mintz et al., 1993). Included in the 
diverse repertoire of the well-characterised Pseudomonas elastase is an ability to 
inactivate IFN-y, thereby diminishing activation of macrophages and other inflammatory 
cells (Horvat, 1989). 
2. 6. 3 Activation of the kallikrein-kinin cascade 
The bradykinin-generating cascade plays an important part in the host's attempt 
to attract phagocytes to the site of infection. Physiological activation of this system 
results in vasodilation and increased vascular permeability, improving access of 
phagocytic cells to the area of infection. Inappropriate stimulation or upregulation of this 
system results in persistent vasodilation, hypotension and shock. In fact, Khan & James 
(1993) demonstrated that the activation of the kallikrein-kinin cascade is a critical factor 
in the development of septic shock. A large number of bacterial proteases are able to 
activate the bradykinin-generating cascade at one or more steps (Figure 2.2) (Molla et al., 
1989; Kaminishi et al., 1990; Shibuya et al., 1991; Maeda & Yamamoto, 1996). The 
resulting enhancement of vascular permeability ensures an adequate supply of nutrients 
to the site of infection, promoting bacterial growth. Some bacteria exploit the increase in 
vascular permeability to gain access to the systemic circulation, aiding dissemination 
(Sakata et al., 1996). Activation of human plasma kallikrein can also lead to the 
activation of neutrophils (neutrophil proteases may contribute to tissue damage and 
dysregulation of physiological processes), the coagulation cascade, fibrinolytic system 
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Figure 2.2. The role of bacterial proteases in activating the bradykinin generating cascade. The 
steps where bacterial proteases are known to be involved are highlighted in grey. Adapted from Maeda & 
Yamamoto (1996). 
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The host attempts to localise invading bacteria, thereby allowing it to focus 
bactericidal mechanisms on a specific area. Localisation is partly achieved by the 
coagulation cascade, which when activated, deposits fibrin, entrapping the bacteria and 
preventing dissemination. However, some bacterial proteases activate plasmin, 
dissolving fibrin clots and allowing dissemination (Lottenberg et al. , 1994). Although 
activation of the clotting cascade is a well-regulated universal host response to bacterial 
infection, dysregulation of this response by bacterial proteases can result in increased 
fibrin deposition (Kaminishi et al., 1994). This, together with inhibition of antithrombin 
III by some microbial proteases, results in a hypercoagulable state or disseminated 
intravascular coagulation syndrome. 
2. 6. 4 Cytotoxicity 
Pathogenic bacteria have developed methods of targeting their proteases into the 
interior of host inflammatory cells. This involves a mechanism dependent on 
a 2-macroglobulin, an inhibitor of diverse proteases present in human serum. The 
a 2-macroglobulin-protease complex gains access to fibroblasts and macrophages via 
a 2-macroglobulin receptors present on their surface. Once inside lysosomes, partial 
degradation of this complex regenerates the activity of the protease, resulting in 
degradation of intracellular proteins and cell death (Maeda et al. , 1987). Both the 
Serratia 56 K protease and Pseudomonas alkaline protease can induce cell death through 
this mechanism (Maeda et al. , 1987; Maeda & Molla, 1989). 
2. 6. 5 Inactivation of plasma protease inhibitors 
Host proteolytic systems are usually finely controlled by a number of plasma 
protease inhibitors. Bacterial proteases can dysregulate this homeostatic mechanism by 
degrading the inhibitors, allowing unregulated proteolytic activity by both bacterial and 
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host proteases. The pathological consequences of antithrombin III degradation have 
already been mentioned. Similarly, degradation of al-protease inhibitor, complement 
component Cl-inhibitor, and a2-macroglobulin, result in pathological consequences for 
the host. For example, the elastase/antielastase system in mammals is controlled by 
serum protease inhibitors, especially al-protease inhibitor (Stockley, 1983). A decrease 
in this inhibitor may result in unopposed elastolysis resulting in tissue destruction. 
Examples of bacterial proteases that promote elastolysis include Pseudornonas elastase 
and C. albicans acid protease (Morihara, 1979; Kaminishi et al., 1995). These proteases 
degrade a I-protease inhibitor ( and in the case of the C. albicans acid protease also a 2-
macroglobulin) thereby releasing normally inhibited host serine proteases (for example, 
neutrophil elastase), promoting tissue destruction. Similarly, the coagulation cascade, 
fibrinolysis, complement activation, and phagocytosis, all regulated by host-derived 
proteases, may also be affected. 
2. 6. 6 Nutrition 
Many bacteria (for example, Pseudornonas, Serratia, and Bacillus) produce 
proteases that degrade macromolecules as a nutrient source (Travis et al., 1995). 
Involvement of these proteases in nutrient acquisition is demonstrated by the inability of 
protease-deficient strains to grow on media containing large peptides and few sources of 
nitrogen (Travis et al., 1995); growth resumed once free amino acids or proteolytic 
enzymes were added. Organisms unable to adequately degrade host proteins may instead 
exploit the activities of phagocyte-derived proteases (Travis et al., 1995). 
2. 6. 7 Activation of bacterial toxins 
Several bacterial toxins are activated by bacterial and host proteases, for example: 
diphtheria toxin, anthrax toxin, botulinum toxin, cholera toxin, and tetanus and botulinum 
neurotoxins (Gordon & Leppla, 1994). Furthermore, the botulinus and tetanus 
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neurotoxins (BoNT and TeNT, respectively) are now known to be proteases 
(Montecucco & Schiavo, 1993). These two neurotoxins are zinc metalloproteases that 
both act specifically on protein components of the neuroexocytosis apparatus 
(Montecucco & Schiavo, 1994). Sellner et al. (1993) proposed a hypothesis for general 
intracellular membrane fusion in all eukaryotic cells. This hypothesis requires NSF 
(N-ethylmaleimide-sensitive fusion protein) and SNAPs (soluble NSF-attachment 
proteins) as soluble factors for transport vesicle docking and fusion at multiple stages of 
the secretory and endocytic pathways. NSF interacts with SNAPs that have attached to 
SNAREs (SNAP receptors) present on transport vesicles (v-SNAREs) and target vesicles 
(t-SNAREs). Thus, each transport vesicle has its own specific v-SNARE that will attach 
to a cognate t-SNARE found only on the intended target membrane (Sellner et al. , 1993). 
VAMP (vesicle-associated membrane protein)/synaptobrevin, SNAP-25, and syntaxin 
are all SNAREs that are involved in the neuroexocytosis apparatus (Clary et al., 1990; 
Whiteheart et al. , 1993). Both BoNT and TeNT cleave these SNAREs, thereby 
impairing the assembly of the neuroexocytosis apparatus and blocking neurotransmitter 
release (BoNT-B, -D, -F, -G and TeNT cleave VAMP/synaptobrevin, BoNT-A, -E cleave 
SNAP-25 , and BoNT-C cleaves syntaxin) (Montecucco & Schiavo, 1994). The same 
kinds of vesicle membrane proteins likely regulate endocytosis and phagocytosis, thus it 
can be speculated that intracellular pathogens, such as M tuberculosis, may elaborate 
proteases that degrade specific SNAREs, and thus promote intracellular survival by 
inhibiting membrane fusion events integral to host defense. 
2. 6. 8 Other pathogenic mechanisms 
Many bacterial proteases have a specific function, which is related either to the 
physiology of the bacterium or to the pathogenesis of disease. However, there are 
bacterial proteases that possess a diverse repertoire of functions that could contribute to 
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pathology in a number of ways. A typical example is the S. pyogenes cysteine protease 
(SCP). SCP releases biologically active proteins, such as M proteins and protein H, from 
the streptococcal surface (M proteins possess antiphagocytic properties and promote 
adherence; and protein H is an immunoglobulin-binding protein) (Berge & Bjorck, 
1995). The release of M proteins promote bacterial dissemination, and the binding of 
protein H to immunoglobulin G (thereby forming immune complexes) contributes to the 
development of glomerulonephritis and rheumatic fever. SCP activates the streptococcal 
C5a peptidase, thereby blocking C5a-mediated granulocyte migration and prevents 
phagocytes reaching the site of infection (Cleary et al., 1992). In addition, SCP also 
activates kinins and a human endothelial cell matrix metalloprotease (Herwald et al., 
1996; Burns et al., 1996); it acts synergistically with other S. pyogenes products, further 
increasing tissue injury (Shanley et al., 1996); and it enhances the ability of the 
bacterium to invade human respiratory epithelial cells (Tsai et al., 1998). 
Recently, a novel pathogenic mechanism of microbial metalloproteases was 
described. It is well known that various endogenous host membrane-bound 
metalloproteases are responsible for the release of effector molecules (for example, TNF-
a and its receptor, angiotensin converting enzyme, interleukin-6 receptor (IL-6R), and 
the Fas ligand). Vollmer et al. (1996) showed that the S. marcesens metalloprotease and 
various bacterial supernatant samples (S. aureus, P. aeruginosa, L. monocytogenes, and 
B. subtilis) released biologically active IL-6R in vitro. The ability of bacteria to cleave 
cell surface recognition molecules or receptors for growth factors and cytokines could 
contribute to the virulence of the organism by disturbing inter-cell communications and 
cellular interactions. This may also result in the cells becoming refractory to cytokine 
stimulation. 
Lastly, the ability of intracellular bacteria to manipulate the phagosome and 
preventing phagosome-lysosome fusion is presumed to be a potential virulence 
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mechanism employed by some bacteria to promote intracellular survival. At least one 
bacterial protease has been demonstrated to degrade an endosomal membrane protein 
preventing phagosome-lysosome fusion. The IgAl protease of Neisseria meningitidis 
and Neisseria gonorrhoeae cleaves LAMPI, an integral membrane glycoprotein of late 
endosomes and lysosomes that is thought to play an important role in maintaining the 
stability of these compartments (Lin et al., 1997). In addition, the ability to cleave 
LAMPI has been associated with an enhanced survival in human epithelial cells. Since 
these proteases are only produced by pathogenic Neisseria spp., it is presumed that their 
function is related to virulence. If phagosome-lysosome fusion occurs, it is possible that 
bacterial proteases are capable of inactivating lysosomal hydrolases. Leishmania 
mexicana amazonensis depends on the surface membrane Zn-protease, gp63, for 
phagolysosomal survival (Seay et al., 1996). The exact mechanism by which gp63 
accomplishes this is unknown; however, it has been proposed that this protease is able to 
degrade lysosomal hydrolases, creating a hydrolase-free microenvironment around the 
parasite cell body. 
2.7 PROTEASES IN MYCOBACTERIA 
I 
Very little is known about the diversity and functions of mycobacterial proteases. 
Until 1997 there were only four short reports of proteases in mycobacteria: three reports 
studying the enzymatic profile of M tuberculosis detected extracellular protease activity 
(Reich et al., 1981; Casal & Linares, 1984; Kannan et al., 1987), and one report 
described the identification of a putative serine protease in M paratuberculosis 
(Cameron et al., 1994). This putative serine protease is homologous to HtrA proteases, 
which are stress proteins that are induced by heat shock and oxidative stress, thus 
suggesting a role for this protease in the M paratuberculosis stress response. 
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More recently, candidate proteases have been reported in mycobacteria, including 
FtsH, two secreted serine proteases (MTB32A and MTB32B), and an unidentified 
elastolytic metalloprotease in M tuberculosis (Rowland et al., 1997; Raynaud et al., 
1998; Anilkumar et al., 1998; Skeiky et al., 1999); the 20S proteasome and the Lon 
protease in M smegmatis (Knipfer & Schrader, 1997; Roudiak & Schrader, 1998; 
Roudiak et al., 1998b) and the Clp protease A TPase subunit, ClpC, in M leprae 
(Roquette et al., 1998); but the data remain sparse. Amongst the paucity of research data 
on M tuberculosis proteases there are two studies that provide compelling evidence for 
the expression and secretion of proteases by this organism. The first describes the 
identification of a zinc metalloprotease in M tuberculosis H37Rv culture filtrates 
(Rowland et al., 1997). This metalloprotease degrades elastin and was found to be most 
abundant in the stationary phase of the M tuberculosis growth cycle. Since elastin is an 
integral component of the lung tissue architecture (30% of the lung is elastin), elastin 
degradation would result in severe lung tissue damage. It is possible that 
M tuberculosis, in response to the nutritional stress present in the stationary phase of 
growth, secretes this metalloprotease that provides essential nutrients through the 
degradation of elastin but in so doing causes severe lung tissue damage. This may partly 
explain the lung tissue damage characteristic of tuberculosis. Unfortunately, the authors 
were unable to purify this protease so its substrate preferences and function are unknown. 
The second report describes the identification of two putative secreted serine 
proteases in M tuberculosis (Skeiky et al., 1999). One of these proteases induced IFN-y 
secretion from peripheral blood mononuclear cells isolated from only purified protein 
derivative (PPD)-positive individuals. Thus, the authors concluded that this protease 
may be part of the hosts immune response to M tuberculosis and could be a candidate for 
inclusion in a subunit vaccine. 
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The few reports suggesting the presence of secreted proteases in M tuberculosis 
have been verified by the M tuberculosis genome sequence that revealed the presence of 
of more than 20 putative protease genes (a partial list is presented in Table 2.5), some of 
them containing putative signal peptides, suggesting that they may be secreted 
(Cole et al., 1998). However, at present, little is known about the diversity of 
mycobacterial proteases, patterns of expression, substrate specificities, and their role in 
pathogenesis. 
Table 2.5. Putative protease genes detected in the M. tuberculosis genome 
Gene number Designation Homology match 
Rv2223c Probable exported protease 
Rv2224c Probable exported protease 
Rv2672 Probable exported protease 
Rv3596c clpC ATP-dependent Clp protease 
Rv3419c gcp G lycoprotease 
Rvl223 htrA Serine protease 
Rv0125 pepA Probable serine protease 
Rv2213 pepB Aminopeptidase A/I 
Rv0800 pepC Aminopeptidase I 
Rv2467 pepD Probable aminopeptidase 
Rv2089c pepE Cytoplasmic peptidase 
Rv2535c pepQ Cytoplasmic peptidase 
Rv2782c pepR Protease/peptidase, Ml6 family 
Rv2109c prcA Proteasome - type subunit 1 
Rv2110c prcB Proteasome - type subunit 2 
Rv0457c Probable peptidase 
Rv0983 Probable serine protease 
Rvl977 Probable zinc metallopeptidase 
Rv3668c Probable alkaline seine protease 
Rv367lc Probable serine protease 
Rv3886c Protease 
Rv0198c Probable zinc metallopeptidase 
2.8 CONCLUSION 
The pathogenesis of tuberculosis compnses a number of critical processes in 
which proteases produced by M tuberculosis could, m principle, be involved. The 
hallmark of an M tuberculosis infection is the ability of the bacillus to evade the 
bactericidal mechanisms of the macrophage and to multiply intracellularly. Many 
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investigators believe that the inability of the M tuberculosis-containing phagosome to 
fuse with lysosomes is a consequence of manipulation of the phagosome membrane by 
bacterial products. M tuberculosis proteases could be involved in this process. In 
addition, the ability of the bacterium to grow and multiply intracellularly may depend on 
the proteolytic degradation of macromolecules thereby releasing amino acids and 
peptides as a nutrient source. 
The ability of the host to limit an M tuberculosis infection is dependent on an 
intense cell-mediated immune response. By elaborating proteases that degrade 
complement components, immunoglobulins, chemokines, and cytokines, T cell function 
would be severely compromised, enabling the bacillus to evade the immune response and 
promoting intracellular survival. The tissue destruction pathognomonic of active 
tuberculous lung disease has been attributed to delayed-type hypersensitivity to bacterial 
antigens. Although there is probably a large component of immune-mediated tissue 
destruction, it is possible that M tuberculosis proteases could play a significant role. 
Factors that promote dissemination of mycobacteria to other sites can be regarded 
as virulence factors . Post-primary reactivation disease is poorly understood but one 
possible scenario is escape of quiescent bacilli from fibrosed pulmonary foci , which in 
turn, may depend on the expression of proteases that degrade surrounding tissue proteins, 
aiding dissemination via the airways, lymphatics and bloodstream. As already discussed, 
such protease functions have been demonstrated in other bacteria. 
In light of these considerations and the prevalence of proteases as virulence-
associated factors in phylogenetically diverse bacterial pathogens, it is plausible that 
proteases may contribute to the pathogenic capacity of M tuberculosis. Hence a search 
for and analysis of protease-encoding genes, and an investigation of the properties and 
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Microbial pathogens frequently produce extracellular proteases as virulence 
factors, which often contribute significantly to pathology (Travis et al. , 1995; Maeda et 
al., 1996; Goguen et al., 1995). There has been speculation on the mechanisms and 
molecules involved in the pathogenesis of the pathological sequelae ( especially the 
pulmonary damage) characteristic of M tuberculosis infection. The favoured view is 
that the observed pathology is a consequence of a robust host immune response. 
Although there is evidence linking the pathology to host factors, it remains possible that 
the observed pathology is bacterially mediated. The hallmarks of an M tuberculosis 
infection are its ability to evade intracellular killing, to cause massive tissue destruction, 
and to cause reactivation disease after having remained dormant for many years. Other 
pathogenic bacteria are able to resist host immune attack and produce tissue destruction 
through the elaboration of proteases, thus making a search for M tuberculosis proteases 
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warranted (Travis et al., 1995; Harrington, 1996). At the start of this study, apart from 
three short reports suggesting the presence of proteolytic activity in M tuberculosis 
(Reich et al., 1981; Casal et al., 1984; Kannan et al., 1987), nothing was known about 
the diversity of M tuberculosis proteases, patterns of expression, substrate specificity, 
and possible links to pathogenesis. This chapter describes the efforts made to induce and 
detect proteolytic activity in M tuberculosis culture filtrates. 
3.2 M. TUBERCULOSIS CULTURING METHODS 
For years microbiologists have debated the wisdom of studying bacteria under 
laboratory conditions, necessitating cultivation in artificial media, as in vitro 
manipulation of bacteria may alter the gene expression profile compared to that driving 
in vivo propagation. M tuberculosis, as a prime example, has been a constant challenge. 
In their quest to study the bacillus in its natural state, researchers have noticed that 
culture conditions influence the organisms' physiology, antigenicity, pathogenicity and 
chemical composition, which significantly influence our interpretation of the fate of 
tubercle bacilli within the host. 
During the establishment of tuberculosis, the M tuberculosis bacilli encounter, and 
overcome, a variety of host defense mechanisms. The bacilli are able to survive these 
initial salvos by the host defense and multiply, suggesting that they possess the 
machinery required to survive adverse conditions. Therefore, to accurately study 
M tuberculosis, attempts are made to approximate in vivo conditions. However, to 
achieve this in the laboratory has proven difficult, and it has been the concern of many 
researchers that M tuberculosis bacilli cultivated in vitro are not representative of in 
vivo-grown bacilli. To this end numerous studies have been performed comparing in 
vitro- and in vivo-propagated M tuberculosis bacilli. Although no differences have been 
noted when comparing in vitro and in vivo grown bacilli with respect to morphology, 
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staining properties, colony characteristics and rate of growth, biochemical differences 
and differences in their pathogenicity for mice have been noted (Segal & Bloch, 1956 
1957). Early experiments showed a significant difference in lipid content as well as total 
lipid concentration between in vitro and in vivo grown M tuberculosis H37Rv (Sheehan 
& Whitwell, 1949). In addition, several chemical compounds (phthicol, tuberculostearic 
acid, phthioic acid, and polysaccharides) characteristic of in vitro grown M tuberculosis 
bacilli could not be found in tuberculous lung tissue (Anderson et al., 1943). 
More recently, intracellular residence of M tuberculosis bacilli in macrophages 
was shown to induce at least 16 and repress about 28 M tuberculosis proteins (Lee et al., 
1995). When these bacteria were exposed to in vitro stress conditions - including heat-
shock, low pH and H20 2 - about 10 of the macrophage-induced proteins were produced. 
Thus, at least 6 proteins were not detected during in vitro growth under both normal or 
stress conditions. Furthermore, the pattern of induced and repressed proteins was unique 
to each stress condition. From these experiments it is clear that in vivo-grown bacilli are 
dissimilar to the same bacilli grown in vitro. 
Apart from the in vitro vs in vivo question other factors have been shown to be 
important in the culturing of M tuberculosis. Much attention has focused on the level of 
aeration of M tuberculosis cultures. This is based on the presumption that, in diseased 
tissues, the bacilli are primarily exposed to anaerobic conditions. Thus, some 
investigators conclude that aerating M tuberculosis cultures will give rise to 
'unphysiological' bacteria. Aeration fosters logarithmic growth (Volk & Myrvik, 1953) 
and can prevent early autolysis (Wayne & Diaz, 1967) giving rise to high yields of viable 
organisms. Smaller yields of viable bacilli are obtained under anaerobic conditions and 
these bacilli appear to behave differently in vivo after infection of mice. 
Collins et al. (1974) showed that as cultures aged, and especially under conditions of 
oxygen restriction, an increasing proportion of an intravenous challenge inoculum of 
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M tuberculosis bacilli could be recovered from the lung compared with the spleen of an 
infected mouse. This suggests that varying the degree of aeration of M tuberculosis 
cultures may alter the phenotype of the bacillus. Proof of an altered phenotype was 
obtained by the electron microscopic demonstration that anaerobically ( or 
microaerobically) grown bacilli have a thicker cell wall outer layer and a reduced cell 
diameter compared to bacilli grown aerobically (Cunningham & Spreadbury, 1998). The 
altered phenotype, together with the presence of most of the enzymes required for 
anaerobic metabolism, and the induction of some proteins by reduced oxygen tension 
[e.g., the 16-kDa small heat shock protein (Cunningham & Spreadbury, 1998)], suggests 
M tuberculosis has developed methods to survive anaerobic conditions. This may 
contribute significantly to its virulence as it encounters a large variation in partial oxygen 
pressures during the disease process and/or may play a pivotal role in the establishment 
of the dormant state. 
The "aeration-effects" are influenced by the carbon source present in the culture 
medium. Growth of M tuberculosis was inhibited under aerobic conditions when the 
medium contained glucose, but growth was stimulated when glycerol served as the 
source of carbon (Lyon et al., 1961). Wayne (1994) suggests that the presence of 
glycerol may direct metabolism into a pathway that is not representative of the 
physiologic state of in vivo propagated bacilli and thus may be counterproductive in the 
in vitro study of M tuberculosis. This notwithstanding, glycerol-containing medium can 
be beneficial as it has been reported to be able to maintain virulence of a strain of 
M tuberculosis whereas there was decreased virulence (for the experimental mouse) 
when this strain was grown in detergent-containing medium (Wayne, 1994). This 
suggests that the addition of a detergent may influence the M tuberculosis phenotype and 
would probably be counterproductive in attempting to approximate in vivo conditions. 
However, without a detergent in the culture medium, M tuberculosis, due to its 
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hydrophobic nature, will grow as a waxy pellicle in a stationary culture and with 
extensive clumping in a stirred culture. As each bacterium within a clump has various 
degrees of access to oxygen and other nutrients, clumping will generate a physiologically 
heterogenous group of bacteria (Wayne, 1979). The presence of a detergent in the culture 
medium minimises the amount of clwnping and ensures a more homogenous population 
of bacteria, but adds to the risk of potentially altering the M tuberculosis phenotype. 
In order to accurately study the biochemistry and physiology of M tuberculosis, a 
culture containing bacilli that are at the same stage of their growth cycle (i.e. , 
synchronised) is ideal. This is very difficult to achieve with M tuberculosis. 
Nevertheless, bacilli that are propagated without rotation are more likely to yield 
synchronous cultures. As bacilli settle slowly through a natural oxygen gradient present 
in stationary cultures replication stops yet viability is not impaired for several weeks 
(Wayne, 1976). These bacilli arrive in the microaerophilic sediment in a uniform stage 
of their replication cycle and are thus synchronised (Wayne, 1977); approximately 8 h 
after reaeration the bacilli multiply in a synchronous manner. 
Apart from the type of carbohydrate present, other compounds have been shown to 
affect the growth or biochemical nature of the bacilli. Two examples are, first, the 
absence of sulphur in the medium results in a decreased rate and extent of growth of 
M tuberculosis (Youmans, 1946) and, second, phosphate starvation enhances the 
expression of P38, the irnrnunodominant 38-kDa protein of M tuberculosis (Espitia et 
al. , 1992). 
75 
3.3 MATERIALS AND METHODS 
3.3.1 Bacterial stocks 
Laboratory strains were M tuberculosis H37Rv-HH (Cywes et al., 1996) and 
Erdman (ATCC 35801). A clinical isolate of M tuberculosis was GSH-3052 (from a 
pleural effusion) (Cywes et al., 1997). The clinical isolate was obtained from the 
Bacteriology Laboratory, Department of Medical Microbiology, Groote Schuur Hospital, 
Cape Town, South Africa. 
3.3.2 Culture media 
Bacterial stocks were initially cultured on Lowenstein Jensen (L-J) agar slopes. An 
inoculum of the pure bacterial stock was then transferred into a liquid culture medium. To 
assess the effect of the type of culture medium on the production of proteolytic activity, the 
bacteria were grown in different media: Kirchner's (K+), Sauton's (S) and minimal 
Kirchner's (Kirchner's without glycerol and asparagine; K) with or without an added 
protease substrate ( either elastin, casein, BSA or haemoglobin). 
































All M tuberculosis strains were initially grown on L-J slopes at 37°C for 2 
weeks. The bacteria were then gently dislodged with a sterile cotton bud and transferred 
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into 2 ml Kirchner's medium. After passing this suspension through the tip of a 1 ml 
Gilson pipette to break up the larger clumps, it was then diluted 1 :25 in the same 
medium. The liquid culture was incubated, shaking at 200 rpm, for 2 weeks at 37°C. 
Thereafter, 25 ml of the culture were inoculated into 75 ml of fresh Kirchner's medium 
and incubated, shaking at 200 rpm or standing, at 3 7°C for up to 4 weeks. 
At 7 days, 14 days, 21 days and 28 days of incubation the cultures were harvested. 
After pelleting the bacteria by centrifugation at 3,000 x g for 20 min at 4°C, the 
supernatant was passed through a 0.22 µm low-protein-binding filter to remove residual 
bacteria that were not pelleted during centrifugation. To prevent adventitious microbial 
contamination, sodium azide was added to a final concentration of 0.02%, after which the 
culture filtrate was concentrated 20-fold using an Amicon concentration device 
containing a membrane with a 10-kDa cut-off. All of the procedural steps involving the 
preparation of the supernatant were carried out at 4°C to limit any proteolysis. Aliquots 
of the 20-fold concentrate of the culture filtrate were used to assay for proteolytic 
activity. 
3.3.4 Preparation and iodination of fibrinogen 
Fibrinogen ( obtained from the MRC Liver Research Centre, Groote Schuur 
Hospital, Cape Town) was iodinated using IODO-GEN™ (Pierce and Warner, Cheshire, 
England) as an oxidising agent in the presence of 0.5 µCi [
125I]-Na/µg fibrinogen 
(Amersham International, England) (Shephard et al., 1989; Fraker et al., 1978). The 
iodinated protein is designated 125I-fibrinogen. 
3.3.5 Detection of proteolytic activity 
l;\ 1251-fib . 1 - 1 nnogen assay 
Culture filtrate (20-fold concentrate; 200 µl) was added to a glass Kimble tube 
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containing 500 µl HEPES (100 mM, pH 7.3) and 3 µl 125I-fibrinogen (1.5-2 x 106 cpm). 
A reaction without culture filtrate and a reaction without culture filtrate but containing 1 
µl trypsin (lµg/ml) were run in parallel as the negative and positive control, respectively. 
The reactions were incubated (with constant agitation) at 37°C for 16-18 h. At various 
time-points, 50 µl of this reaction was used to measure degradation, quantitatively by 
7.5% trichloracetic acid (TCA)-soluble peptide formation, and qualitatively by 
SDS-PAGE analysis and autoradiography. The TCA precipitation reaction mixture 
contained 300 µl PBS and 50 µl bovine serum albumin (5%) to which 50 µl protease 
assay was added. This reaction mixture was precipitated by the addition of 70 µl 50% 
(w/v) TCA at 4°C to result in a final concentration of 7.5%. After 1 h on ice, the 
precipitation reaction was gently mixed and 100 µl was transferred into a plastic Kimble 
tube (tube A), representing the total cpm. The rest of the reaction was centrifuged at 
12,000 x g for 1 min and 100 µl of the supernatant was transferred into a second plastic 
Kimble tube (tube B), representing the TCA soluble peptide fraction. In all figures , 
percentage degradation refers to the percentage TCA solubility of 125I-fibrinogen and was 
calculated using the following formula : % degradation= (tube B cpm/tube A cpm) x 100. 
For qualitative analysis using SDS-PAGE, 50 µl of the assay was mixed with an equal 
volume of SDS-PAGE loading buffer (2x), boiled for 5 mins and then subjected to 
electrophoresis under reducing conditions in a 7.5% SDS-polyacrylamide gel (Appendix 
A.5). Approximately 15,000 cpm were loaded per lane. Following electrophoresis, the 
gels were dried and the products visualised by autoradiography. 
ii) Elastin-Congo red assay 
Elastin-Congo red (Sigma) (10 mg) was added to 1 ml 30 mM Tris-HCl (pH 7.2) 
and immediately vortexed to prevent aggregation. A sample of the culture filtrate (500 
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µl) was added and the mixture was incubated at 3 7°C for 6 h. After centrifugation at 
1,200 x g, the absorbance of the supernatant was read at 495 nm. A reaction containing 
sterile distilled water (sdH20) or 20 ng elastase (Sigma) instead of the culture filtrate 
sample served as the negative and positive control, respectively. 
3.3.6 Characterisation of the proteolytic activity 
i) Inhibitor profile 
Inhibition of proteolytic activity was examined by incubation of the culture 
filtrate in the presence of various protease inhibitors (listed in Table 3.2) and 
i2sl fib . - 1 rmogen. The assay was then subjected to TCA precipitation and SDS-PAGE 
analysis, as described in section 3.2.5 . 
Table 3.2. Protease inhibitors used to establish the catalytic-type 
of protease activity 
Inhibitor Solvent Working 
concentration 
Aprotinin H20 4 µg/ml 
Leupeptin H20 0.4mM 
Pefabloc H20 lmM 
TLCK HCI (lmM) 0.6mM 
TPCK methanol 0.6mM 
Chymostatin DMSO 0.2mM 
PMSF DMSO lmM 
3,4-dich loroisocoumarin DMSO lmM 
(3,4-DCI) 
ALLN DMSO 200 µg/ml 
ALLM DMSO 100 µg/ml 
E-64 Ethanol : H20 0.2mM 
(] : ]) 
Pepstatin A DMSO 0.07mM 
1, 10-phenanthro I ine methanol IOmM 
Phosphoram idon H20 0.09mM 
EDTA H20 IOmM 
ii) pH and temperature optima 
The effect of pH was examined by incubation of the culture filtrate with 
125I-
fibrinogen under the standard assay conditions with exception of the buffer. The buffers 
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used were 100 mM sodium acetate (pH 4.5; 5.0), 100 mM tri-sodium citrate (pH 5.5-6.5), 
100 mM HEPES (pH 7.0-8.0), and 100 mM sodium borate (pH 8.5-9.5). 
The temperature dependence of the proteolytic activity was assessed using the 
standard assay conditions except that the assay was incubated at 4°C, 25°C and 37°C. 
Thermostability of the activity was determined at -70°C and 80°C. After exposure of the 
culture filtrate to these temperatures for 10 min, the samples were incubated under 
standard assay conditions at 3 7°C. 
iii) Effect of metal ions 
Culture filtrate samples were incubated under standard assay conditions in the 
presence of 2.5 mM CaCb or 0.1 mM ZnS04. 
3.3.7 Zymography 
M tuberculosis GSH-3052 culture filtrate (20 ml) was dialysed overnight against 
sdH20 [dialysis tubing (Spectrapor, Los Angeles, USA) with a 12-14 kDa size cut-off] , 
lyophilised, and resuspended in 40 µl sdH20 and 40 µl non-reducing SDS-PAGE 
solubilisation buffer. The sample was not boiled. An aliquot (20 µl) was applied to a 
10% SDS-polyacrylamide gel copolymerised with casein (lmg/ml). After 
electrophoresis at 4 °C (to prevent autodigestion), SDS was removed by successive 
washes in 2.5% (w/v) Triton X-100 in distilled water (dH20) for 20 min, 2.5% (w/v) 
Triton X-100 in 50 mM Tris-HCl (pH 7.4) for 20 min, and 50 mM Tris-HCl (pH 7.4) for 
20 min. The gel was then incubated overnight at 37°C in 50 mM Tris-HCl (pH 7.4), 
fixed in 10% methanol/I 0% acetic acid for 10 min, stained with Coomassie brilliant blue 
R-250 and then destained with 10% methanol/ IO% acetic acid. The gel was then viewed 
on a light box and dried. 
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3.4 RESULTS 
3.4.1 Detection of proteolytic activity in M. tuberculosis culture filtrates 
To test whether M tuberculosis secretes proteases, two well characterised strains, 
H37Rv and Erdman, and a clinical isolate, GSH-3052, were grown in Kirchner's 
medium. The supematants (equal volumes) were assayed for proteolytic activity using 
1251-fibrinogen as substrate. Proteolytic activity could be detected in the culture filtrates 
of all 3 strains, with the clinical isolate having the highest levels (56%) of degradation, 
followed by Erdman (44%), and then H37Rv (18%) (Figure 3.1). 
C: 
















Figure 3.1. Detection of proteolytic activity in culture filtrates of 3 strains of M. tuberculosis. All 
strains were cultured in Kirclmer's medium. The supernatants were filtered , concentrated and then 
assayed for proteolytic activity using 1251-fibrinogen as substrate ( equal cpm counts added per assay). The 
amount of degradation of fibrinogen was assessed by TCA precipitation (as described in Materials and 
Methods). Samples with no culture filtrate or trypsin (500 ng) were used as the negative (- ve) and 
positive (+ ve) controls, respectively. Data are the means and standard deviations of three samples from 
two independent cultures. 
Although the proteolytic activity, as measured by TCA precipitation, was variable 
from experiment to experiment, SDS-PAGE analysis revealed a consistent pattern of 
degradation (Figure 3 .3B). It appears that the observed fibrinogen degradation is 
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consistent with that described in the literature (i.e., initially the a chain is degraded, 
followed by the ~ chain, and finally the y chain), however, since a time-dependent 
proteolytic assay was not performed the possibility of an alternative pattern cannot be 
excluded. Since no specific degradation products were obtained may be suggestive of 
non-specific proteolytic activity or the presence of more than one protease. Culture 
filtrates prepared after -21 -28 days of incubation showed maximal and most consistent 
levels of proteolytic activity ( data not shown). However, to achieve the levels of 
proteolysis indicated, the culture filtrates required at least 20-fold concentration and an 
incubation period of between 16-18 hours. To assess the effect of the type of culture 
medium on the production of proteolytic activity, the bacteria were grown in different 
media, including minimal media with or without an added protease substrate ( either 
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Figure 3.2. Growth of M. tuberculosis H37Rv in different media with or without elastin. Bacteria 
were grown in the indicated media with or without elastin (E) and the culture filtrates were then assessed 
for protease activity using (A) the standard 1251-fibrinogen protease assay (fibrinogen degradation was 
assessed by TCA precipitation of the uncleaved products) and (8) elastin-Congo Red assay. A sample 
with no culture filtrate or with 20 ng elastase served as the negative (- ve) and positive (+ ve) controls, 
respectively. Data are the means and standard deviations from three samples of a typical experiment. 
Key: K+, Kirchner's medium; K", minimal Kirchner's medium; S, Sauton's medium. 
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The use of minimal media was based on the premise that extracellular proteases 
may be induced under conditions of relative nitrogen limitation. In addition, a protease 
substrate (i.e., protein) was added to the different media in an attempt to induce protease 
production. 
All cultures contained fibrinogen-degrading activity (Figure 3.2A). Although the 
levels of degradation were similar, the K+ and S cultures produced the most consistent 
results. Cultures propagated in K- or media supplemented with elastin produced 
inconsistent levels of degradation, as reflected by the error bars. Positive results using 
the elastin-Congo Red assay were obtained only for K+ and S cultures. Highest levels of 
proteolytic activity were observed when both culture media were supplemented with 
elastin (Figure 3.2B). Differential protease expression was thus observed, in that the K+ 
+ E and the S + E culture filtrates contained both fibrinogen- and elastin-degrading 
activities, whereas the K- + E culture filtrates only contained fibrinogen-degrading 
activity. The other protease substrates did not affect the proteolytic activity (data not 
shown). Although these results indicated differences in the proteolytic activity 
depending on the choice of culture medium, there was a high degree of interexperimental 
variability and the same results could not be consistently reproduced. 
Since the literature suggests that aeration of M tuberculosis cultures can effect 
the physiology and biochemistry of the bacterium, the bacteria were propagated rotating 
(aerated) or standing (non-aerated) and the resultant culture filtrates were assessed for 
proteolytic activity. Although there was slightly higher activity in the rotating cultures, it 
was not significant ( data not shown). These experiments were done on both 
M tuberculosis H37Rv and the GSH-3052 clinical isolate. In general, the most 
consistent results were obtained with M tuberculosis GSH-3052, especially when grown 
in standard Kirchner' s medium (K+), and it was therefore used in all subsequent 
experiments. 
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3.4.2 Inhibitor profile of the protease activity 
The effects of different protease inhibitors were investigated by incubating 
M tuberculosis GSH-3052 culture filtrate samples in the presence of various standard 
inhibitors (Table 3 .1 ). Fibrinogen degradation was assessed quantitatively by TCA 
precipitation of the soluble cleaved products (Figure 3.3A) and qualitatively by 
SDS-PAGE analysis (Figure 3.38). The samples were compared to a control that 
contained no inhibitor and the TCA precipitation results are expressed as a percentage of 
this control. Strongest inhibition was obtained with chymostatin (77 ± 14%), ALLN (69 
± 20%), ALLM (66 ± 22%), and PMSF (66 ± 22%); moderate inhibition was obtained 
with 3,4-dichloroisocoumarin (38 ± 8%) and EDTA (33 ± 9%); whereas inhibition by 
other inhibitors was variable and generally less than 30%. Dimethylsulfoxide (DMSO) 
had no effect on the proteolytic activity. SDS-PAGE analysis (Figure 3.38) shows that 
in culture filtrates containing chymostatin, ALLM, and ALLN, only the a-band is 
degraded while the P- or y-bands are not degraded at all. In the presence of the 
remaining inhibitors the a-band is completely degraded with various levels of 
degradation of the P-and y-bands. There were no significant differences in the inhibitor 
profile of the proteolytic activity in culture filtrates of M tuberculosis H37Rv or 
GSH-3052 when propagated in K+ or K media (data not shown). These data indicate 
that the predominant proteolytic activity is a serine protease, although there is also 
evidence for a metal-dependent activity. 
3.4.3 The effect of pH, temperature, and metal ions on the protease activity 
The effect of pH was examined by using 125I-fibrinogen under the standard assay 
conditions, except for the buffer. Protease activity was detected over a broad pH range 
with two optima at pH 4.5 and 7.0 (Figure 3.4). Although this experiment was repeated 
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Figure 3.3. Inhibitor profile of the proteolytic activity in M. tuberculosis GSH-3052 culture filtrate. 
Aliquots of culture filtrate were incubated at 37°C for 16 h in the presence of 
1251-fibrinogen and the 
indicated inhibitor. Thereafter, degradation of 
1251-fibrinogen was determined by (A) TCA precipitation 
and (B) SDS-PAGE analysis, as described in Materials and Methods. The control consisted of culture 
filtrate with no inhibitor. All TCA results are expressed as a percentage of the control and represent the 
mean and standard deviation from six separate experiments. 
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Figure 3.4. Effect of pH on the proteolytic activity in M. tuberculosis GSH-3052 culture filtrates. 
Culture filtrate samples were incubated with 1251-fibrinogen under standard assay conditions, except for the 
buffer. A variety of buffers were used which provided a pH range of 4.5-9 .5. After incubation at 37°C 
fibrinogen-degradation was assessed by TCA precipitation ofuncleaved protein. 
The effect of temperature on the proteolytic activity was assessed by incubating 
the culture filtrate at both standard and extreme temperatures, and then using the standard 
assay to assess the activity. Optimal activity was detected at 25-37°C but still present at 
4°C (Figure 3.5A). Thermostability of the proteases was measured at -70°C and 80°C. 
The effect of temperature on the proteolytic activity was assessed by incubating the 
culture filtrate at both standard and extreme temperatures, and then using the standard 
assay to assess the activity. Optimal activity was detected at 25-37°C but still present at 
4°C (Figure 3.5A). Thermostability of the proteases was measured at -70°C and 80°C. 
After exposure to these temperatures for 10 minutes the samples were incubated under 
standard assay conditions at 37°C. Activity was abolished by incubation at 80°C and 
was not affected by freezing at -70°C (Figure 3.5B). 
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Figure 3.5. Effect of temperature on proteolytic activity in M. tuberculosis GSH-3052 culture 
fil trates. A) Samples of the culture filtrate were incubated with 1251-fibrinogen for 16 hat the indicated 
temperatures . B) Samples of the culture fi ltrate were first exposed to the indicated temperatures for 10 
min and then assessed for protease activity using the standard protease assay. Fibrinogen degradation was 
assessed by (i) TCA soluble peptide formation and (ii) SOS-PAGE analysis, as described in Materials and 
Methods. Data are means and standard deviations from three separate experiments. 
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As some inhibition was obtained with the metalloprotease inhibitors EDTA and 1, 10-
phenanthroline, the effects of two metal ions ( calcium and zinc) were examined. 
Addition of calcium resulted in a 37.5% increase in protease activity (Figure 3.6) which 
was abolished by the addition of EDT A. EDTA alone inhibited the activity by 22%. 
Complete inhibition was not expected as this was a crude sample and probably contained 
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Figure 3.6. Effect of Ca2+ and Zn2+ on proteolytic activity in M tuberculosis GSH-3052 culture 
filtrates. Samples of the culture filtrate were incubated under the standard assay conditions in the 
presence of CaCl2 (2.5 rnM) and ZnS04 (0.1 rnM). Fibrinogen degradation was assessed by (A) 
TCA-soluble peptide fo1mation and (B) SDS-PAGE analysis, as described in Materials and Methods. A 
sample with culture filtrate only was used as the control. 
3.4.4 Zymography. 
To determine the apparent molecular weight/s of the proteases in the culture 
filtrates, samples were resolved by electrophoresis in SDS-gels copolymerised with a 
protease substrate, casein. After incubating the gel overnight at 37°C in Tris-buffer (pH 
7.4), the gels were stained and destained and assessed for zones of clearing. Caseinolytic 










Figure 3.7. Zymogram of caseinolytic activity in the culture filtrate of M. tuberculosis GSH-3052. A 
20 µl sample of concentrated culture filtrate (CF) was applied to a SDS-polyacrylamide gel copolymerised 
with casein (I mg/ml). The gel was incubated overnight at 37°C, stained with Coomassie Brilliant Blue 
and destained. Caseinolytic activity is seen as a zone of clearing. Numbers on the left are molecular 
masses (in kilodaltons) of the markers. Trypsin (500ng; MW 23.5 kDa) was used as a positive (+ ve) 
control. 
3.5 DISCUSSION 
There has been little research into the potential of proteases as virulence 
determinants in M tuberculosis. The current dogma (as espoused in textbooks of 
medicine and microbiology) that the bacterium is inert and that the pathology of 
tuberculosis is entirely a consequence of the host's immune response is a view that has 
been widely held for some time (Dannenberg, 1991; Toossi & Ellner, 1998; Orme, 
1998). However, a wide range of microbes, especially those causing lung pathology, 
have been shown to possess proteases as potential virulence factors, thus making a search 
for M tuberculosis proteases, and in particular secreted proteases, reasonable. In recent 
years, it has become evident that mycobacteria produce a surprising quantity and 
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diversity of soluble protein antigens (Andersen et al. , 1991; Andersen & Brennan, 1994). 
Moreover, M tuberculosis possesses all of the components of the sec-dependent general 
export pathway (Chubb et al., 1998). Therefore, it is possible that this organism 
expresses and secretes proteases. 
To accurately assess, characterise, and purify proteolytic activity m bacterial 
supematants requires a high yield of viable orgamsms. The slow growth rate of 
M tuberculosis ensures that high yields are difficult to achieve with this bacterium. In 
addition, attempts to do so are usually at the expense of creating "unphysiological" 
conditions. This becomes important if approximation of in vivo conditions is of critical 
importance to the questions pursued. Furthermore, to accurately identify the stage of the 
growth cycle at which a specific protein is produced requires synchronised cultures. 
This, too, is difficult to achieve with M tuberculosis, as in vitro culture conditions 
generate physiologically heterogeneous populations of bacilli. Growth of the bacilli 
without rotation would result in synchronous cultures and is probably closer to in vivo 
conditions, but the yields of bacteria are much lower than with rotating cultures. 
Similarly, higher yields of viable organisms are obtained from aerated cultures, but as the 
bacilli are more likely to be exposed to microaerobic or anaerobic conditions in vivo, it 
becomes a "juggling act" to approximate in vivo conditions and obtain cultures with high 
yields of viable organisms. 
In this study, culture conditions were selected that would provide high yields of 
viable organisms and detectable levels of proteolytic activity but at the same time 
attempting not to deviate too far from in vivo conditions. Data are presented that show 
that M tuberculosis culture filtrates contain proteolytic activity, albeit at a comparatively 
low and inconsistent level. The pattern of fibrinogen degradation (i.e., first the a chain 
then the p chain and lastly the y chain is degraded) is consistent with the proteolytic 
degradation of fibrinogen reported in the literature. The a chain is most susceptible to 
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proteolytic cleavage, followed by the ~ chain, and then the y chain. The increasing 
intensity of the y band that is observed as more of the fibrinogen is degraded is probably 
due to the generation of a degradation product of the same molecular weight as the y 
chain. This too has been observed previously (Kelly et al., 1994; Jennings et al., 1999). 
The low level of inter-experiment reproducibility and low activity may be explained by: 
(a) all extracellular microbial proteases are secreted as inactive zymogens with 
propeptides that require processing for activation (Wandersman, 1989), and in vitro 
culture conditions may not contain the necessary stimuli for activation; (b) extracellular 
proteases in M tuberculosis may be induced and/or activated under specific conditions 
that remain to be identified; ( c) exported proteases may not be truly soluble, and thus the 
secreted proteases may remain largely associated with the bacterial cell envelope; ( d) 
M tuberculosis may not produce exported proteases and the activities found are due to 
cytosolic proteases released from lysed bacteria; or ( e) the preferred substrates remain to 
be identified. 
Despite these problems the activity was partially characterised and found to be 
inhibited, to varying degrees, by both serine protease and metalloprotease inhibitors. As 
the class-specific cysteine protease inhibitor E-64 did not inhibit activity and most 
bacterial proteases belong to either the serine or metallo families, it is likely that 
inhibition by ALLM and ALLN (which are generally regarded as cysteine protease 
inhibitors) is due to their known cross-reactivity with some serine proteases. This 
usually arises when a serine protease (and sometimes a metalloprotease) contains a 
cysteine residue close to an active site residue, as it is then susceptible to inhibition by 
cysteine-type protease inhibitors (Barrett, 1994; Barrett & Rawlings, 1991 ). 
Further characterisation of the activity revealed some enhancement by the 
addition of Ca2+, but not of Zn2\ suggesting that the culture filtrate activity could be 
partly attributed to a metal-dependant protease, consistent with moderate inhibition by 
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EDTA, although it was unlikely to be a true Zn-metalloprotease. It is worth noting that 
the activity of subtilisins and cal pains are also augmented by Ca2+ and may therefore also 
show some inhibition with EDTA (Rawlings, 1994; Rawlings & Barrett, 1994). Thus, 
the metal-dependent activity detected in the culture filtrate may be consistent with the 
presence of a metalloprotease, subtilisin, or cal pain. 
Many bacteria produce proteases in response to nutrient deprivation. This occurs 
physiologically when bacteria enter their stationary phase of growth, as it is at this stage 
that bacteria usually encounter nutritional stress and many have been shown to secrete 
proteases (Gibb & Strohl, 1988; Roitsch & Hageman, 1983; Long et al. , 1981). 
Maximum activity of the proteolytic activity in the M tuberculosis culture filtrates was 
detected after 4-5 weeks of growth, which likely coincided with the stationary phase of 
the M tuberculosis growth cycle. To assess the effect of nutrient deprivation on the 
induction or repression of proteases, bacilli were cultured in nutrient-depleted media with 
or without a protein supplement (elastin, casein, BSA, or haemoglobin). Although there 
was no significant difference in the levels of activity, only complete media with or 
without elastin contained fibrinogen- and elastin-degrading activities, suggesting some 
nutritional influence on the induction of certain protease genes. This indicates that 
M tuberculosis may utilise proteases for the breakdown of macromolecules, yielding 
amino acids required for protein synthesis and growth. Since elastin is an integral 
structural component of the lung (30% of lung tissue is elastin), detection of elastolytic 
activity may suggest a possible contribution of M tuberculosis proteases to the tissue 
destruction characteristic of pulmonary tuberculosis. The presence of elastolytic activity 
in M tuberculosis culture filtrates has been reported by Rowlands et al. (1997) who 
demonstrated the presence of an elastolytic calcium-dependent metalloprotease in culture 
filtrates of M tuberculosis H37Rv grown in Sauton's medium. The assessment of the 
proteolytic activity produced in Sauton's medium that is presented in this chapter was 
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done partly in an attempt to reproduce the results obtained by Rowlands et al. (1997) as 
well as to assess the contribution of different culture media. The activity detected in the 
K+ + E and S + E cultures was similar to that detected by Rowlands et al. (1997) in that 
both showed elastolytic activity. However, the protease activity detected by Rowlands et 
al. (1997) was completely inhibited by EDTA and retained activity after 10 min at 80 °C, 
whereas the activity detected in the K+ cultures only showed 37% inhibition by EDTA 
and complete loss of activity by exposure to 80 °C for 10 min. This suggested that the 
activity detected in the K+ culture filtrates was probably due to a protease that was 
different to that detected by Rowlands et al. (1997), motivating further characteristion of 
this activity. 
Survival and growth of the bacilli in the host depend on its ability to overcome 
the numerous host defences and adverse conditions encountered. It is generally accepted 
that when bacilli are confined to the centre of well-organised granulomas they are 
subjected to bacteriostatic conditions of anoxia, acidity and nutrient deprivation. 
Frequently, the bacilli are not contained and the granulomas progressively enlarge with 
increasingly necrotic centres, often coalescing with neighbouring granulomas or eroding 
into adjacent tissues, producing large, necrotic, cavitating lesions. This sequence of 
events has been suggested to be entirely due to a self-defeating delayed-type 
hypersensitivity reaction on the part of the host. An alternative explanation could be that 
this kind of disease progression is partly due to the multiplication of virulent bacilli that, 
under adverse conditions of a well-organised granuloma, are able to synthesise and 
secrete proteases, that allow them to escape into a more favourable environment. To this 
end it is worth noting that the culture filtrate proteolytic activity is present over a broad 
pH and temperature range. This makes it tempting to suggest that the wide pH and 
temperature range of activity is indicative of the protease' s potential role in benefiting the 
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bacillus under adverse conditions, but it may also indicate the presence of more than one 
protease. 
Attempts to purify the protease/s - which included High Performance Liquid 
Chromatography (HPLC), affinity chromatography using a bacitracin column, and ion-
exchange chromatography - were unsuccessful. This was probably due to the low 
expression levels and possibly to instability of the protease/sunder the conditions used. 
In conclusion, proteolytic activity has been detected in the culture filtrates of 
M tuberculosis. The inhibitor profile suggests the presence of at least 2 proteases, one of 
which is a serine protease and the other possibly a metalloprotease. The low and 
inconsistent level of activity indicates that we are presently unable to reproduce the 
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Intracellular residence of M tuberculosis within macrophages induces the 
expression and secretion of specific proteins not evident during in vitro growth (Lee et 
al. , 1995). Although these proteins are presumed to play a role in invasion and 
intracellular survival, their precise contribution to the pathogenicity of M tuberculosis is 
unknown. As an approach to identify M tuberculosis secretory proteins, Mdluli et al. 
(1995) devised a signal sequence-detection strategy using vectors tailored to generate 
alkaline phosphatase (phoA) fusions to M tuberculosis DNA. Using this strategy, a gene 
for a putative secreted serine protease, Rv3883, was identified. Homology matching of 
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this sequence with unannotated M tuberculosis genomic DNA sequences deposited on 
databases at the Sanger Centre (Cambridge, UK) revealed a further 4 putative serine 
protease genes in the M tuberculosis genome. The proteins encoded by these genes 
share 36-47% identity, and initial primary sequence analysis indicates that they are most 
homologous to members of the subtilisin family of serine proteases (Brown et al. , 1999). 
Furthermore, primary sequence analysis indicates that they constitute a novel subfamily 
of the subtilisins. For simplicity, these putative serine protease genes were designated 
mycP 1-5 (based on their sequential identification; Rv3883 has been designated mycP 1), 
and the proteases they encode mycosin-1-5, respectively. Each gene encodes a protein 
with a typical signal sequence and one or more hydrophobic sequences in the C-terminal 
half of the protein, suggesting that these proteins are likely secreted and anchored in the 
cytoplasmic membrane or lipid-rich regions of the cell envelope. It is possible that 
secreted proteins, and more specifically secreted proteases, may contribute to the 
virulence of M tuberculosis, tempting one to speculate that this novel family of 
subtilisin-like proteases may play a role in the pathogenic lifestyle of this organism. 
Although these protease genes were identified prior to the annotation of the 
M tuberculosis genome sequence, the recent publication of the genome sequence 
confirmed the presence of this family of proteases and indicated the presence of over 20 
additional putative protease genes (Cole et al. , 1998). One of these additional genes, 




The subtilisin family is the second largest family ( clan SB, family S8) of serine 
proteases and is present in members from phylogenetically diverse classes of organisms, 
namely eubacteria, archaebacteria, eukaryotes, and viruses (Rawlings & Barrett, 1994). 
Almost all are endopeptidases, although there is also a tripeptidyl-peptidase. The 
prototypical member, subtilisin, is secreted into the medium by a wide variety of Bacillus 
species (Subtilisin BPN' by B. amyloliquifaciens, subtilisin Carlsberg by 
B. licheniformis, subtilisin E from B. subtilis 168, subtilisin Savinase by B. lentus, and 
others). In addition, numerous subtilisin-like proteases are expressed and secreted by 
other bacteria. 
A distinct subfamily of the subtilisins, the kexin subfamily, has been 
demonstrated in yeasts and animals and their main function is proprotein-processing. 
The subtilisins have been widely studied and their kinetics and mechanism of activity are 
well understood. Furthermore, over 50 X-ray structures have been determined (Wells & 
Estell, 1988). 
4. 2.1. Mechanism of action 
Although the mechanism of action of subtilisin is identical to that of trypsin-like 
serine proteases, they are evolutionarily and structurally distinct. Their well-documented 
active-site involves the side chains of Ser-221 , His-64, and Asp-32 (subtilisin BPN' 
numbering). 
In the kinetic scheme for subtilisin, acylation is controlled by k2 and deacylation by k3, 
where E is enzyme, S is substrate, Pr1 and Pr2 are hydrolysed products, and E-Pr2 is the 
acyl-enzyme complex (Carter et al., 1991). In the rate-limiting acylation step for 
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hydrolysis of peptide bonds, His-64 accepts a proton from Ser-221 (Wells & Estell, 
1988; Carter et al., 1991). This results in a tetrahedral oxyanion intermediate (E-S) 
which is stabilised by at least two hydrogen bonds. Asn-155 provides one of the 
hydrogen-bonding groups in the oxyanion hole, and His-64 the other hydrogen-bonding 
group (Bryan et al., 1986; Wells & Estell, 1988). As His-64 donates a proton to the 
leaving group amine, the tetrahedral E-S collapses to form an acyl-enzyme intermediate. 
The enzyme is released from this complex by hydrolysis, involving His-64 that removes 
a proton from a water molecule leading to nucleophilic attack upon the acyl-enzyme 
complex and finally to reprotonation of Ser-221 (Carter et al., 1991). Therefore, in the 
overall mechanism, Ser-221 serves as a catalytic nucleophile; His-64 functions as a 
general acid-base; and Asp-32 positions the correct form of His-64 in the E-S complex 
and provides electrostatic stabilisation (Wells & Estell, 1988). 
4.2.2. Secretion 
All subtilisins are synthesised as a preproprotein with a signal peptide (-27-29 
amino acids), and an N-terminal propeptide (- 77-79 amino acids), which is followed by 
the mature protein. The signal peptide resembles a typical bacterial signal sequence and, 
in the case of the Bacillus spp. subtilisins, has a consensus signal peptidase cleavage site, 
Ala-X-Ala-Ala (Wong & Doi, 1986). The subtilisin propeptides have received a 
significant amount of attention as they appear to be intricately involved in the 
determination of the activity of subtilisin. The subtilisin propeptides are characterised by 
a highly homologous region at the C-terminal end, a common sequence, Tyr-Ile-Val-Gly-
Phe-Lys, at the N-terminal end, and the presence of a large number of charged residues 
(-30%) (Jacobs et al., 1985; Ikemura et al., 1987). In addition, the predicted secondary 
structure and hydrophobic residue distribution of the propeptides show a high degree of 
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similarity among all subtilisins, even in regions where their primary structures are quite 
different (Jacobs et al., 1985). 
The full-length precursor form of subtilisin is associated with the cell membrane 
where it undergoes autocatalytic processing (Power et al. , 1986). The propeptide is 
essential for the correct folding of the protein and current evidence suggests that once the 
protein is folded the propeptide is autoprocessed hydrolytically by mature, active 
subtilisin (Eder et al. , 1993; Li et al., 1995; Ikemura et al., 1987). The cleaved 
propeptide is not released from the enzyme but remains noncovalently associated with 
the catalytic domain, acting as an autoinhibitor (Bryan et al. , 1995; Li et al. , 1995). 
Propeptides have been shown to be both substrates and strong slow-binding inhibitors of 
subtilisins BPN' and Carlsberg (Hu et al. , 1996). The cleaved propeptide is necessary for 
activation of subtilisin but not for maintenance of activity. The driving force behind the 
autocatalytic processing is unknown. Only preprosubtilisin is detected when produced 
by coupled transcription-translation in vitro, suggesting that some structural, enzymatic 
or cofactor function is missing in vitro that is necessary to initiate processing (Power et 
al., 1986). 
There is some debate whether the autoprocessing/folding pathway is inter- or 
intramolecular. Denatured subtilisin is unable to refold by itself but refolding does occur 
with exogenously added synthetic propeptides or a prosubtilisin active-site mutant. Li et 
al. (1995) suggest that the exogenously added propeptide behaves as an intramolecular 
chaperone for folding and that its ability to perform this function is directly related to the 
affinity with which it can bind the mature active subtilisin to inhibit its activity. Since a 
prosubtilisin active-site mutant can direct the folding of denatured subtilisin, Hu et al. 
(1996) proposed a model that has the propeptide of one prosubtilisin behaving as a 
refolding template for the mature sequence of another. In this context the hydrolytic 
process would also be intermolecular. Although it has proven very difficult to 
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unequivocally distinguish intra- from intermolecular processing, the bulk of the evidence 
supports an intermolecular process. However, in saying this, there are some investigators 
that believe that both are feasible. Hu et al. (1996) suggest that when there is a low 
concentration of preprosubtilisin with little or no active enzyme around, then 
intramolecular processing or processing by a different protease may be a requirement. 
As more active mature subtilisin is produced, the intermolecular pathway probably takes 
precedent. 
4.2.3. Kinetics, Inhibitors and Activators 
The subtilisins exhibit typical Michaelis-Menten kinetics and have broad 
substrate specificity. They are usually active in the neutral to alkaline pH range and are 
stimulated by Ca2+. Members of the kexin subfamily preferentially cleave after di-basic 
or multi-basic amino acids (Rawlings & Barrett, 1994). Some members of the kexin 
subfamily as well as some yeast subtilisin-like proteases are activated by thiol-containing 
compounds and inhibited by cysteine protease inhibitors (Rawlings & Barrett, 1994; Jany 
et al., 1986). This has been attributed to the presence of a cysteine residue close to the 
active site histidine. Almost all bacterial subtilisins do not contain cysteine residues, the 
only exception being the subtilisin from B. smithii (Jany et al., 1986). The subtilisins and 
subtilisin-like proteases are inhibited by serine protease inhibitors, notably PMSF, 
chymostatin, and others (Suzuki et al., 1997). In addition, since they are stimulated by 
ca2+, EDTA also inhibits the activity of these proteases to some degree (Suzuki et al., 
1997). This is in contrast to the mammalian subtilisin-like proprotein convertases that, 
despite being serine proteases, are insensitive to typical serine protease inhibitors such as 
PMSF, TLCK, and TPCK. 
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4.3. IDENTIFICATION OF A PUTATIVE SUBTILISIN-LIKE PROTEASE 
GENE (MYCPJ}, AND SEQUENCE ANALYSIS OF ITS PREDICTED 
PRODUCT, MYCOSIN-1. 
4.3.1. INTRODUCTION 
The culture filtrate results presented in Chapter 3 are consistent with the presence 
of a serine protease and/or metalloprotease. The Ca2+ -stimulation and mild inhibition by 
EDT A is suggestive of the presence of a Ca2+ -requiring protease - either a subtilisin, 
metalloprotease or calpain. Furthermore, inhibition obtained with the cysteine protease 
inhibitors, ALLM and ALLN, is not uncommon with some members of the subtilisin 
family. Since these data are consistent with the discovery of a novel subfamily of 
putative subtilisin-like secreted serine proteases in the M tuberculosis genome, it was 
decided to initiate the characterisation of the first member of this family, mycosin-1. The 
first part of this chapter details the sequence analysis of the mycP I protease gene and its 
predicted product, mycosin-1. 
4.3.2. MATERIALS AND METHODS 
4.3.2.1. Sequence analysis 
All non-redundant sequence databases were scanned for sequences homologous 
to the mycP I gene and its predicted product, mycosin-1 (Table 4.1 ). In addition, various 
internet servers (Table 4.1) were used to further characterise the predicted mycosin-1 
sequence: alignments with homologous sequences were optimised with Multalin v. 5.3.3; 
the signal peptide cleavage site was predicted using SignalP; transmembrane domain and 
topology predictions were determined with the Tmpred, TopPred2 and Sosui 
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programmes; a hydrophobicity plot was obtained using Tmpred; and secondary structure 
predictions were derived by the GOR v. 4 method. 
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4.3.3.1. Sequence analysis of mycPJ and its product, mycosin-1. 
The mycP 1 gene is 1341 bp in length (Figure 4.1) and encodes a putative 446 
ammo acid protein (Figure 4.2). Using various internet databases (Table 4.1), mycPJ 
was shown to have 77 % homology with a putative M leprae senne protease gene 
(Yl 4967). Comparison of the deduced amino acid sequence of the mycosin-1 protein 
with sequences in databases was even more informative, revealing 79 % identity with the 
M leprae serine protease (Yl 4967), 32.9% identity with an S. coelicolor serine protease 
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- 100 gccgttacgt ctaaaatgca cacaggtccg tcaagtggcc caaggtagca 
-so acgcagctca atgaatcgca atgaatctca acgaatjggagl tgttctggga 
1 gtgcaccgta tctttctgat cacggtggcg ctggcgttgc tcaccgcgtc 
51 gcccg:catcg gcca tcacgt caccgccgat cgatccgggc gcgttgccgc 
101 ccgacgtgac gggcccggat cagcctaccg aacagcgcgt tttgtgcgcg 
151 tcgcccacca cgctgccggg gtccgggttc cacgatccgc cgtggagcaa 
201 cacgtatctg ggcgtggccg atgcccacaa gttcgcgacc ggggccgggg 
251 tgacggtggc ggtgatcgac accggtgtcg acgcttcgcc acgggtcccg 
301 gcggaacctg gcggcgattt cgtcgaccag gccggtaacg gcctgtctga 
351 ctgtgatgcc catgggactc tcacagcatc catcatcgcg ggccggcccg 
401 cgcccaccga cgggttcgtc ggcgtcgcgc ccgacgctcg actgctctcg 
451 ctacgtcaga cgtctgaggc cttcgaaccg gtcggctcac aagccaaccc 
501 gaatgacccc aacgccaccc cggccgccgg ttccatccgc agtcttgccc 
551 gcgccgtggt gcacgccgcc aacctcggcg tgggtgtgat caacatcagt 
601 gaagccgcct gctacaaggt gagcaggccg atcgatgaaa cctcactggg 
651 tgcatccatc gactatgcgg tcaacgtcaa aggcgtggtg gtggtggtcg 
701 cggccggcaa caccggtggc gattgcgtac agaatccggc gccggacccg 
751 tccacacccg gcgacccacg cggctggaac aatgtgcaga ccgttgtcac 
801 cccggcgtgg t acgcaccgc t ggtgttaag cgtcggcggt atcggccaga 
851 ccgggatgcc cagctcgttc tcgatgcacg gaccgtgggt ggacgtggcc 
901 gcgcccgcag aaaacatcgt cgcgctcggc gacaccggtg aaccggtgaa 
951 tgcgctgcaa ggccgggagg ggccggtacc catcgccggc acctcgtttg 
1001 ccgcggcata tgtgtcgggt ctggcggccc tgcttcggca gcggttcccc 
1051 gacctgacgc cggcgcagat catccaccgg atcaccgcca ccgcgagaca 
1101 ccccgggggc ggggtcgacg acctggtcgg cgccggcgtc atcgatgcgg 
1151 tggccgcgct gacgtgggac attccgcccg gccctgcttc ggcgccatac 
1201 aacgtcagac gacttccacc cccggtggtg gagccgggtc ccgatcgtcg 
1251 cccgattacg gctgtggcgt tggtggccgt cggccttacg ttggccctgg 
1301 gcctgggcgc gctggctaga cgggcgctga gccgccgalEg""""a) 
Figure 4.1. Nucleotide sequence of mycPJ and its upstream flanking region. The translational start 
codon (boldtype letters) is preceded by a Shine-Dalgarno ribosome binding site (boxed letters). Also 
shown are the positions of the 3 primers used for PCR amplification of mycP I , i.e., p I mycf (boldtype italic 
letters) , p 1 f (underlined italics), and p 1 r (underlined bold type letters) . The reverse primer (pl r) 
incorporates the translational stop codon (boxed boldtype letters). 
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(U33176), 33.2% identity with a B. subtilis serine protease, and 30.2% identity with 
B. subtilis subtilisin. The latter three proteases belong to the subtilisin subfamily (Family 
S8) of serine proteases. In addition, mycosin-1 showed various degrees of identity to 
other subtilisin-like serine proteases, especially around the active site residues (Figure 
4.3). It is not unusual for bacterial proteases to have poor overall homology, but to reveal 
a high degree of sequence identity for the amino acids around the active site residues 
(Barrett, 1994; Barrett & Rawlings, 1995). 
1 11 31 41 
VHRIFLITVA LALLTASPAS AITPPPIDPG ALPPDVTGPD QPTEQRVLCA 
51 61 71 81 91 
SPTTLPGSGF HDPPWSNTYL GVADAHKFAT GAGVTVAVID TGVW\SPRVP 
101 111 131 1 41 
AEPGGDFVDQ AGNGLSDCDA IH]GTLTASIIA GRPAPTDGFV GVAPDARLLS 
15 1 1 61 171 18 1 1 91 
LRQTSEAFEP VGSQANPNDP NATPAAGSIR SLARAVVHAA NLGVGVINIS 
20 1 2 11 221 23 1 241 
EAACYKVSRP IDETSLGASI DYAVNVKGVV VVVAAGNTGG DCVQNPAPDP 
251 261 271 281 291 
STPGDPRGWN NVQTVVTPAW YAPLVLSVGG IGQTGMPSSF SMHGPWVDVA 
301 311 32 1 341 
APAENIVALG DTGEPVNALQ GREGPVPIAG T~ FAAAYVSG LAALLRQRFP 
35 1 361 371 38 1 391 
DLTPAQIIHR ITATARHPGG GVDDLVGAGV IDAVAALTW IPPGPASAPY 
401 411 42 1 43 1 44 1 
NVRRLPPPVV EPGPDRRPIT AVALVAVGLT LALGLGALAR RALSRR 
Figure 4.2. Deduced amino acid sequence of mycosin-1. The amino acid sequence was predicted fro 
the mycP J gene obtained from the M tuberculosis database at the Sanger Centre (Cambridge, UK). The 
gene was translated using Protein translate (part of Expasy tools). Key: arrow, signal peptide cleavag 
site; boxed letters, active site residues . 
The N-terminal sequence consists of an initial stretch of 5 polar amino acids (net 
positive charge), followed by 11 amino acids that are predominantly hydrophobic 
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residues (especially alanine and leucine), and which culminate in a stretch of 5 ammo 
acids that are less hydrophobic and contain an alanine at the -1 and -3 positions of a 
potential signal peptidase cleavage site (marked by an arrow between amino acid 21 and 
22 in Figure 4.2). This stretch of 21 amino acids complies with the criteria for a standard 
signal peptide (Pugsley et al. , 1985) and is consistent with what is predicted by the 
SignalP V 1.1 internet server for signal peptide predictions. This suggests that mycosin-1 
is likely translocated across the cell membrane. 
Aligning mycosin-1 with the active site residues of various well-characterised 
subtilisins, the active site residues of mycosin-1 were predicted to be Asp-90, His-121, 
and Ser-332 (Figure 4.3). 
* * 
~I1 · RPAPTDGEV F! AAY 1 A 
2 EVGI II • PAEGTGEV s FSAP 
3 LNNI H~I • ETNNATGIA s M~ SPH 
4 NNGI HIT•. LNNSIGVLG s ~ TPH 
5 CNGI H! T• GGTTYGVAKGV s Mi TPH 
6 GSSI H • Tl· LNNSIGVLG N M•TPH 
7 GNGI H • Tl· LNNSIGVLG N M! TPH 
8 VVGI HtI~ TGAQSKGTY s M; TPH 
9 NNSI H · T · LNNSIGVLG N 
H~ T~ LDNTTGVLG 
M! SPH 
10 GNGI N ] SPH 
11 CNGI H~T~GGSLYGVAKNV s MiiTPH 
Figure 4.3. Active site homology of mycosin-1 to subtilisin and subtilisin-like serine proteases. All 
amino acids homologous to mycosin-1 are indicated in boldtype letters. Those residues that are common 
to all are highlighted in black and those residues that are common in > 50% (and including mycosin-1) are 
highlighted in grey. 1, M tuberculosis mycosin-1 ; 2, S. coelicolor serine protease (U33 l 76); 3, B. subtilis 
serine protease (L29506); 4, B. subtilis thermostable alkaline serine protease (s50880); 5, Thermus sp. 
serine protease (U 17342); 6, B. subtilis subtilisin (KO 1988); 7, B. sub ti/is alkaline protease (D 13157); 8, S. 
albogriseolus subtilis in-like protease (083672); 9, B. amyloliquifaciens subtilisin BPN ' (XOO 165); 10, B. 
licheniformis subtilisin Carlsberg (X91262); 11 , V. alginolyticus alkaline serine protease (M25499) 
* active site residue 
All subtilisins and subtilisin-like proteases are produced as inactive zymogens 
with signal peptides (27-29 residues) and propeptides (77-79 residues). It is therefore 
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likely that mycosin-1 also includes a propeptide. Despite variable homology with the 
subtilisin propeptides, there appear to be 3 conserved amino acids, L-55 , D-62, and P-63 
(mycosin-1 numbering) (Figure 4.4) near the C-terminus of the propeptide. By aligning 
the predicted amino acid sequence of mycosin-1 with the above-mentioned conserved 
propeptide residues it appears likely that amino acids 22-63 comprise the mycosin-1 
propeptide (Figure 4.4). 
22 63 
Mycosin-1 ITPPPI DPGALPPDVT GPDQPTEQRV LCASPTT• PG SGFH .. .. • · 
Carl AQPA KNVEKDYIVG FKSGVKTASV .. KKDIIKES GGKVDKQFRI INAAKAK• DK EALKEVK oo • ... AHAL 
BPN K SNGEKKYIVG FKQTMSTMSA AKKKDVISEK GGKVQKQFKY VDAASAT• NE KAVKELK 
E NMSAQAAGK SSTEKKYIVG FKQTMSAMSS AKKKDVISEK GGKVQKQFKY VNAAAAT• DE KAVKELK 
NAT NMSAQAAGK SSTEKKYIVG FKQTMSAMSS AKKKDVISEK GGKVQKQFKY VNAAAAT• DE KAVKELK 
J 
Amylo 
AGK SSTEKKYIVG FKQTMSAMSS AKKKDVISEK GGKVQKQFKY VNAAAAT• DE KAVKELK 
GK SSTEKKYIVG FKQTMSAMSS AKKKDVISEK GGKVQKQFKY VNAAAAT• DE KAVKELK 
Y AEEAKEKYLI GFKEQEVMSQ FVDQIDG.DE YSISSQAEDV EIDLLHEFDF IPVLSVE• DP EDVDALE 








Figure 4.4. Propeptide homology. The putative propeptide of mycosin-1 was aligned with various 
subtilisin propeptides. Amino acids identical in all are highlighted in black and residues homologous to 
those in mycosin-1 are highlighted in grey. Key: mycosin-1, M. tuberculosis putative serine protease; Carl, 
B. licheniformis subtilisin Carlsberg (P00780); BPN, B. amyloliquifaciens subtilisin BPN' (P00782); E, 
B. subtilis subtilisin E (P04189); NAT, B. subtilis var. natto subtilisin NAT (P35835); J, 
B. stearothermophilus subtilisin J (P29142); Amylo, B. amylosacchariticus subtilisin Amylosacchariticus 
(P00783); Y, Bacillus spp. Strain Y AB, alkaline elastase Y AB ((p20724); A, B. alcalophilus alkaline 
protease (P27693). 
Furthermore, aligning putative mature mycosin-1 with three well-characterised 
mature subtilisins reveals that mature mycosin-1 likely starts with the amino acids 
proline-64 and tryptophan-65 (Figure 4.5). Therefore, prepromycosin-1 would have a 
molecular weight of 46.14 kDa and a pl of about 5, whereas mature mycosin-1 would 
have a molecular weight of 38.67 kDa and a pl of about 5. 
The C-terminal half of mycosin-1 is predicted to be strongly hydrophobic, 
containing five hydrophobic regions (in addition to the N-terminal signal peptide), as 
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64 117 
Mycosin-1 .. .. PWSNTY LGVADAHKFA . TGAGVTVAV I DTGVDAS .P RVPAEPGGDF VDQAGNGLSD 
Savinase AQSVPWGISR VQAPAAHNRG LTGSGVKVAV LDTGI.STHP DLNIRGGASF VPGEPST . QD 
'BPN AQSVPYGVSQ IKAPALHSQG YTGSNVKVAV I DSGIDSSHP DLKVAGGASM VPSETNPFQD 
Carlsberg AQTVPYGIPL IKADKVQAQG FKGANVKVAV LDTGIQASHP DLNVVGGASF VAGEAYN . TD 
118 177 
Mycosin-1 CDAHGTLTAS IIAGRPAPTD GFVGVAP DAR LLSLRQTSEA FEPVGSQANP NDPNATPAAG 
Savinase GNGHGTHVAG TIAALNNSI. GVLGVAPSAE LYAVKVLGAS .......... ....... GSG 
' BPN NNS HGTHVAG TVAALNNSI. GVLGVAPSAS LYAVKVLGAD .......... ..... . . GSG 
Carlsberg GNGHGTHVAG TVAALDNTT. GVLGVAPSVS LYAVKVLNSS ..... .. ... ....... GSG 
178 237 
Mycosin-1 SIRSLARAVV HAANLGVGVI NI SEAACYKV SRPIDETSLG ASIDYAVNVK GVVVVVAAGN 
Savinase SVSSIAQGLE WAGNNGMHVA NLS .. ... . L GS PSPSATLE QAVNSATS.R GVLVVAASGN 
'BPN QYSWIINGIE WAIANNMDVI NMS ..... . L GGPSGSAALK AAVDKAVA . S GVVVVAAAGN 
Carlsberg TYSGIVSGIE WATTNGMDVI NMS ..... . L GGPSGSTAMK QAVDNAYA.R GVVVVAAAGN 
238 297 
Mycosin-1 TGGDCVQNPA PDPSTPGDPR GWNNVQTVVT PAWYAPLVLS VGGIGQTGMP SSFSMHGPWV 
Savinase SGAG ...... .... .. . ... . ..... SISY PARYAN.AMA VGATDQNNNR ASFSQYGAGL 
' BPN EGTS ...... ..... ..... .. GSSSTVGY PGKYPS . VIA VGAVDSSNQR ASFSSVGPEL 
Carlsberg SGSS ..... . ... .. ... .. . . GNTNTIGY PAKYDS.VIA VGAVDSNSNR ASFSSVGAEL 
298 357 
Mycosin-1 DVAAPAENIV ALGDTGEPVN ALQGREGPVP IAGTS FAAAY VSGLAALLRQ RFPDLTPAQI 
Savinase DIVAPGVNVQ STYPGSTYAS .......... LNGTSMATPH VAGAAALVKQ KNPSWSNVQI 
'BPN DVMAPGVSIQ STLPGNKYGA .......... YNGTSMASPH VAGAAAL ILS KHPNWTNTQV 
Carlsberg EVMAPGAGVY STYPTSTYAT . ......... LNGTSMASPH VAGAAALILS KHPNLSASQV 
358 417 
Mycosin-1 IHRITATARH PGGGVDDLVG AGVIDAVAAL TWDIPPGPAS APYNVRRLPP PVVEPGPDRR 
Savinase RNHLKNTATS LGS .. TNLYG SGLVNAEAAT R ......... . . . . . . . . . . . . . . . . . . . . 
' BPN RSSLENTTTK LGD .. SFYYG KGLINVQAAA Q ......... . . . . . . . . . . ....... ... 
Carlsberg RNRLSS TATY LGS .. SFYYG KGLINVEAAA Q ......... .......... . . . . . . . . . . 
418 446 
Mycosin-1 PITAVALVAV GLTLALGLGA LARRALSRR 
Savinase ........ .. . . . . . . . . . . . . . . . . . . . 
' BPN .... . ..... . . . . . . . . . . . . . . . . . . . 
Carlsberg ....... . .. . . . . . . . . . . . . . . . . . . . 
Figure 4.5. Alignment of putative mature mycosin-1 with mature subtilisin. The predicted ammo 
acid sequence of mature mycosin-1 was aligned with mature subtilisin Savinase, BPN' and Carlsberg. The 
alignment was optimised using Multalin v. 5.3.3. Mycosin-1 numbering 
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evidenced by the hydrophobicity plot (Figure 4.6B; sequences indicated with overlines in 
Figure 4.6A and labelled 1 to 5). 
Three independent internet servers (SOSUI, TopPred 2, and Tmpred; Table 4.2) 
that predict potential transmembrane (TM) domains and preferred orientations of the 
amino and carboxy termini, were used to make some theoretical predictions for the 
potential TM topology of mycosin-1. The TMpred programme predicts 
membrane-spanning regions and their orientation by comparing the given sequence with 
a database (TMbase) of naturally occuring transmembrane proteins (Hofmann & Stoffel, 
1993). This differs from the SOSUI programme which, using the physicochemical 
properties (i.e., hydrophobicity and charges) of the amino acid sequence, is able to 
predict the existence of a membrane protein, transmembrane helices and transmembrane 
helical regions with accuracies of 99%, 96% and 85%, respectively (Takatsugu et al., 
1998). Similarly, TopPred2 also uses physicochemical properties but in addition it uses 
the "positive-inside rule" (the observation that positively charged amino acids tend to be 
more prevalent in cytoplasmic than in extra-cytoplasmic segments in transmembrane 
proteins) to determine preferred orientations of each transmembrane segment (Von 
Heijne, 1992) 
Table 4.2. Transmembrane segment predictions 
TMpred To~Pred 2 SOSUI 
amino acid preferred amino acid preferred amino acid preferred 
sequence orientation sequence orientation sequence orientation 
4-22 4-22 1-23 
184-204 0-1 
223-243 1-0 
271-290 0-1 262-282 0-1 
327-345 1-0 325-345 i-o 
419-439 0-1 419-439 0-1 419-439 -
i, inside; o, outside 
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Figure 4.6. Sequence analysis of the mycPJ gene product, mycosin-1. (A) Sequence alignment of 
mycosin-1 with the B. amyloliquifaciens subtilisin BPN' protein. Single-letter amino acid code; conserved 
residues are in bold. The catalytic residues (D-90, H-121 , and S-332; mycosin-1 numbering) are in open 
boxes; the oxyanion hole (N-237) is in a closed box. The mycosin-1 signal peptide cleavage site (A-21 /1-
22) is shaded. The arrows below the BPN' sequence bracket the propeptide sequence; arrows above 
mycosin-1 indicate a presumed propeptide. Overlines (numbered 1-5) above the mycosin-1 sequence 
indicate hydrophobic regions and correspond to domains 1-5 shown in (8) and in Figure 4.7. (B) 



















Figure 4.7. Transmembrane topology models of mycosin-1. Using three independent algorithms 
(Tmpred, TopPred2 and SOSUI, Table 4.1) predicting transmembrane domains and preferred orientations 
of the N- and C-termini, 3 transmembrane topological models were constructed. Regions 1-5 correspond 
to those depicted in Figure 4.6. 
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These three algorithms predict three possible models, with 1, 3 and 5 TM 
domains, respectively (Figure 4.7). Notably, each of the algorithms predicted an odd 
number of TM domains, which provides for an extracytoplasmic N terminus and an 
intracytoplasmic C terminus (i.e., a type I transmembrane orientation). Moreover, all 3 
algorithms provided a strong consensus for region 5 (Figure 4.6A) as TM domain. This 
is consistent with its high hydrophobicity (Figure 4.6B), length (21 residues), and 
flanking arginine residues. Both TMpred and TopPred2 predictions have regions 4 and 5 
in common, and significant overlap in region 3. However, the presence of active site 
residues in regions 2 and 4 reduce the likelihood that these sequences are true TM 
domains. Based on these results, Model A (Figure 4.7) would seem to be the most likely 
topological model for mycosin-1. This suggests that following translocation and 
cleavage of the signal peptide between alanine-21 and isoleucine-22 (Figure 4.6A), the 
bulk of the protein is extracytoplasmic and anchored in the cell membrane by a single, 
C-terminal TM domain, leaving a short 7-residue cytoplasmic tail. Secondary structure 
predictions support this model, indicating a strong likelihood of a a-helix for the entire 
segment 5, but only weak a-helical predictions for segments 1-4 (data not shown). 
Domains 1-4 may interact by hydrophobic interactions or hydrogen bonding (as shown in 
Figure 4.7A and 4.7B), but this is purely speculative. 
4.3.4. DISCUSSION 
Mycosin-1 shows various degrees of identity to subtilisins and subtilisin-like 
senne proteases. Although there is often poor overall homology between bacterial 
proteases, even if they are part of the same clan/family, the active site residues and 
flanking sequences are usually highly conserved. This is especially true for members of 
the subtilisin family that show considerable conservation of the amino acid sequence 
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around the catalytic triad Asp-32, His-64, and Ser-221 (subtilisin numbering) (Barrett & 
Rawlings, 1991). The catalytic triad of mycosin-1 (Asp-90, His-121, and Ser-332), 
similarly, shows a high degree of sequence identity with that of other subtilisin-like 
serine proteases. Furthermore, the residues around the catalytic site residues of mycosin-
1 satisfy two out of the three consensus signatures for the catalytic site of subtilisins. If a 
protein includes at least two of the three active site signatures, the probability of it being 
a serine protease from the subtilisin family is 100% (Siezen & Brannigan, 1997). 
All known subtilisin-like serine proteases and most extracellular bacterial 
proteases are produced as inactive zymogens with propeptides of varying lengths 
(Wandersman, 1989; Khan & James, 1998). These require processing and cleavage to 
produce the mature, active protease. It is likely that mycosin-1 is also produced as an 
inactive zymogen. By comparison with two well-characterised subtilisins, subtilisin 
Savinase and subtilisin BPN', the region comprising amino acids 22 to 63 appeared to be 
the propeptide of mycosin-1. Should cleavage of the mycosin-1 propeptide occur via an 
intermolecular process (usually by another protease), then the presence of the candidate 
protease or the stimuli necessary for the induction of this protease would be essential for 
activation of mycosin-1. Alternatively, autocatalytic processing of the mycosin-1 
propeptide would require the optimum pH, temperature, and co-factors necessary for 
optimal activity of mycosin-1. Failure to provide any of the parameters required for 
either inter- or intra-molecular processing would result in inactive mycosin-1 . Most 
subtilisins require in vivo factors for activation and activity (Power et al., 1986). If this is 
true for mycosin-1 then it may be very difficult to obtain active enzyme in vitro as 
approximation of in vivo conditions is often very difficult to achieve in the laboratory. 
This could explain why a low level of proteolytic activity was found in the culture 
filtrates. 
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Theoretical analysis of the deduced amino acid sequence of mycosin-1 reveals a 
21 amino acid signal peptide, a 42 amino acid propeptide, active site residues that show 
homology to subtilisin-like serine proteases, 4 hydrophobic domains and a C-terminal 
region that may contain a hydrophobic transmembrane domain. The hydrophobic nature 
of this protein together with a C-terminal region that may be a membrane-anchor indicate 
that mycosin-1 is likely to be a cell-envelope associated protein. It is not uncommon for 
subtilisins or subtilisin-like proteases to contain membrane-anchoring sequences 
(Power et al. , 1986). 
Mycosin-1 has 4 cysteine residues : the first (Cys-49) is in a region that is most 
likely to be the propeptide and will probably not be involved in the function of the 
enzyme; the second (Cys-118) is close to the catalytic histidine, which is also found in 
thermitase from Thermoactinomyces vulgaris, and in some eukaryotic homologues 
(proteinase K, yeast proteinase), and may be involved in catalysis; the last 2 residues 
(Cys-204 and Cys-242) are between the catalytic histidine and serine residues and may 
play a role in catalysis or stabilisation of the enzyme by disulphide bridge formation. It 
is unusual for bacterial subtilisins to contain any cysteine residues; however, there are 
some members of the subtilisin family, especially the eukaryotic homologues, that 
contain a single cysteine residue close to the catalytic histidine (as does mycosin-1 , i.e. 
Cys-118). This residue has been shown to react with some thiol-reactive reagents, 
resulting in inhibition by cysteine protease inhibitors. In addition, Ca2+ has been shown 
to stimulate the activity of most subtilisins. This phenomenon of inhibition of some 
subtilisin-like proteases by cysteine protease inhibitors may help explain the culture 
filtrate results where, in addition to some Ca2+ stimulation, significant inhibition was 
obtained with calpain inhibitors I and II (i.e., ALLM and ALLN), inhibitors of calpain-
like cysteine proteases. Since no putative cysteine protease genes have been found in the 
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M tuberculosis genome sequence, it is possible that this inhibition reflects the inhibition 
of members of this newly identified subfamily of subtilisin proteases. 
Homologues of mycosin-1 have been identified in various mycobacterial species. 
It has 79% identity to an M leprae serine protease and 100% identity to a gene in the 
flanking region of deletion region 1 (RDl) of M bovis BCG. RDl, and two other 
regions RD2 and RD3, represent regions of DNA that are absent from most M bovis 
BCG strains, but present in most virulent M bovis and M tuberculosis strains. Of these 
three regions, RD 1 has received much attention as it appears to be potentially involved in 
the regulation of multiple genetic loci (Mahairas et al., 1996). To assess the expression 
of mycosin-1 in M bovis BCG, Western Blot experiments using affinity-purified anti-
mycosin-1 antiserum as the primary antibody were performed on cell extracts of M bovis 
BCG, M smegmatis-P19 (negative control), M smegmatis-Pl and M tuberculosis 
H37Rv (the latter two served as positive controls). Both positive controls revealed a 
single immunodominant band corresponding to mycosin-1. In contrast, nothing was 
observed in the cell extracts of the negative control or M bovis BCG. This experiment 
was repeated using anti-mycosin-2 or anti-mycosin-3 antiserum as the primary antibody. 
Using these antibodies an immunodominant band was observed in the cell extract of 
M bovis BCG. In addition, only mycosin-3 was detected in the cell extract of 
M smegmatis. Thus, it was concluded that mycosin-1 is the only member of this family 
that is not expressed in M bovis BCG. Since mycP 1 is in the flanking region of RD 1, it 
is tempting to suggest that RD 1 contains regulatory elements essential for the expression 
of mycosin-1, although this remains to be proven. The contribution of mycosin-1 to the 
virulence potential of M tuberculosis, M bovis or M leprae remains to be elucidated. 
However, the presence of this subtilisin subfamily (of which mycosin-1 was the first 
member to be identified) mainly in virulent mycobacterial species [ only mycP 3 was 
detected in avirulent M smegmatis (Brown et al., 1999)], may suggest that it plays a role 
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in disease pathogenesis. This may include critical house-keeping functions, processing 
of secreted and/or extracellular proteins, immune system modulation, phagosome 
modulation, or other pathological processes. In addition, if the mycosins are anchored in 
the membrane then it is likely that they are embedded in the arabinogalactan layer of the 
cell wall and their function may be related to processing of cell wall components. 
However, until the substrate specificities and expression patterns of these proteases are 
determined the above suggestions remain speculative. 
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4.4. SEQUENCE ANALYSIS OF A PUTATIVE METALLOPROTEASE GENE, 
MPRJ, AND ITS PREDICTED PRODUCT, MPRl 
4.4.1. INTRODUCTION 
The culture filtrate data presented m Chapter 3 indicated the presence of a 
metal-dependent proteolytic activity. Although this activity may be due to a member of 
the newly identified subfamily of subtilisin, it is possible that the activity may also be 
due to a metalloprotease. Many bacteria produce metalloproteases and the 
M tuberculosis genome sequence has revealed the presence of at least three putative 
metalloprotease genes. Hence, it was decided to attempt the expression of one of these 
genes in parallel with that of mycosin-1. This part of the chapter details the sequence 
analysis of a putative metalloprotease gene, mpr 1, and its predicted product, Mprl. 
4.4.2. MATERIALS AND METHODS 
Sequence analysis of mpr 1 and its predicted product, Mpr 1, was performed as 
described for mycosin-1 in section 4.2.3 .1. 
4.4.3. RESULTS 
4.4.3.1. Sequence analysis of mprl and its product, Mprl 
The mpr 1 gene is 1497 bp in length (Figure 4.8) and encodes a putative 498 
amino acid protein (Figure 4.9) with a predicted molecular weight of 52.95 kDa and a pl 
of 5.20. The N terminus consists of a polar region followed by a strongly hydrophobic 
stretch that ends in Ala-Gly-Cys which is a potential signal peptidase cleavage site with 
116 
-100 tgccaaaccg tgatccgggc ctgatctcgc cactgacccc gcaccgaccg 
- 50 atctagaatg ggat ttcctt ggtgcatgcc gggcgggacg gggttaggag 
1 atgcatggtc gcgggcggta tcgacctctg gtccgctgtg ttcgccctcg 
51 ccgggtggcc gcgtcggt gc ggaccccgat cgcctgtcta gcggcggtgg 
101 tcgtgatagc cggctgcacg accgtcgtcg acgggcgggc gctgtccatc 
151 ctcaacgacc cgttccgggt ggggggtctg cccgcgacca acggtccgag 
201 cggcgcccgc cccgacgcac cggctgcgtc gggcacggtg atcaacacca 
251 acaacggagc gatcgacaag ttgtcgttgt tgtcggtcaa cgacatcgag 
301 gactactgga tggcggtcta cagcgaatcg ctgaagggca ccttccggcc 
351 ggtcggcaag ctggtgtcct acgattccaa cgacccaagt agtccgatcg 
401 tctgccacat tgacacctat cagctcgtca acgccttttt cagctctcgg 
451 tgcaacttga ttgcctggga tcgaggggtc ttcatggcgg tcgcgcaaga 
501 atacttcggc gacatgtccg tcaatggtgt gctggcacac gaattcgggc 
551 atgctctgca agtgatggcg aatttggtta ccaggaaaga tcccaccatc 
601 gtccgcgagc agcaagcgga ttgcttcgcc ggggtctatc tgtggtgggt 
651 ggccgaaggt aagtcgacac gctttacgct gagcaccgcg gacgggctcg 
701 accacgtgct cgccggcatc atcaccaccc gagacccggt gatggaagcc 
751 gatgcggaaa acgacgacga acatgggtcg gccttggatc gggtcagcgc 
801 gttccagctg ggcttcatca acggcacgcc ggcgtgcgcg gcgatcgacg 
851 aggacgaagt cgagcggcgc cgcggtgacc tgccgacggc gttgcgggtc 
901 gatgccagcg gcaacccaga gaccggcgag gtcggaatca acgaagagac 
951 cctctcgacg ttgatggagt tgatgggcaa gatcttctcg ccgaagaatc 
1 001 cgcccacgct gtcctaccag ccggccggtt gcccagacgc caagcccagc 
1051 ccaccggccg cctactgtcc ggccaccaac accatcgtgg tcgacctgcc 
1101 cgccctggcg aggatgggca aggtggcctc ggcagcggaa cacagcctgc 
11 51 cgcagggcga tgacacgtcg ttgtcgattg tgatgtcgcg gtacgcgttg 
1201 gcggtgcagc acgaacgcgg gctgccgatg cagagcccgt ggaccgcctt 
1251 acggacggcg tgcctgaccg gcgttgcgca ccgcaagatg gccgtgccca 
1301 tcgacctgcc ctccggccag caactcgtac ttaccgcggg tgatctcgac 
1351 gaagcggttt ccgggttgct gaccaaccgc atggtcgcca gtgacgccga 
1401 cggtgtcagc gttccggccg gtttcactcg gatagccgcg ttccgtgccg 
1451 gcgtgggcgg cgacatggac gcatgctatg cccggtatcc fl_ggata2: 
Figure 4.8. Nucleotide sequence of mprl and its upstream flanking region. The transcription initiation 
site (boldtype letters) is preceded by a Shine-Dalgarno ribosome binding site (boxed letters) . Also shown 
are the positions of the 3 primers used for PCR amplification of mprl i.e. p8mycf (boldtype italic letters), 
p8f (underlined italics) and p8r (underlined boldtype italic letters) 
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features consistent with those of a lipoprotein signal peptide (Pugsley, 1993 ). 
Furthermore, the sequence HEFGH ( amino acids 180-184) is characteristic of the 
HEXXH motif of Zn-metalloproteases of the endopeptidase class (Vallee and Auld, 
1990). These data suggest that Mprl is a Zn-metalloendopeptidase that is secreted but 
may remain anchored in the cell membrane as a lipoprotein with a lipid anchor. 
1 11 21 31 ,!. 41 
MHGRGRYRPL VRCVRPRRVA ASVRTPIACL AAVVVIAGCT TVVDGRALSI 
51 61 71 81 91 
LNDPFRVGGL PATNGPSGAR PDAPAASGTV INTNNGAIDK LSLLSVNDIE 
101 111 121 131 141 
DYWMAVYSES LKGTFRPVGK LVSYDSNDPS SPIVCHIDTY QLVNAFFSSR 
151 161 171 181 191 
CNLIAWDRGV FMAVAQEYFG DMSVNGVLA~ EFGHALQVMA NLVTRKDPTI 
201 211 221 231 24 1 
VREQQADCFA GVYLWWVAEG KSTRFTLSTA DGLDHVLAGI ITTRDPVMEA 
251 261 271 281 291 
DAENDDEHGS ALDRVSAFQL GFINGTPACA AIDEDEVERR RGDLPTALRV 
301 311 321 331 341 
DASGNPETGE VGINEETLST LMELMGKIFS PKNPPTLSYQ PAGCPDAKPS 
351 361 371 381 391 
PPAAYCPATN TIVVDLPALA RMGKVASAAE HSLPQGDDTS LSI VMS RYAL 
401 411 421 431 441 
AVQHERGLPM QSPWTALRTA CLTGVAHRKM AVPIDLPSGQ QLVLTAGDLD 
451 4 61 471 481 491 
EAVSGLLTNR MVASDADGVS VPAGFTRIAA FRAGVGGDMD ACYARYPG 
Figure 4.9. Deduced amino acid sequence of Mprl. The signal peptide cleavage site is marked by an 
arrow; the HEXXH motif characteristic ofmetalloproteases is shown (underlined boldtype italic letters) . 
Analysis of published bacterial metalloprotease sequences reveals that there appear to be 
two major groups that are differentiated by the conservation of the residues around the 
HEXXH motif and the spacing between the second and third zinc ligands (Figure 4.10). 
One group has 13 residues between the 2nd and 3rd zinc ligands and the other 19. A 
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lineup of Mpr 1 with other bacterial metalloproteases shows that it belongs to the second 
group, of which the prototype is thermolysin. However, apart from some homology 
around the HEXXH motif, Mpr 1 did not have any significant homology with any known 
proteins. 
1. ... YGRQTFT EIG ALGLSHPGDYNAGI GNP ... 
2. . .. YGRQTLT EIG TLGLSTP-DYNAG GDP ... 
3 . . .. YGRQTFT EIG ALGLAHPGEYNAG GDP ... 
4. R-VVT EMA ALGFSGP ... 
5 . NGVLA EFG AL-QVMANLVTRKDPTIVR QQA ... 
6. LDVTA EMT GVTQETANLIYENQPGALN SFS ... 
7. MDVTA EMT GVTQETANLNYENQPGALN SFS ... 
8 . LDVAA EVS GFTEQNSGLIYRGQSGGMN AFS ... 
9. IDVVA ELT AVTDTTAGLIYQNESGAIN AIS ... 
Figure 4.10. Comparison of the primary structure of Mprl with known metalloproteases. Conserved 
amino acid sequences around the HEXXH motif (grey background; the two His residues in bold white 
constitute the first and second Zn ligands) and the third Zn ligand (Glu : black background) are placed into 
two groups, based on the degree of sequence homology and on the spacing between the second and third 
Zn ligands (sequences 1-3 and 5-9). Sequence 4 partly fits with the first group (1-3), even though, 
surprisingly, it is not a bacterial protein, but derives from the surface glycoprotein gp63 of Leishmania. 
Sequences 9 and 10 show no homology other than the HEXXH motif. Sequences : 1) Serratia neutral 
protease, 2) P. aeruginosa alkaline protease, 3) E. chrysanthemi extracellular metalloprotease B, 4) 
Leishmania gp63, 5) M. tuberculosis Mprl , 6) B. subtilis neutral protease, 7) B. amyloliquefaciens neutral 
protease, 8) P. aeruginosa elastase, 9) B. thermoproteolyticus thermolysin, 10) V. alginolyticus 
collagenase, 11) S. cacaoi neutral protease. 
Hydropathy plots show that this protease does not have any likely TM domains 
and is most probably secreted into the medium (not shown), unless it is a lipoprotein as 




Theoretical analysis of the deduced amino acid sequence of Mprl reveals an N-
terminal lipoprotein signal peptide and a HEXXH motif characteristic of the 
metalloprotease family (Jongeneel et al., 1989). There are no significant hydrophobic 
regions, making it unlikely to be a transmembrane protein. However, since it is likely a 
lipoprotein, it will probably remain membrane-bound and not be secreted. Rowland et 
al. (1997) have described the presence of a calcium-dependent Zn-metalloprotease in 
stationary phase culture filtrates of M tuberculosis H37Rv. In addition, this protease 
exhibited elastolytic activity, hinting at a potential role in the tissue destruction 
characteristic of pulmonary tuberculosis (30% of lung tissue is elastin). Notably, 
bacterial metalloproteases often possess collagenolytic and elastolytic activity, and have, 
therefore, been implicated in the pathogenesis of a number of disease processes 
(Harrington, 1996; Hase et al., 1993). Although a definitive role for bacterial matrix-
metalloproteases in disease pathogenesis has not yet been established, their association 
with diseases characterised by host tissue damage warrants further study of these 
enzymes. 
The M tuberculosis genome sequence contains at least three putative 
metalloprotease genes (Rv0419, Rv0198, and Rv1977) (Cole et al., 1998). If the 
activities of these M tuberculosis metalloproteases are consistent with the activities of 
other microbial metalloproteases, they could contribute to the tissue-destructive potential 
of M tuberculosis. In addition, degradation of fibrotic capsules or connective tissue may 
provide an escape route for latent M tuberculosis bacilli, thus aiding dissemination and 
disease progression. 
However, for the purpose of this study, attention was focused on mycosin-1, as it 
was the first member of a novel family of subtilisin-like serine proteases to be detected. 
We have hypothesised that this family plays a significant role in the pathogenic potential 
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of M tuberculosis (Brown et al., 1999). In this study, Mprl was used as a negative 
control in the cloning and expression experiments involving mycosin-1, but its potential 
involvement in the pathogenic lifestyle of M tuberculosis warrants future investigation. 
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5.1 HOSTS AND VECTORS USED IN MYCOBACTERIAL GENETICS 
5.1.1 Introduction 
For decades tuberculosis has been endemic in Third World Countries. Despite 
this, molecular analysis of mycobacteria has lagged behind that of other pathogens. This 
was partly a consequence of a lack of interest in First World Countries, due to successes in 
controlling this disease. Thus, 15 years ago, when tuberculosis cases began increasing 
world-wide, investigators found themselves challenged by the virtual absence of 
mycobacterial molecular biology, as bacterial molecular techniques had not been applied 
to this pathogen. Steadily, however, systems have been developed over the past decade 
that are suitable for the study of mycobacterial genetics and now, through the concerted 
effort of researchers around the world, the scientific community is becoming more 
familiar with the genetics of this genus, and especially M tuberculosis. The recent 
publication of the M tuberculosis genome sequence represents a great triumph in this 
regard, and has paved the way for the study of a diverse array of M tuberculosis genes 
and proteins. 
Proteins that are secreted or released by M tuberculosis are thought to play a 
significant role in the ability of the bacterium to establish disease. Moreover, these 
proteins are becoming recognised as primary candidates for vaccine development and as 
potential drug targets. Nevertheless, despite the advances in mycobacterial genetics, the 
study of these proteins has been hampered by the difficulties experienced in manipulating 
M tuberculosis. Its slow growth, infectious potential, and peculiar biochemical 
composition have made identification and purification of cellular constituents difficult. In 
addition, established techniques for the introduction of foreign DNA into bacteria 
provided disappointing results, necessitating the development of novel methods. 
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5.1.2 Alternative host species 
To circumvent the problems associated with the study of M tuberculosis, 
researchers have sought alternative host species that allow expression of M tuberculosis 
genes. Although E. coli is able to translate some mycobacterial genes and produce active 
proteins (Leao et al. , 1995), including examples with N-terminal signal peptides 
(Hewinson et al. , 1993), expression is generally characterised by a low yield of soluble, 
correctly processed recombinant protein (Garbe et al., 1993; Harth et al. , 1997). It has 
been suggested that high yields of protein can be obtained if the expressed proteins are 
highly conserved, for example, the M tuberculosis heat shock proteins that are present in 
eukaryotes and prokaryotes (Mehlert & Young, 1989). Expression of proteins that are 
destined for the cell membrane has been shown to interfere with the function of the host 
membrane. Hence, some investigators have expressed these proteins without their signal 
peptides, thus directing the proteins into the cytoplasm (Pullen et al., 1995; Schmid et al., 
1996). However, these proteins were subsequently found to be insoluble and inactive; in 
some cases, refolding and reactivation were possible. 
The high GC content (- 65%) of mycobacterial DNA suggests that uncommon 
transcription and translation signals may be used. It is likely, therefore, that bacteria with 
a similar GC content may be useful hosts for the expression of mycobacterial genes. 
Streptomyces lividans, a Gram positive bacterium belonging to the Actinomycetes order, 
as do mycobacteria, has a high GC content (- 73%) and has been shown to recognise a 
variety of prokaryotic promoters. This organism has been used successfully for the 
expression of genes from M bovis BCG, M tuberculosis, and M leprae, using their own 
promoters (Kieser et al. , 1986; Lamb & Colston, 1986). However, the non-pathogenic 
relatives of M tuberculosis seem the most likely hosts for the successful expression of 
M tuberculosis genes. M bovis BCG, a sister-species of M tuberculosis, seems an 
obvious choice as a host for M tuberculosis genes. However, M bovis BCG is a slow-
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growing organism that tends to grow in clumps, making working with this organism 
tedious. M smegmatis grows in clumps that are more tractable, it is fast growing, and 
heterologous mycobacterial genes have been successfully expressed in this organism. 
The gene encoding the superoxide dismutase enzyme of M tuberculosis was 
expressed from its own promoter in M smegmatis and active enzyme was obtained (Zhang 
et al., 1991). In contrast, when this enzyme was expressed in E. coli an exogenous 
promoter was essential for expression and the recombinant protein was functionally 
inactive. In addition, Harth et al. (1997) obtained high levels of expression and secretion 
of four major extracellular proteins of M tuberculosis using M smegmatis as host. All 4 
proteins were expressed from their own promoters and were indistinguishable from their 
native counterparts. Attempts to obtain high-level expression and secretion of these 
proteins in E. coli or B. subtilis were unsuccessful. Both M smegmatis and M aurum 
have become the preferred host species as they are both members of the fast growing 
group of mycobacteria, are less prone to clumping, and methods have been developed that 
improve transformation efficiencies (Hermans et al., 1990; Jacobs et al., 1991). 
5.1.3 Vectors 
Numerous vectors have been developed for the shuttling of mycobacterial DNA 
between strains and/or species. The construction of these vectors has rested on the ability 
of the plasmid to replicate in a variety of organisms, in order to overcome the need to 
construct vectors with different replication functions for different hosts. Initial 
E. coli/mycobacterium shuttle vectors were derivatives of an M fortuitum plasmid, 
pAL5000 (Hermans et al., 1996). Additional vectors were constructed using pMSC262 
from M scrofulaceum (Goto et al., 1991) and pNG2 from Corynebacterium (Radford & 
Hodgson, 1991). Most of the early vectors coded for kanamycin-resistance for the 
selection of transformants. This was not ideal as kanamycin was used for the treatment of 
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tuberculosis and there was some concern that kanamycin-resistant M tuberculosis bacilli 
could develop. Thus, alternative selection markers were sought and hygromycin became 
the marker of choice. The majority of vectors contained mycobacterial sequences as those 
vectors lacking mycobacterial sequences were unable to replicate in some mycobacterial 
species. 
Mycobacteriophages have also been used in the construction of vectors that are 
able to replicate in both E. coli and mycobacteria. It appears that incorporation of parts of 
the phage-specific replication mechanism stabilises plasmids in mycobacteria (Hermans & 
De Bont, 1996). Therefore, vectors have included either the whole phage (phAEl from 
mycobacteriophage TM4, phAEI5 from mycobacteriophage LI) (Jacobs et al., 1987; 
Snapper et al. , 1988), the phage attachment site and integration genes (pMV36I and 
pMH5 from mycobacteriophage LS) (Stover et al., 1991; Lee et al., 1991), or a phage 
origin of replication (pRM64 using the mycobacteriophage D29 origin of replication) 
(Lazraq et al. , 1991), and in each case have been cloned into E. coli plasmids. These 
vectors stably insert foreign genes by a site-specific integration into the mycobacterial 
chromosome. 
A further set of vectors was constructed based on homologous recombination. An 
example being the vector pY6002 (containing a copy of the M smegmatis pyrF gene) that 
integrates itself into the chromosome of M smegmatis (Husson et al. , 1990). Insertion of 
a foreign gene into the vector' s copy of pyrF results in the integration of the gene into the 
chromosome thereby inactivating the host's pyrF gene. Finally, some investigators have 
constructed "artificial transposons" (e.g. , pUS70I , pUS702) whereby foreign sequences 
are inserted adjacent to a selection marker gene, introduced into the host, and integrated 
into the chromosome in the same way as a natural transposon (Dellagostin et al. , 1993). 
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5.2 CLONING AND EXPRESSION OF MYCPT IN E.COLI AND 
PRODUCTION OF AN ANTI-MYCOSIN-1 ANTIBODY IN RABBITS 
5.2.1 INTRODUCTION 
Mycosin-1 is a putative membrane-bound protease of M tuberculosis. Although 
functional M tuberculosis proteins have been expressed in E. coli (Hewinson & Russell, 
1993), mycosin-1 expression in E.coli may present three potential problems. First, E.coli 
does not accurately process some M tuberculosis signal peptides, leading to the expressed 
product being located intracellularly, making it prone to degradation by host proteases and 
subjecting it to an environment that may not support its function. Second, difficulties 
have been reported when expressing foreign membrane-active proteins in E. coli, as they 
may interfere with host membrane function (Senaratne et al., 1998). Attempts to negate 
this have rested on removing the signal peptide that would direct the protein to its 
intramembrane location. However, this may lead to the production of an expressed 
protein that is insoluble and that will require detergents and/or denaturants to restore it to 
its native, active state. Third, expression of M tuberculosis genes in E. coli is often 
characterised by a low yield of expressed product (Harth et al., 1997), compromising 
detection and purification. 
Mycobacterial species have been shown to accurately process M tuberculosis 
signal peptides (Harth et al., 1997). Therefore, it was decided to amplify mycP I without 
the signal sequence for expression in E. coli, and with a signal peptide and potential 
ribosome binding site for expression in M smegmatis. Although expression in E. coli has 
potential disadvantages, it often provides a good expression system generating sufficient 
quantities of protein for the purpose of purification and production of antibodies. As will 
be described, this strategy provided sufficient protein for the production of an anti-
mycosin-1 antibody. This part of the chapter describes the cloning of mycP r into 
127 
pGEX-2T, expression in E. coli, purification of the recombinant protein, and generation of 
an anti-mycosin-1 antibody in rabbits. 
5.2.2 MATERIALS AND METHODS 
5.2.2.1 Transformations of cosmids Y15F10 and Y22G 10 into E. coli 
Lyophilised samples of M tuberculosis H37Rv cosmids Y15F10 and Y22G10 
were obtained from the Pasteur Institute, Paris, France. Sixteen nanograms of each 
cosmid was transformed into competent E. coli XLl-Blue cells (Appendix A.3) and plated 
onto Luria agar (LA) plates containing ampicillin (50 µg/ml). After an overnight 
incubation at 37°C, ampicillin-resistant colonies were used to inoculate 5 ml Luria broth 
(LB), incubated overnight at 37°C and the cosmid DNA was extracted using a shortened 
mini-prep protocol (Appendix A.4). LB (50 ml) containing ampicillin (50 µg/ml) was 
inoculated with cosmid-containing clones, incubated overnight at 3 7°C and preparative 
amounts of cosmid DNA were isolated using the Qiagen mini-prep DNA kit (Qiagen 
GmbH, Hilden, Germany), as per manufacturer's instructions. The amount of DNA was 
quantitated spectrophotometrically and by agarose gel electrophoresis. 
5.2.2.2 PCR amplification of mycP 1 and mpr 1 protease genes. 
Primer design was based on cosmid DNA sequences generated by the 
M tuberculosis genome project (Sanger Center, UK); cosmid Y15F10, accession no. 
Z94121, for Rv3883 (designated mycPJ), and cosmid Y22Gl0, accession no. Z84724, for 
Rv0419 (designated mprl). Amplification was performed with the Expand™ High 
Fidelity PCR System (Boehringer Mannheim) using 100 ng of cosmid M tuberculosis 
DNA as a template. 
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a) The mycPJ gene was amplified using one reverse primer (plr), 5'-AA AGA ATT CTG 
CAG TCA TCG GCG GCT CAG CG-3 (including EcoRl and Pstl sites at the 5' end) and 
one of two different forward primers. The first forward primer (plf), 5'- CGT TCT AGA 
GGA TCC CCC GCA TCG GCC ATC ACG-3' (including aXbal and BamHl site at the 5 
' end), corresponded to nucleotides 52-69 (Figure 4.1) and generated a product without the 
signal sequence (mycPT) (Figure 5.1). The second forward primer (plmycf), 5'- ACA 
GGA TCC GTC AAG TGG CCC AAG GTA GCA-3' (including a BamHl site at the 5' 
end), corresponded to nucleotides -71 to -51 (Figure 4.1) and generated a product 
(mycP 1+) which incorporated 71 nucleotides upstream of the annotated translational start 
site thus containing the putative ribosomal binding site and signal sequence (Figure 5.1). 
plmycf plf p Ir 








Figure 5.1. Schematic diagram of the PCR amplified fragments of mycPJ . Fragment mycP r was 
amplified using primers plf and plr and represents mycPJ without the signal sequence(*). Fragment 
mycP J+ was amplified using primers p 1 mycf and p Ir, and represents mycP 1 plus some sequence upstream 
of the putative translational start site (gtg) which likely contains the ribosome binding site. For ease of 
cloning, appropriate restriction endonuclease sites were included at the 5'-end of each primer. 
b) The mprl gene was also amplified using one reverse primer (mlr), 5'- AAT CAA TTG 
CTG CAG CTA TCC CGG ATA CCG-3' (including Munl and Pstl sites at the 5' end) and 
one of two forward primers. The first forward primer (mlf), 5'- GGA TCC TCT AGA 
GGC TGC ACG ACC GTC-3' (including BamHl and Xbal sites at the 5'end), 
corresponded to nucleotides 112 to 126 (Figure 4.8) and generated a product without the 
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signal sequence (mprT) (Figure 5.2). The second forward primer (mlmycf), 5'- ATT 
GGA TCC TTC CTT GGT GCA TGC CG-3' (including a BamHI site at the 5' end), 
corresponded to nucleotides -20 to -36 (Figure 4.8) and generated a product (mpr I+) 
which incorporated 36 nucleotides upstream of the annotated translational start site and 
thus contained the putative ribosomal binding site and signal sequence (Figure 5.2). 
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Figure 5.2. Schematic diagram of the PCR amplified fragments of mprl. Fragment mprr was 
amplified using primers m If and m lr and represents mpr I without the signal sequence (*) . Fragment 
mpr I+ was amplified using primers m I mycf and m Ir, and represents mpr I plus some sequence upstream of 
the putative translational start site (atg) which likely contains the ribosome binding site. For ease of 
cloning, appropriate restriction endonuclease sites were included at the 5'-end of each primer. 
5.2.2.3 Cloning of mycPT into pGEX-2T and transformation into E.coli 
pGEX-2T DNA (2µg) (Pharmacia) and mycP r DNA (2µg) were each digested 
with BamHI and EcoRl (Appendix A.1 ). The purified products were ligated (Appendix 
A.2; designated pGEX-Pl) and transformed into E. coli XLl-Blue rendered competent by 
the rubidium chloride method (Appendix A.3) (designated E. coli-Pl). Vector DNA only 
was also transformed into competent E. coli cells ( designated E. coli-pGEX; served as the 
negative control). Each transformation mixture (100 µl) was plated onto LA plates 
containing ampicillin (50 µg/ml) and, after an overnight incubation at 37°C, ampicillin-
resistant colonies were used to inoculate 5 ml LB. After another overnight incubation at 
37°C, the recombinant pGEX-Pl construct was extracted using the shortened mini-prep 
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protocol (Appendix A.I). To confirm the presence of the mycPT insert, pGEX-Pl DNA 
was digested with BamHI and EcoRI. Glycerol stocks (25%) were prepared from E. coli-
p 1 and stored at -70°C (Sambrook et al., 1989). 
5.2.2.4 Expression and purification of recombinant mycosin-1 
The GST-fusion protein was expressed and purified essentially as described by 
Frangioni et al. (1993). Briefly, E. coli-Pl cells were grown in LB to an OD600 of 0.8, 
induced with 0.1 mM IPTG for 2 hat 37°C and pelleted by centrifugation at 1,000 x g for 
10 min. After washing with STE [10 mM Tris (pH 8.0), 150 mM NaCl, 1 mM EDTA], 
the bacteria were gently resuspended in 0.075 x vol of STE containing lysozyme (final 
concentration 100 µg/ml). After a 15 min incubation on ice, dithiothreitol (DTT) was 
added to a final concentration of 5 mM and the mixture was left standing on ice for 15 
min. N-laurylsarcosine (Sarkosyl) was added to a final concentration of 1.5% and the 
mixture was gently mixed for 10 min. The cells were then disrupted by sonication 
(Transsonic 310 water bath sonicator, Elma, Germany, 35 kHz) on ice-cold water for 2 
mm. The sonicate was centrifuged at 12,000 x g for 20 min and the supernatant 
recovered. Triton X-100 was added to the supernatant to a final concentration of 4% 
before the mixture was passed over a GST-agarose affinity column (0.5 ml/min). The 
fusion protein (GST-mycosin-1) was eluted with glutathione elution buffer [75 mM 
HEPES, 150 mM NaCl, 20 mM reduced glutathione, 5 mM DTT, 2% (w/v) N-
octylglucoside ]. 
Samples (100 µl) of E. coli-Pl and E. coli-pGEX pre- and post-induction of the 
GST-fusion protein, as well as a sample of purified products, were mixed with an equal 
volume of SDS-PAGE solubilisation buffer. After boiling the samples at 100°C for 5 min 
they were resolved on a 10% SDS-polyacrylamide gel and subjected to Western blot 
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analysis using an anti-GST mouse monoclonal antibody (1: 1,000) as the primary antibody 
and peroxidase-labelled anti-mouse IgG as the secondary antibody (Appendix A.5). 
5.2.2.5 Polyclonal antibody production 
Blood was taken from each of two New Zealand White rabbits, centrifuged at 
3,000 x g for 10 min, and the serum fraction (referred to as pre-immune serum) was 
removed and stored at -70°C in 1 ml aliquots. Purified GST-mycosin-1 fusion protein 
(100 µg) resuspended in incomplete Freund' s adjuvant was injected subcutaneously into 
each rabbit. Three additional booster injections were administered at 3-week intervals. 
Blood (10 ml) was taken from each rabbit at 1 and 2 weeks after the last booster injection, 
centrifuged at 3,000 x g for 10 min, and the serum fraction (referred to as anti-mycosin-1 
antiserum) was removed and stored at -70°C in 1 ml aliquots. 
5.2.2.6 Affinity purification of the pre-immune serum and anti-mycosin-1 antiserum 
LB (1 litre) containing ampicillin (50 µg/ml) was inoculated with E. coli-pGEX 
cells. After an overnight incubation at 37°C, GST production was induced by the addition 
of 0.1 mM IPTG for 2 hat 37°C. The bacteria were pelleted by centrifugation at 3,000 x g 
for 10 min and resuspended in 100 ml 0.1 M sodium borate/I M NaCl, (pH 8.0). 
Lysozyme (2 mg/ml) was added and the mixture incubated at room temperature. After 20 
min, DNAse I (10 µg/ml) and Triton X-100 (0.005%) were added and the mixture again 
incubated at 4°C for 1 h. After centrifugation at 8,000 x g for 20 min at 4°C, the 
supernatant was recovered and the pH adjusted to 9.0 with 1 M NaOH. 
Two grams CnBr-activated Sepharose 4B (Sigma) was washed 4 times with 1 mM 
HCl and then equilibrated with coupling buffer [0.1 M sodium borate/0.5 M NaCl, (pH 
9.0)]. The equilibrated sepharose was added to the supernatant (containing E. coli proteins 
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and GST) and incubated rotating at 4°C overnight. The uncoupled protein was removed 
by washing with coupling buffer. A sample was retained for OD determination to predict 
the coupling efficiency. To block remaining active sites, sepharose with bound protein 
was incubated with 0.2 M glycine (pH 8.2) at room temperature for 2-3 hand then washed 
with alternating coupling buffer and acetate buffer [0.1 M sodium acetate / 0.5 M NaCl 
(pH 4.0)]. Two columns, each containing 2 ml of sepharose, were prepared and washed 
with 10 column volumes of PBS. Pre-immune serum and anti-mycosin-1 antiserum were 
each passed 4 times over a column. Between each passage the column was regenerated 
with alternating washes of 0.1 M Tris/0.5 M NaCl (pH 8.5) and 0.1 M NaAc/0.5 M NaCl 
(pH 4.0). After the last passage the resultant eluent, containing pre-immune serum and 
anti-mycosin-1 antiserum depleted of antibodies to E. coli proteins and GST, was stored at 
4°C. After a final wash with alternating 0.1 M Tris/0.5 M NaCl (pH 8.5) and 0.1 M 
NaAc/0.5 M NaCl (pH 4.0), the columns were washed with 3 column volumes of PBS and 
then stored at 4°C in PBS containing 0.02% sodium azide. 
5.2.3 RESULTS 
5.2.3.1 Transformation of cosmids 
The cosmids, Y15F10 and Y22G10, containing mycPJ and mprl , respectively, 
were transformed into competent E. coli XLl-Blue cells and incubated overnight at 37°C. 
DNA extraction from ampicillin-resistant colonies from each plate confirmed the presence 
of the cosmids and 25 µg of each cosmid was prepared. 
5.2.3.2 PCR amplification of mycPJ and mprl. 
Amplification of M tuberculosis H37Rv cosmid DNA with primers based on the 
genome sequence generated four fragments: a) a 1318-bp fragment (mycPT) and a 1386-
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bp fragment (mpr T) representing the genes without their signal sequences (Figure 5.3A) 
and b) a 1434-bp fragment (mycPJ+) and a 1557-bp fragment (mprl+) which represent 
amplification of both genes to yield products incorporating their signal peptides and 
potential ribosome binding sites (Figure 5.3B). The sequence integrity of the PCR 
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Figure 5.3. PCR amplification of mycPJ and mprl protease genes. Both protease genes were amplifie 
by 30 cycles of PCR. Template DNA was M. tuberculosis H37Rv cosmids YI5FIO and Y22GI0 for 
mycP 1 and mpr I , respectively; IO µI of each reaction was electrophoresed on a 0.8% agarose gel and then 
stained with ethidium bromide. Lane I, PCR negative control (primers but no template DNA); lane 2, 
PCR negative control (template DNA but no primers); lane 3, PCR reaction (template DNA and primers) . 
The numbers on the left are molecular weight markers in kb. A) mycP I and mpr I without a signal 
sequnce; B) mycP I and mpr I with a signal sequence and putative ribosome binding site 
5.2.3.3 Cloning and expression of mycPT in E.coli 
For ease of cloning, mycP r was amplified with Xbal and BamHI restriction 
endonuclease sites at the 5' end and Pstl and Eco RI restriction endonuclease sites at the 3' 
end. This 1318-bp fragment was cloned into the BamHI and EcoRI restriction 
endonuclease sites of pGEX-2T in frame with the GST gene. Since the fragment lacks the 
mycP 1 signal sequence, a fusion protein of - 73 kDa (27-kDa GST protein fused to an 
expected 46-kDa mycosin-1) was expected to accumulate intracellularly. Both pGEX-Pl 
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and pGEX-2T (negative control) were transformed into E. coli XLl-Blue. Numerous 
ampicillin-resistant colonies were obtained and the presence of both plasmids was 
confirmed by isolation of plasmid DNA followed by restriction enzyme analysis using 





Figure 5.4. Agarose gel of pGEX-2T and the pGEX-Pl construct. E. coli XLI-Blue cells transformed 
with pGEX-2T and pGEX-Pl were grown at 37°C, pelleted, and plasmid DNA extracted (Appendix A.4). 
The presence of mycP r was confirmed by digestion of the DNA with BamHI and Eco RI. Lanes 1 and 2 
contain molecular weight markers and the numbers on the left are molecular weights in kb. 
After growth at 37°C and induction with IPTG, whole cell lysates of uninduced and 
induced bacteria, as well as products purified on a GST-agarose affinity column, were 
analysed by SDS-PAGE and Western blotting (Figure 5.5). As expected, a 27-kDa 
protein corresponding to GST was observed in the induced and purified fractions of 
E. coli-pGEX (E. coli transformed with the vector pGEX-2T). The induced and purified 
fraction of E. coli-Pl (E. coli transformed with pGEX-Pl) revealed the presence of a new 
band at - 73 kD, likely representing the GST-mycosin-1 fusion protein, based on 
cross-reactivity with an anti-GST monoclonal antibody (Figure 5.5). 
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Figure S.S. Expression of mycPT in E. coli. E. coli XLI-Blue cells transformed with pGEX-2T and 
pGEX-Pl were grown at 37°C and fusion protein production was then induced with 0.1 mM IPTG for 2 h. 
Thereafter, the bacteria were pelleted and sonicated. GST and the fusion protein were purified using a 
GST-agarose affinity column. Whole cell extracts of uninduced (U), induced (I) and purified (P) fractions 
were analysed by (a) SDS-PAGE and (b) Western blotting using an anti-OST monoclonal antibody as the 
primary antibody. 
Most GST-mycosin-1 was recovered from the insoluble (cell lysate) fraction (data 
not shown) and significant amounts were lost during purification, consistent with the high 
degree of hydrophobicity predicted from the amino acid sequence. Addition of detergents 
to solubilise the fusion protein increased the amount of GST-mycosin-1 in the soluble 
fraction and improved purification yields, but significant amounts were still lost to the 
insoluble fraction. 
The SDS-PAGE and Western blot of purified GST-Pl revealed additional lower 
molecular weight products, possibly representing degradation products of the fusion 
protein (Figure 5.5). The use of protease inhibitors, alternative E. coli hosts, or shorter 
expression times did not significantly reduce GST-mycosin-1 degradation (not shown). 
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5.2.3.4 Production of an anti-mycosin-1 antibody 
Western blot analysis of cell fractions of E. coli-pOEX and E. coli-Pl revealed that 







Figure 5.6. Detection of E. coli proteins using pre-immune serum. Whole cell extracts of uninduced 
and induced fractions of E. coli transformed with pGEX-2T and an induced fraction of E. coli transformed 
with pGEX-Pl were resolved on a 10% SDS-polyacrylamide gel. The proteins were transferred to a 
nitrocellulose membrane and then subjected to Western blotting (Appendix A.5) using the pre-immune 
serum as the primary antibody (1: 1,000). The numbers on the left are molecular weight markers in kDa. 
The polyclonal anti-mycosin-1 antiserum, however, recognised the fusion protein, 
as well as OST and several E. coli proteins (Figure 5.7a). To improve the specificity of 
the antisera both were affinity-purified by passage over a CnBr-activated Sepharose 4B 
column bound to proteins from an induced fraction of E. coli transformed with pOEX-2T. 
After 2-3 passages over the column, all cross-reacting E. coli and OST antibodies were 
removed. The resulting affinity-purified polyclonal anti-mycosin-1 antiserum only 


















Figure 5.7. Detection of GST-mycosin-1 using anti-mycosin-1 polyclonal antiserum . Whole cell 
extracts of uninduced (U), induced (I) and purified (P) fractions of E. co/i-pGEX and E. coli-PI were 
resolved on a I 0% SDS-polyacrylamide gel. The proteins were transferred to a nitrocellulose membrane 
and then subjected to Western blotting using (a) polyclonal anti-mycosin-1 antiserum and (b) affinity 
purified polyclonal anti-mycosin-1 antiserum as the primary antibody. The numbers on the left ar 
molecular weight markers in kDa. 
5.2.4 DISCUSSION 
This chapter describes the recombinant expression of the mycP 1 gene product, 
mycosin-1, in E. coli. Since mycosin-1 is likely to be an exported, membrane-anchored 
protein, it was produced as a recombinant protein without its signal sequence to minimise 
the disturbance in the host membrane. Without the signal sequence mycosin-1 would not 
be translocated across the plasma membrane but would accumulate intracellularly. 
However, this, together with its hydrophobic nature, led to the production of recombinant 
GST-mycosin-1 that was insoluble. In addition, due to its intracellular residence there was 
a significant amount of degradation. Although the use of detergents in the purification 
procedure ensured that sufficient soluble protein was obtained to induce a useful antibody 
response in rabbits, a significant amount of recombinant protein remained in the insoluble 
fraction. Various strategies were attempted to prevent degradation - altering expression 
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times and temperatures, using protease deficient strains of E. coli, and using protease 
inhibitors - all unsuccessful. 
The activity of some denatured proteins can be restored after renaturation. 
However, this is especially difficult to achieve with subtilisins. As mycosin-1 is predicted 
to be a subtilisin-like protease and part of our objective was to obtain an active 
recombinant protein, purification procedures were selected that would lead to as little 
denaturation as possible of the expressed product. This, unfortunately, was at the expense 
oflosing a significant amount of the fusion protein to the insoluble fraction. For a number 
of technical reasons it was decided not to cleave off the GST portion but to assess activity 
of the fusion protein instead : a) Since the mycosin-1-GST fusion protein was mostly 
degraded it was felt that there would probably be insufficient amounts of undegraded 
mycosin-1 to purify and assess for activity; b) During the purification procedure further 
amounts of mycosin-1 would be lost; c) Separating thrombin (used to cleave the GST 
portion) from mycosin-1 would present a technical challenge. Although fusion to GST 
may render mycosin-1 inactive, there are reports indicating that despite fusion to GST, the 
activity of the heterologous enzyme can be retained. Activity of the GST-mycosin-1 
fusion protein was assessed using 1251-fibrinogen as the substrate (see section 3.2.5). 
However, no activity was detected. There are a number of possible explanations for this: 
the expression of some mycobacterial proteins in E. coli can yield inactive proteins; the 
GST fusion partner may be affecting activity; the choice of substrate may be incorrect; and 
propeptide cleavage may be required for activity. 
The purified recombinant protein and the degradation products were used to 
generate an anti-mycosin-1 antibody. The resulting polyclonal antiserum reacted with 
mycosin-1 but also cross-reacted with GST and some E. coli proteins. This cross-
reactivity was removed by affinity chromatography using a sepharose column containing 
bound GST and E. coli proteins. 
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5.3 EXPRESSION AND DETECTION OF MYCOSIN-1 IN TRANSFORMED 
M. SMEGMATIS AND WILD-TYPE M. TUBERCULOSIS. 
5.3.1 INTRODUCTION 
The slow growth and pathogenicity of M tuberculosis have made working with 
this organism both tedious and hazardous. This has encouraged investigators to search for 
alternative host species for the study of M tuberculosis genes. Since it is likely that all 
mycobacteria respond to the same DNA transcription and translation signals, several 
mycobacterial species have been investigated as hosts for M tuberculosis genes. 
M smegmatis and M aurum have become the surrogate hosts of choice due to the fact that 
they grow faster and are less prone to forming clumps compared to other members of this 
genus. In addition, efficient transformation procedures have been developed for these 
organisms. It is the opinion of some investigators that for high protein expression and 
secretion of relatively unconserved mycobacterium-specific proteins, a mycobacterial host 
is required. 
As mycosin-1 expressed in E. coli was degraded and inactive, an alternative 
approach was sought and M smegmatis was the host of choice. It was likely that 
M smegmatis would recognise the transcription and translation signals of M tuberculosis 
genes, and thus the complete mycP 1 gene was amplified, incorporating 71 bp of upstream 
sequence that were likely to contain the ribosome-binding site and promoter sequences 
( designated mycP 1+). The amplified fragment was cloned into p 19Kpro ( a gift from Koen 
De Smet, Imperial College Medical School at St Mary ' s, London, UK), a derivative of 
pOL YG, downstream of the constitutive M tuberculosis 19 kDa antigen promoter. This 
part of the chapter describes the cloning of mycP 1+ and mpr 1+ into p 19Kpro, expression of 
mycP 1+ in transformed M smegmatis, and detection of mycosin-1 in M tuberculosis . 
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5.3.2 MATERIALS AND METHODS 
5.3.2.1 Cloning of mycPJ+ and mprl+ into pBluescriptsK (pBS) 
pBS DNA (3 µg) (Stratagene) and mycP 1+ DNA (3 µg) were each digested with 
BamHl and Eco RI, and mpr 1+ DNA (3 µg) was digested with BamHl and Munl 
(Appendix A.I). All products were separated by electrophoresis in a 0.8% agarose gel and 
purified using NucleoSpin Columns (Macherey Nagel, Germany), as per manufacturer' s 
instructions. The purified products were quantitated by agarose gel electrophoresis and 
spectrophotometry. An equal amount ofmycP1+ DNA (150 ng) and mpr1+ DNA (150 ng) 
was ligated to 300 ng pBS DNA (Appendix A.2). The ligated products are designated 
pBS-mycP 1+ and pBS-mpr 1+, respectively. 
5.3.2.2 Transformation of pBS-mycPJ+ and pBS-mprl+ into E.coli 
Of each ligation reaction, 10 µl (approximately 150 ng plasmid DNA) was 
transformed into competent E. coli XLI-Blue cells (Appendix A.3). Several white 
colonies were each inoculated into 5 ml LB, incubated overnight at 37°C, and plasmid 
DNA was extracted using a shortened mini-prep protocol (Appendix A.4). The insert size 
was confirmed by digestion with BamHl and EcoRI for mycP 1+, and BamHl and EcoRv 
for mpr 1+. The insert-containing clones were then used to generate preparative amounts 
of DNA using the Qiagen mini-prep DNA kit (Qiagen GmbH, Hilden, Germany), as per 
manufacturer' s instructions. 
5.3.2.3 Subcloning of mycPJ+ and mprl+ into p19Kpro and transformation into E.coli 
pBS-mycP 1+ DNA (3 µg) , pBS-mpr 1+ DNA (3 µg) , and p 19Kpro DNA (3 µg) 
(Figure 5.8) were each digested with BamHl and EcoRv (Appendix A.I). The purified 
products were quantitated by agarose gel electrophoresis and spectrophotometry. One 
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hundred nanograms of mycPJ+ and mprl+ DNA was ligated to 200 ng p19Kpro (Appendix 
A.2), transformed into competent E. coli XL I-Blue cells (Appendix A.3), and plated onto 
LA plates containing hygromycin B (200 µg/ml). After an overnight incubation at 37°C, 
hygromycin-resistant colonies were inoculated into LB containing hygromycin B (200 
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Figure 5.8. Restriction enzyme map of p19Kpro. This vector contains a hygromycin resistance 
cassette (Hyg) and the 19 kDa protein promoter has been cloned upstream of the multiple cloning site. 
All restriction enzyme sites that are in bold represent unique sites. This vector was a gift from Koen De 
Smet, Imperial College Medical School at St Mary 's, London, UK. 
Plasmid DNA was extracted usmg a shortened mm1-prep method (Appendix A.4). 
Preparative amounts of p I 9Kpro-mycP l + ( designated p 19K-P 1) and p 19Kpro-mpr l+ 
(designated p19K-Ml) DNA was prepared from those clones containing mycPJ+ or mprl+ 
insert DNA, using the Qiagen mini-prep DNA kit (Qiagen GmbH, Hilden, Germany), as 
per manufacturer's instructions. 
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5.3.2.4 Electroporation of p19K-Pl and p19K-Ml into M. smegmatis 
Middlebrook's (MB) medium (100 ml) supplemented with OADC (0.05% oleic 
acid, 5% BSA, 2% dextrose, 0.004% catalase, 0.085% NaCl) was inoculated with 
M smegmatis MC2155 bacteria (1 x 106). After 20 h growth at 37°C, the culture was 
placed on ice for 1.5 h, the bacteria were pelleted by centrifugation at 3,000 x g for 10 
min, washed 3 times in ice-cold sdH20, and then resuspended in 0.5 ml ice-cold 10% 
glycerol. The electroporation procedure is very sensitive to the concentration of salts 
present in the DNA sample, therefore each DNA sample was cleaned with 
chloroform/isoamyl alcohol (24:1) and phenol, then re-precipitated with 100% ethanol. 
Aliquots (50 µl) of the bacteria prepared above were mixed with 50 ng pI9K-Pl DNA, 50 
ng p19K-Ml DNA, 50 ng pI9Kpro DNA or sdH20 (the latter two serving as the positive 
and negative control, respectively) and placed on ice for 1 min. These reactions were then 
added into an electroporation cuvette (0.2 cm electrode gap; BioRad) which was placed in 
the pulser (BioRad). After ensuring that all air bubbles had been removed, the cuvette was 
exposed to 2 pulses (2500 V, 25 µF , 1,000 ohms); 800 µl MB medium was added to each 
cuvette and the contents were transferred to a 6-well tissue culture dish. The dishes were 
incubated at 37°C for 4 h to allow for full expression of the hygromycin-resistance gene 
resident on p 19Kpro. Thereafter, the contents of each well were plated onto MB agar 
plates containing hygromycin B (50 µg/ml) and incubated at 37°C for 4 days. 
Hygromycin-resistant colonies were transferred into 20 ml MB medium supplemented 
with OADC and hygromycin B (50 µg/ml) , incubated for 20 hat 37°C and plasmid DNA 
was isolated (described below). 
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5.3.2.5 Isolation of plasmid DNA from transformed M. smegmatis. 
Five millilitres of the above cultures were centrifuged at 2,500 x g for 20 min. The 
pelleted bacteria were resuspended in 150 µl GTE (25 mM Tris-HCl, pH 8.0, 10 mM 
EDTA, 50 mM glucose) containing 10 mg/ml lysozyme, and incubated overnight at 37°C, 
after which 300 µl 0.2 M NaOH/1 % SDS was added and the mixture incubated on ice for 
20 min. After adding 225 µl 5 M potassium acetate, the mixture was incubated on ice for 
a further 30 min. The suspension was then centrifuged at 12,000 x g for 45 min, the 
supernatant was retained, and 300 µl chloroforrn/isoamyl alcohol (24: 1) and 300 µl phenol 
were added, mixed well, and centrifuged at 12,000 x g for 10 min. The aqueous phase 
was recovered and the plasmid DNA was precipitated by the addition of 1,200 µlice-cold 
100% ethanol. After a 1-h incubation at -70°C, the DNA was pelleted by centrifugation at 
12,000 x g for 10 min, the pellet washed with 70% ethanol and air-dried. The plasmid 
DNA was resuspended in 50 µl sdH20 and quantitated spectrophotometrically. 
An aliquot from each plasmid preparation was digested with BamHI and EcoRv to 
confirm the presence of mycP 1+ and mpr 1+ insert DNA. M smegmatis transformed with 
p19Kpro, p19K-Pl and p19K-Ml have been designated M smegmatis-P19, 
M smegmatis-Pl and M smegmatis-Ml, respectively. 
5.3.2.6 Expression and detection of mycosin-1 in M. smegmatis. 
Wild-type M smegmatis and transformed M smegmatis (M smegmatis-P19, 
M smegmatis-Pl and M smegmatis-Ml) were grown in MB medium supplemented with 
OADC and hygromycin B (50 µg/ml). The cultures were incubated rotating (200 rpm) at 
37°C for 24-44 h, centrifuged at 3,000 x g for 10 min, and the pellet washed twice with 
PBS before being resuspended in the same buffer. The suspension was sonicated (W-385 
sonicator, Heat Systems-Ultrasonics, Inc; output level 3; 80% duty cycle) on ice for 3 
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bursts of 4 min each, separated by 2-min cooling intervals. SDS was added to the sonicate 
to a final concentration of 2% and proteins extracted at 60°C for 2 h. The extract was 
centrifuged at 8,000 x g for 10 min to remove insoluble material, the supernatant mixed 
with an equal volume of 2 x SDS solubilisation buffer, and boiled at 100°C for 5 min. All 
fractions were subjected to SDS-PAGE and Western blotting analysis (Appendix A.5) 
using polyclonal anti-mycosin-1 antiserum (1: 1,000) as the primary antibody and 
peroxidase-labelled anti-rabbit IgG as the secondary antibody. 
5.3.2. 7 Detection of mycosin-1 in wild-type M. tuberculosis. 
M tuberculosis GSH-3052 was inoculated into 100 ml Kirchner's medium and 
grown rotating (200 rpm) at 37°C for 1, 2, 3, 4 and 6 weeks. The bacteria were pelleted 
by centrifugation at 3,000 x g for 30 min, resuspended in PBS and heat-killed at 85°C for 
45 min. The heat-killed bacteria were disrupted by sonication (W-385 sonicator, Heat 
Systems-Ultrasonics, Inc; output level 3; 80% duty cycle) on ice for 3 bursts of 4 min 
each, separated by 2-min cooling intervals. SDS was added to a final concentration of 2% 
and the proteins extracted by incubation at 60°C for 2 h. Insoluble material was pelleted 
by centrifugation at 8,000 x g for 10 min. An aliquot of the supernatant was mixed with 
an equal volume of 2 x SDS solubilisation buffer and boiled at 100°C for 5 min. In 
addition, the culture supernatants were filtered (0.22 µm; low-protein binding) to remove 
any remaining M tuberculosis bacilli, dialysed against sdH20, and lyophilised. Equal 
amounts of protein (determined using the BioRad assay, as per manufacturer's 
instructions) from each week's filtrate was dissolved in an equal volume of sdH20 and 2 x 
SDS solubilisation buffer, and boiled at 100°C for 5 min. The SDS-extract fractions and 
the culture filtrate fractions were subjected to SDS-PAGE and Western blotting analysis 
(Appendix A.5) using the polyclonal anti-mycosin-1 antiserum (1:1000) as the primary 
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antibody and peroxidase-labelled anti-rabbit IgG as the secondary antibody. In the 
following text and chapters of this thesis, whenever M tuberculosis is mentioned it refers 
to wild-type M tuberculosis. 
5.3.2.8 Affinity purification of the pre-immune serum and anti-mycosin-1 antiserum 
M smegmatis-Ml bacteria were inoculated into MB medium supplemented with 
OADC and hygromycin B (50 µg/ml), incubated at 37°C for 44 h, pelleted by 
centrifugation at 3,000 x g for 10 min, the pellet was washed in PBS, and the bacteria were 
then sonicated (W-385 sonicator, Heat Systems-Ultrasonics, Inc; output level 3; 80% duty 
cycle) on ice for 3 bursts of 4 min each, separated by 2-min cooling intervals. After 
removing the cell debris by centrifugation at 3,000 x g for 10 min, the sonicate containing 
whole cell proteins of M smegmatis-M l was added to 2 g CnBr-activated sepharose-4B. 
The proteins were attached to the sepharose as described in section 5.2.2.4. 
5.3.3 RESULTS 
5.3.3.1 Cloning of mycPJ+ and mprl+ into pBS and p19Kpro 
Both mycP 1+ and mpr 1+ were PCR amplified using primers designed to introduce 
restriction endonuclease sites at the 5' and 3' ends of the template genes. For the mpr 1+ 
fragment, a Munl site (generating EcoRI-compatible ends) was constructed instead of a 
EcoRI site, as the fragment contained an internal EcoRl site. For ease of cloning it was 
decided to use the BamHI and EcoRv sites of p19Kpro. Therefore, both fragments were 
first cloned into the BamHI and EcoRI sites of pBS, excised with BamHI and EcoRv, and 
then subcloned into the corresponding sites of p19Kpro. After transformation of p19K-Pl 
and p19K-Ml into E. coli, hygromycin-resistant colonies were randomly selected from 
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each transformation and their plasmid DNA isolated (Appendix A.1 ). Digestion with 






Figure 5.9. Ligation of mycPJ+ and mprl+ into p19Kpro. Both protease inserts were excised from 
pBS-mycPI+ and pBS-mprl+ using BamHI and EcoRv and ligated into the corresponding sites in 
pl 9Kpro. The constructs were transformed into competent E. coli XL l-Blue cells, cultured at 37°C and 
plasmid DNA was isolated. The DNA was assessed for the presence of mycP I+ and mpr I+ insert DNA by 
digestion with BamHI and EcoRv. The digested products were resolved in a 0.8% agarose gel and then 
stained with ethidium bromide. The numbers on the left represent molecular weights in kb. 
Preparative amounts of p19K-Pl and p19K-Ml DNA for electroporation into 
M smegmatis were prepared using the Qiagen mini-prep DNA Kit (Qiagen GmbH, 
Hilden, Germany), as per manufacturer's instructions. 
5.3.3.2 Electroporation of p19Kpro, p19K-Pl, and p19K-Ml DNA into M. smegmatis 
After electroporation of p19Kpro, p19K-Pl, and P19K-Ml into M smegmatis, 
numerous hygromycin-resistant colonies were obtained on the plates of M smegmatis 
transformed with the plasmid constructs. No hygromycin-resistant colonies were obtained 
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on the plates when the plasmid DNA was replaced with H20 (negative control for DNA 
contamination). Ten colonies were harvested from each electroporation event, plasmid 
DNA was isolated, and digested with BamHI and EcoRv. All colonies were shown to 
contain the correct constructs. 
5.3.3.3 Detection of mycosin-1 in transformed M. smegmatis and in M. tuberculosis. 
Dense cultures of M smegmatis transformed with p19K-Pl, p19K-Ml, and 
p19Kpro (the latter two were used as negative controls) were harvested after 24-44 h, and 
the bacterial cell pellets were subjected to sonication and SDS extraction of whole cell 
proteins. Although SDS extraction is likely to denature mycosin-1 , it was thought that due 
to the insoluble nature of mycosin-1, SDS would solubilise enough mycosin-1 for 
detection. Since the aim of this experiment was to detect the presence of mycosin-1 and 
not its activity, denaturation of mycosin-1 was not a concern. Proteins were extracted 
from wild-type M tuberculosis (after 3 weeks growth) in a similar manner as described 
for M smegmatis. The only difference was that the M tuberculosis bacteria were 
heat-killed at 85°C for 45 minutes prior to sonication and extraction of whole cell proteins. 
SDS-PAGE analysis of the SDS extracts from transformed M smegmatis and 
wild-type M tuberculosis revealed a large number of proteins but no dominant band or 
significant difference between the samples (Figure 5.10A). Analysis of the extracts by 
Western blotting using the preimmune antiserum and polyclonal anti-mycosin-1 antiserum 
as the primary antibody revealed cross-reactivity with numerous mycobacterial proteins 
(Figure 5.11A and C). There was, however, an immunodominant band at about 50 kDa 
(mycosin-1 is expected to be 46 kDa) in whole cell protein extracts of M smegmatis-Pl 
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Figure 5.10. Detection of mycosin-1 in transformed M smegmatis and wild-type M tuberculosis. 
Transformed M smegmatis and wild-type M tuberculosis were grown at 37°C, the bacterial cells were 
pelleted, sonicated, and the proteins extracted witth SDS. The extracts were resolved by (A) 10% 
SDS-polyacrylamide gel electrophoresis and transblotted onto nitrocellulose membranes. (B) Western 
blots were performed using affinity purified anti-mycosin-1 antiserum as the primary antibody. An equal 
amount of protein was added to each lane. The numbers on the left represent molecular weights in kDa. 
Key: MS, M smegmatis; PI9, M smegmatis-P19; Pl, M smegmatis-Pl; Ml, M smegmatis-Ml; TB, 
wild-type M tuberculosis. 
The preunmune antiserum and anti-mycosin-1 antiserum were further affinity 
purified by passage over a CnBr-activated Sepharose 4B column with bound 
M smegmatis proteins. Western blot analysis using the antisera affinity-purified of 
antibodies to E. coli and M smegmatis proteins revealed no immunoreactive band with the 
preimmune serum (Figure 5.11B) and a 50 kDa immunodominant band in whole cell 
protein extracts of M smegmatis-Pl and M tuberculosis (Figure 5.10B and 5.1 lD). 
Whole cell protein extracts of M smegmatis-Pl9 and M smegmatis-Ml, both serving as 
negative controls, did not show any immunoreactivity. In addition, wild-type mycosin-1 
expressed by M tuberculosis and heterologous, recombinant mycosin-1 expressed by 
M smegmatis appeared to have the same molecular weight (Figure 5.lOB). In all 
subsequent experiments the antiserum that was used was affinity-purified of antibodies to 
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Figure 5.11. Detection of mycosin-1 in transformed M. smegmatis and in M. tuberculosis. Whole cell 
protein extracts from transformed M smegmatis and M. tuberculosis were resolved by 10% 
SDS-polyacrylamide gel electrophoresis and subjected to Western blot analysis using (A) preimmune 
antiserum (B) affini ty-purified preimmune antiserum (C) anti-mycosin-1 antiserum, and (D 
affinity-purified anti-mycosin-1 antiserum. An equal amount of protein was added to each lane. Key: MS, 
M. smegmatis; PI9, M. smegmatis-PI9; Pl , M. smegmatis-PI ; Ml , M. smegmatis-MI ; TB, 
M. tuberculosis. 
5.3.3.4 Detection of mycosin-1 in M. tuberculosis culture filtrates 
In Chapter 4 the likely presence of a serine protease in M tuberculosis culture 
filtrates was described. To assess whether mycosin-1 is present and could possibly 
contribute to the serine protease activity detected in M tuberculosis culture filtrates, whole 
cell protein extracts and filtrate proteins were analysed by Western blotting using affinity-
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purified anti-mycosin-1 antiserum as the primary antibody. In addition, whole cell protein 
extracts and filtrate proteins from various stages of the M tuberculosis growth cycle were 
assessed for the presence of mycosin-1, enabling some prediction on the stage of the 
growth cycle at which mycosin-1 may be produced. Western blot analysis revealed that 
mycosin-1 was present in M tuberculosis whole cell protein extracts throughout the 
growth curve, with the highest express10n levels detected m 1-week cultures 
(Figure 5.12a). 
weeks weeks 





Figure 5.12. Detection of mycosin-1 in whole cell protein extracts and culture filtrates of 
M tuberculosis. Proteins were isolated from (A) M. tuberculosis bacteria and (B) culture filtrates at 
various stages of growth. An equal amount of protein was added to each lane and separated by 
electrophoresis in a 10%SDS-poyacrylamide gel, transblotted onto a nitrocellulose membrane and 
subjected to Western blot analysis using affinity-purified anti-mycosin-1 antiserum as the primary 
antibody. The numbers on the left represent molecular weights in kDa. 
Culture filtrates prepared from samples taken throughout the growth cycle contained 
mycosin-1, with a marked increase after the 2nd week of growth (Figure 5.12b). A 
decrease in molecular weight of mycosin-1 was noted in the filtrates from 2-week and 
3-week cultures and a further decrease in the 6-week culture. 
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5.3.4 DISCUSSION 
Expression of M tuberculosis genes in M smegmatis has met with great success. 
Investigators have demonstrated that M smegmatis is able to recognise M tuberculosis 
transcription and translation signals and can express M tuberculosis proteins that are 
identical to their homologously expressed counterparts (Harth et al. , 1997). Furthermore, 
these proteins have been shown to be functionally active (Zhang et al., 1991 ). Expression 
of mycosin-1 in M smegmatis was consistent with this trend and the expressed protein 
was identical in size to the native protein in M tuberculosis. However, despite repeated 
attempts using a variety of potential activation conditions - including treatment with acid, 
heat and trypsin - proteolytic activity could not be detected. Since most bacterial 
extracellular proteases, and especially subtilisins, express prodomains that must be cleaved 
for activation, this is likely true also for mycosin-1. However, the necessary conditions 
required for this cleavage have not been established. 
The subtilisin protease family exhibit a wide spectrum of substrate specificity, 
ranging from the bacterial subtilisins that generally possess a broad substrate specificity to 
the mammalian subtilisin-like proprotein convertases (for example, human furin) that 
show specificity for multi-basic sites (Siezen et al., 1994). In addition to preferring 
specific substrate cleavage sites, the convertases are usually insensitive to the typical 
serine protease inhibitors TLCK and TPCK, and their activity is augmented by Ca2+ 
(Hatsuzawa et al., 1992). This was also a feature of the proteolytic activity detected in 
M tuberculosis culture filtrates, suggesting that the filtrate activity may stem from a 
subtilisin-like protease that is between the primitive bacterial subtilisins and the highly 
diversified eukaryotic convertases in the evolutionary process. Thus, mycosin-1 may be a 
highly specific protease for which the appropriate substrate has not yet been identified, 
providing an alternative explanation for the inability to detect activity. 
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It has been well documented that during growth M tuberculosis sheds envelope 
components into the medium (Ortalo-Magne et al., 1995). Thus, the presence of mycosin-
1 in M tuberculosis culture filtrates is likely due to shedding rather than active secretion, 
although the precise mechanism remains to be elucidated. Interestingly, the molecular 
weight of mycosin-1 decreases from - 50 kDa in I-week filtrates to - 45 kDa in 2-4-week 
filtrates to -40 kDa in 6-week filtrates. Although there is a smear of protein in each lane 
in Figure 5.12, this is likely a result of overloading. When less protein was added a 
discrete band at -50 kDa and - 39 kDa was observed (see wk6 sample in Figure 7.2). As 
mycosin-1 without the putative propeptide has a calculated molecular weight of - 39 kDa, 
the 40-kDa band may represent cleaved, active protease. Consistent with this was the 
detection of a proteolytic activity in M tuberculosis culture filtrates that was inhibited by 
serine protease inhibitors. Furthermore, the proteolytic activity detected m 
M tuberculosis culture filtrates increased after 3 weeks of growth. If activation of 
mycosin-1 is autocatalytic and intramolecular, which would be similar to the B. subtilis 
subtilisins (Power et al., 1986), then it is possible that by 6 weeks of growth, as more and 
more active mycosin-1 accumulated, the majority of mycosin-1 would be present in its 
mature active form, as is suggested by the decreasing size of the mycosin-1 
immunoreactive band on Western blots of filtrates from older M tuberculosis cultures. 
Since attempts to purify proteases from M tuberculosis culture filtrates were unsuccessful, 
the source of the serine protease activity remains to be elucidated. 
In conclusion, mycosin-1 has been expressed in M smegmatis and detected in 
M tuberculosis whole cells and culture filtrates . Both recombinant and wild-type 
mycosin-1 are the same molecular weight. To date, no activity has been demonstrated for 
the 50-kDa forms of both recombinant and wild-type mycosin-1. The appearance of a 40-
kDa form of mycosin-1 in 6-week M tuberculosis culture filtrates may represent 
propeptide cleavage and activation. Interestingly, this corresponds to the appearance of a 
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senne protease activity in M tuberculosis culture filtrates, although it could not be 
definitively demonstrated that mycosin-1 was responsible for this activity. Earlier 
attempts at purifying proteases from M tuberculosis culture filtrates were unsuccessful. 
However, in light of the data presented in this chapter, renewed attempts at 
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Localisation of molecules within M tuberculosis has been hampered by the 
complex structure of the cell envelope. The high lipid and carbohydrate content of the 
mycobacterial cell envelope has challenged conventional visualisation techniques, 
necessitating improved protocols for accurate visualisation of structures. 
Electron microscopy has assisted researchers in appreciating the structural 
elements of the mycobacterial cell envelope. However, the various techniques have 
provided contradictory images, further adding to the complexity and mystique surrounding 
the ultrastructural features of the mycobacterial cell envelope. 
Conventional electron microscopy techniques make use of dehydration steps that 
result in the collapse of structures, especially those containing carbohydrates. Since 
carbohydrates are integral components of the mycobacterial cell envelope, conventional 
electron microscopy provides distorted images (Daffe & Draper, 1998). The solvents used 
in section preparation solubilise and remove components of the cell envelope, further 
distorting the image. In addition, stains providing electron density for the major 
components of the mycobacterial cell envelope, namely carbohydrates and lipids, are few 
and their specificities are uncertain. 
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Preparation of electron microscopy samples using the freeze-substitution technique 
has vastly improved the ultrastructural study of the mycobacterial cell envelope (Graham 
& Beveridge, 1990). This technique results in minimal extraction of material by various 
solvents and maintains the integrity of structures. 
Other techniques, including negative staining and freeze-fracture have contributed 
to the ultrastructural analysis of the mycobacterial cell envelope, but image distortion and 
questionable specificity are both potential shortcomings. Immunostaining is increasingly 
being used for the localisation of molecules within the mycobacterial cell envelope 
(Espitia et al. , 1992; Harth et al., 1994). However, poor resolution and a limited range of 
available antibodies are current drawbacks of this technique. 
It is very difficult to separate out the different components of the mycobacterial 
cell envelope, namely the intracellular, cell membrane, cell wall, and capsular fractions. 
Furthermore, currently there are no molecules that can accurately be localised to only one 
of the cell envelope fractions. Thus, assessment of the purity of each fraction after 
subfractionation is very difficult. Current subfractionation techniques employ differential 
centrifugation to separate out the different cell envelope fractions . This chapter describes 
the attempts made to localise mycosin-1, using differential centrifugation and electron 
microscopy techniques. 
157 
6.2 MATERIALS AND METHODS 
6.2.1 Subcellular fractionation 
The subfractionation technique is an adaptation of conventional techniques used in 
previous studies (Hirschfield et al., 1990; Lee et al., 1992; Ortalo-Magne et al., 1995). 
a) M smegmatis-Pl 
M smegmatis-Pl was grown in MB medium supplemented with OADC and 
hygromycin B (50 µg/ml). After 44 h growth at 37°C, the bacteria were pelleted by 
centrifugation at 3,000 x g for 10 min, washed twice in PBS, and then resuspended in 
PBS. Part of the pellet was used for electron microscopy (section 6.2.2a). The remaining 
part was sonicated (W-385 sonicator, Heat Systems-Ultrasonics, Inc; output level 3; 80% 
duty cycle) on ice for 3 periods of 4 min each, separated by 2-min cooling intervals. The 
sonicate was centrifuged at 1,000 x g for 30 min to remove debris and bacteria that 
resisted sonication. DNAse I (final concentration 0.2 mg/ml) and RNAse (final 
concentration 0.2 mg/ml) were added and the sonicate was left overnight at 4°C. The 
mixture was centrifuged at 20,000 x g for 30 min and the resulting pellet containing the 
cell walls was retained. The supernatant was then centrifuged at 100,000 x g for 3 h to 
separate the cell membranes from the intracellular components. The pellets containing the 
cell walls and cell membranes were resuspended in 0.5 ml 2% SDS and heated at 60°C for 
2 h, after which insoluble components were removed by centrifugation. The intracellular 
fraction (the supernatant resulting from the 100,000 x g centrifugation) was concentrated 
2-3 fold (Amicon spin columns; 10-kDa cut-off). All fractions were subjected to SOS-
PAGE and Western blotting analysis using the affinity-purified anti-mycosin-1 antiserum 
(1: 1,000) as the primary antibody (Appendix A.5). 
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b) M tuberculosis GSH-3052 
M tuberculosis GSH-3052 was grown in Kirchner's medium, rotating at 37°C. 
After 3 weeks of growth the bacteria were pelleted by centrifugation at 3,000 x g for 20 
min, washed twice in PBS, heat-killed at 85°C for 45 min and then resuspended in PBS. 
Sonication and subfractionation was performed as for M smegmatis-Pl (section 6.2.la). 
All samples were subjected to SDS-PAGE and Western blotting analysis using 
affinity-purified anti-mycosin-1 antiserum (1: 1,000) as the pnmary antibody 
(Appendix A.5). 
6.2.2 Electron microscopy 
a) M smegmatis 
A portion of the bacterial cell pellet generated in section 6.2.la was resuspended in 
PBS, incubated with 1 % BSA in PBS for 2 min and then with affinity-purified 
anti-mycosin-1 antiserum ( diluted 1 :30 in PBS containing 1 % BSA) overnight at room 
temperature. After two washes in PBS, the bacteria were fixed overnight in 2% 
paraformaldehyde/0.05% gluteraldehyde in 0.1 M phosphate buffer (pH 7.4). After fixing, 
the bacteria were embedded in 2% low melting point agarose, sucrose infiltrated by serial 
passage through a 50% (w/v) to 100% (w/v) sucrose gradient and then cryosectioned at 
-100 to -110°C. Ultrathin sections were placed onto form var-coated nickel grids and each 
grid was floated on a droplet of PBS to allow for the diffusion of sucrose. Non-specific 
binding was blocked by floating the grids on droplets of 0.02 M glycine (3 x lmin) and 
then 1 % BSA in PBS (5 x 1 min). After blocking, the grids were incubated with goat anti-
rabbit IgG conjugated to 5nm-diameter gold particles at room temperature for 2 h. 
Thereafter, the grids were washed by floating on droplets of 1 % BSA (10 x lmin) and 
PBS (5 x 1 min) and postfixed by floating on a droplet of 1 % gluteraldehyde for 5 min. 
After washing with PBS (2 x 5 min) and sdH20 (5 x 1 min), the sections were stained with 
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2% uranyl acetate/methyl cellulose (1 :9) for 2 x 5 min. The grids were retrieved with a 
wire loop, gently dragged across Whatman filter paper to remove the staining solution, 
and air-dried for 10 min. They were then viewed by transmission electron microscopy. 
M smegmatis-Pl9 bacteria were prepared as described above and were used to control for 
non-specific binding to anti-mycosin-1 antiserum (negative control). 
b) M tuberculosis 
A portion of the bacterial cell pellet generated in section 6.2.1 b was incubated with 
1 % BSA in PBS for 2 min and then incubated with affinity-purified anti-mycosin-1 
antiserum (diluted 1 :30 in PBS containing 1 % BSA) overnight at room temperature. After 
washing with PBS, the bacteria were fixed in 2% paraformaldehyde/0.05% gluteraldehyde 
overnight at room temperature. Cryosectioning, immunogold-labelling and staining were 
performed as in section 6.2.2a. M tuberculosis GSH-3052 bacilli were also labelled with 
affinity-purified pre-immune antiserum prior to fixation and were used to control for non-
specific binding (negative control). 
6.3 RESULTS 
6.3.1 Subcellular fractionation 
Subfractionation of M smegmatis-Pl and M tuberculosis cell lysates into wall, 
membrane and intracellular fractions indicated that mycosin-1 was predominantly present 
in the cell wall fraction (Figure 6.1 ). Minimal mycosin-1 was present in the membrane 
fraction of M smegmatis-Pl , but equivalent amounts were present in the membrane and 
wall fractions of M tuberculosis. This result supports the prediction from the primary 
sequence that mycosin-1 may be a cell-envelope protein ( contains multiple hydrophobic 








Figure 6.1. Subcellular fractionation of M. smegmatis-Pl and M. tuberculosis. Whole cell lysates 
were subfractionated into wall (w), membrane (m) and intracellular (i) fractions by differential 
centrifugation. The fractions were resolved on a 10% SDS-polyacrylamide gel, transblotted onto a 
nitrocellulose membrane and subjected to Western blotting analysis using affinity-purified anti-mycosin-1 
antiserum as the primary antibody. The numbers on the left represent the molecular weights in kDa. 
6.3.2 Electron microscopy 
Using the cryosection immunogold technique abundant specific staining for 
mycosin-1 was detected in the cell envelope in M smegmatis-Pl (Figure 6.2B) and to a 
lesser degree in M tuberculosis (Figure 6.2D). Poor labelling was obtained when the 
bacteria were incubated with anti-mycosin-1 antiserum after fixation suggesting that 
fixative may alter the antigenicity of mycosin-1. To overcome this potential problem, 
whole bacteria were first labelled with anti-mycosin-1 , then fixed and the cryosectioned. 
This way, mycosin-1 present in the cell envelope only would bind to anti-mycosin-1. 
Thus, any intracellular gold-labelling was considered to be non-specific. Clumping of 
M tuberculosis bacilli presented major technical difficulties, hence mycosin-1 was mainly 
detected on bacilli at the edge of a clump. The negative controls, M smegmatis-P19 pre-
labelled with affinity-purified anti-mycosin-1 antiserum (Figure 6.2A) and M tuberculosis 
pre-labelled with pre-immune antiserum (Figure 6.2C), were both negative. 
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Figure 6.2. Localisation of mycosin-1 using electron microscopy. A) M. smegmatis-P19 
(magnification x 49,500), B) M. smegma/is-Pl (magnification x 49,500) and D) M. tuberculosis 
(magnification x 100,000) were labelled with affinity-purified anti-mycosin-1 antiserum and then fixed . 
Thin sections, prepared using cryoelectronmicroscopy techniques, were labelled with goat anti-rabbit IgG 
conjugated to 5 nm-diameter gold particles. After staining, the sections were viewed by transmission 
electron microscopy. C) M. tuberculosis (magnification x 100,000) labelled with preimmune serum serve 
as a negative control. 
6.4 DISCUSSION 
Knowing the location of a protease may assist in postulating its possible functions. 
For example, proteases located on the cell surface are more likely to be involved in 
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virulence as it is from this position that they have direct access to host proteins and an 
intracellular protease is more likely to be involved in "house-keeping"/regulatory 
functions than a secreted protease. Therefore, an analysis of the subcellular location of 
mycosin-1 was undertaken. Cell wall, membrane and intracellular fractions of 
M smegmatis-Pl, M smegmatis-Pl9 and M tuberculosis were prepared using a 
combination of chemical extraction and centrifugation steps. These fractions were 
analysed by Western blotting, which revealed that in both M smegmatis-Pl and 
M tuberculosis mycosin-1 was localised to the cell envelope and was undetectable in the 
cytoplasm. In M tuberculosis there appeared to be an equal distribution of mycosin-1 in 
the cell wall and cell membrane, although the methods used were not quantitative. 
Interestingly, in M smegmatis-Pl, mycosin-1 was almost entirely localised to the cell 
wall. This may suggest, firstly, that the native protein is processed and transported in a 
different manner to the recombinant protein; secondly, it may be a reflection of a more 
advanced stage in its transport, possibly a consequence of M smegmatis being a faster 
grower than M tuberculosis; and finally, it may reflect a greater tendency for the 
recombinant protein to be shed from the cell membrane in this organism 
Electron microscopy techniques often provide distorted pictures. For this study 
ultrastructural clarity was not of prime importance. Rather, techniques providing good 
immunolabelling were considered. Preparation of EM sections using resin was not 
considered as resin may block epitopes, resulting in poor immunogold-labelling. In 
addition, the solvents and chemicals used in the sample preparation result in structural 
collapse and are not associated with good immunolabelling. The favoured technique for 
immunolabelling is cryoelectron microscopy. Using this technique, specific labelling of 
mycosin-1 was observed in the cell envelope of M smegmatis-Pl and M tuberculosis. In 
M smegmatis-Pl, intense staining was found in a loose outer layer of the envelope, which 
may be equivalent to the capsular layer that has been recently characterised (Daffe and 
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Draper, 1998). However, the resolution achieved with the immunogold technique used 
here is not sufficient to localise mycosin-1 immunoreactivity to a particular envelope layer 
with any degree of confidence. Significantly, no labelling was present in the control 
samples, M smegmatis-PI9 labelled with affinity-purified anti-mycosin-1 antiserum and 
M tuberculosis labelled with affinity-purified pre-immune serum. 
During the subfractionation technique it is often useful to use markers specific for 
the various fractions as an indication of the purity of each fraction. This is often achieved 
by detecting an enzyme activity specific for a certain fraction or using an antibody that 
binds to a protein specific for a certain fraction. However, for M tuberculosis this has 
proven difficult. There are a few M tuberculosis enzymes that can be used to assess the 
purity of the cytoplasmic and cell envelope fractions. Unfortunately, this approach could 
not be used with M tuberculosis in this experiment as the bacilli were heat-killed at 85°C 
for 45 min, thus denaturing most enzymes and rendering them inactive. In addition, to 
date, there is a shortage of antibodies that are directed towards a protein specific for a 
certain fraction. 
Nevertheless, the subfractionation and electron microscopy data are consistent with 
the presence of an export-directing signal sequence at the N-terminus of mycosin-1, as 
well as the presence of multiple hydrophobic domains in the C-terminal half, one or more 
of which could serve as membrane anchors. Hence, it is reasonable to conclude that 
mycosin-1 is an exported cell envelope-associated protein that performs an 
extracytoplasmic function. The nature of that function is unknown. It is intriguing that 
mycosin-1 is one member of a family of five highly homologous subtilisin-like proteases 
each with similar hydrophobic N- and C-terminal domains. It is tempting to speculate that 
these putative proteases perform a vital subcellular function that requires five related but 










Detection of mycosin-1 in vivo 
Introduction 
Materials and Methods 
Culture of P3889D 1 macrophage-like cells 
Preparation of M tuberculosis GSH-3052 
RT-PCR detection of mycP I RNA in macrophage-grown M tuberculosis 
Infection of P3889D 1 macrophage-like cells 
Detection of mycosin-1 in P3889Dl cells infected with 
M tuberculosis GSH-3052 
7.2.6 Infection of mice with M tuberculosis GSH-3052 
7.3 Results 






Detection of mycosin-1 in M tuberculosis-infected P3889D1 cells 
Infection of mice with M tuberculosis GSH-3052 

















The wisdom in studying M tuberculosis shaking (or stationary) in artificial media 
in the laboratory has long been debated. It has been recognised that in vivo conditions 
are likely to be very different, suggesting that experimental data obtained in vitro may 
not be applicable to the in vivo scenario. Early studies showed a biochemical difference 
between in vivo and in vitro cultivated M tuberculosis bacilli (Segal & Bloch, 1956). In 
addition, there was also a difference in their pathogenicity for mice, suggesting that in 
vivo factors may be required for the expression of some virulence determinants (Segal & 
Bloch, 1957). More recent studies have shown that at least six proteins are only 
expressed in vivo, emphasising the necessity for the study of in vivo expression patterns 
of proteins (Lee & Horwitz, 1995). However, the study of M tuberculosis in vivo using 
an animal model requires specialised equipment and facilities, both of which are costly 
and require expertise and regular maintenance. Therefore, many laboratories make use 
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of cultured cells infected with M tuberculosis to obtain in vivo data. Whether this truly 
reflects the scenario within tuberculous tissues is debatable. However, it does provide a 
vehicle that approximates in vivo conditions, thus allowing for more accurate speculation 
on expression patterns within M tuberculosis-infected tissues. 
Mycosin-1 is likely expressed with a propeptide that requires cleavage for the 
generation of the mature active protease. Propeptide cleavage may be autocatalytic, as is 
the case with the B. subtilis subtilisins (Power et al., 1986), or via another protease, either 
bacterially derived or from the host. It has been suggested that proteases are expressed in 
an inactive proform to regulate proteolysis and, possibly, to direct activity to a specific 
location. Activation occurs when the protease activity is required or when the protease 
reaches the correct location. Since it appears that mycosin-1 is inactive in vitro, it is 
possible that the factors required for activation are to be found in vivo. If this were the 
case, it would be similar to the B. amyloliquifaciens subtilisin that was only present as a 
preproprotein when produced by coupled transcription-translation and it was thus 
suggested that in vivo factors may be rquired to initiate processing and production of 
active enzyme (Power et al., 1986). 
This chapter details the attempts made to express and detect active mycosin-1 in 
vivo, using cultured macrophage-like cells and a mouse-model. 
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7.2 MATERIALS AND METHODS 
7.2.1 Culture of P3889D1 macrophage-like cells 
P3889D 1 cells, a mouse macrophage-like cell line, were cultured as described 
(Haylett & Thilo, 1986). Briefly, P3889D 1 cells were grown and maintained at 37°C in 
5% CO2 and in medium (RPMI-1640) supplemented with 10% heat-inactivated PCS and 
penicillin/streptomycin. The cells were grown to confluency in tissue culture flasks 
(175 cm2, Nunc flat bottom flasks) and the medium was changed every 48 h. After 4 
days of growth, the medium, containing floating P3889D 1 cells from 3 confluent tissue 
culture dishes, was collected. The cells were pelleted by centrifugation at 1,200 x g, 
resuspended in fresh medium, and replated into 6-well tissue culture plates at a cell 
density of 4 x 106 cells/well. The plates were incubated overnight to allow for adherence 
of the cells to the bottom of the well. 
7.2.2 Preparation of M. tuberculosis GSH-3052 and H37Rv 
M tuberculosis GSH-3052 and H37Rv bacteria were prepared as detailed in 
section 4.2.3. The bacteria were harvested after 3 weeks growth, pelleted by 
centrifugation at 3,000 x g for 20 min, and resuspended in PBS to a turbidity 
corresponding to McFarland's standard 3 (9 x 108 bacteria/ml). 
7.2.3 RT-PCR detection of mycPJ RNA in macrophage-grown M. tuberculosis. 
1774.2 macrophages, grown and maintained in Dulbecco modified Eagle medium 
(DMEM) supplemented with 5% heat-inactivated fetal bovine serum (FBS), were 
synchronously infected (Schlesinger et al. , 1990) with non-opsonized M tuberculosis 
H37Rv at a ratio of 10 bacilli/cell. After 4 h, infected monolayers were washed three 
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times with Hanks' balanced salt solution to remove non-phagocytozed bacteria, refed 
with fresh growth medium, and incubated for 15 h at 37°C in 5% CO2. Intracellular 
bacteria were then harvested by differential lysis using guanidine thiocyanate 
(Butcher et al., 1998). Control bacteria consisted of M tuberculosis bacilli grown in 
Middlebrook 7H9 medium supplemented with 10% OADC and 0.02% (v/v) Tween-80. 
RNA was extracted from the intracellular and broth-grown bacteria by the method of 
Mangan et al. (1997). RNA samples were confirmed to be free of contaminating DNA 
by performing polymerase chain reaction (PCR) amplification on the samples using 
primers that amplify a 275-bp fragment of the M tuberculosis dnaK gene (Patel et al. , 
1991). The RNA samples were then subjected to reverse transcriptase (RT)-PCR 
amplification using primers (5'-TAC GCA CCG GAG AAC AGT-3' and 5'-TAA CGG 
ACC TCC GAA GTG-3') that amplified a 238-bp fragment of the mycPJ gene (encoding 
amino acid residues 149-226, see Figure 4.2). In each case, 1 µg of RNA was reverse 
transcribed with Superscript RNase H-RT (Life Technologies, Paisley, United Kingdom) 
according to the manufacturer's instructions, 1/10 of the cDNA was then PCR amplified 
under standard conditions, and the products were resolved by electrophoresis on a 1 % 
agarose gel. A Southern blot of the gel was performed by transfer onto a nylon 
membrane and hybridization with a PCR-generated probe (using the RT-PCR primers, 
above) labeled with the ECL detection system (Amersham, UK); hybridization, washing, 
ECL substrate reaction, and autoradiography were performed as specified by the 
manufacturer. 
7 .2.4 Infection of P3889D1 macrophage-like cells 
P3889D 1 cells prepared in section 7.2.1 were washed with PBS, and fresh RPMI 
1640 medium supplemented with 10% heat-inactivated FCS was added. No antibiotic 
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was added. M tuberculosis GSH-3052 bacteria [225 µl of a McFarland's standard 3 
dilution (9 x 108 bacteria/ml)] were added to each well to obtain a bacteria:cell infection 
ratio of 50: 1. The tissue culture plates were gently agitated to evenly distribute the 
bacteria, and incubated at 37°C in 5% CO2 for 5 h. The cells were then gently washed 
with PBS to remove non-adherent bacteria, fresh medium (with no antibiotic) was added, 
and the plates were incubated at 37°C in 5% CO2 for 3 days. Fresh medium was added 
and the plates reincubated for a further 2-3 days. 
7.2.5 Detection of mycosin-1 in P3889Dl cells infected with M. tuberculosis 
GSH-3052 
After 5-6 days incubation, the cells were detached in 5 mM EDTA, sonicated 
(W-385 sonicator, Heat Systems-Ultrasonics, Inc; output level 3; 80% duty cycle) on ice 
for 3 bursts of 4 min each, separated by 2-min cooling intervals, and centrifuged at 
100,000 x g for 3 h. The pellet ( containing bacterial envelope components, bacterial 
debris, cell membrane components, and cellular debris) was resuspended in SDS loading 
buffer. The supernatant (containing intracellular components) was concentrated 2-3 fold 
and SDS loading buffer was added. The pellet and supernatant samples were boiled at 
100°C for 5 min, resolved on a 10% SDS-polyacrylamide gel (Appendix A.5), and then 
analysed by Western blotting using affinity-purified anti-mycosin-1 antiserum (1:1,000) 
as the primary antibody (Appendix A.5). Controls included uninfected P3889D 1 cells 
(negative control) and M smegmatis-Pl lysates (positive control for mycosin-1 detection 
by Western blotting, prepared in section 5.3 .2.6). 
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7.2.6 Infection of mice with M. tuberculosis GSH-3052 
BALB/c mice were infected intravenously with 1 x 106 M tuberculosis GSH-
3052 bacilli. After 14 days, 21 days, 28 days and 60 days of infection, the mice were 
euthenased using a mixture containing ketamine (10%)(44mg/kg) and xylazine 
(0.25%)(5mg/kg) in sterile water. For each time-point an uninfected mouse was also 
euthenased. The lungs, liver and spleen from each mouse were harvested and each organ 
was divided in half. One half was rapidly frozen in liquid nitrogen and stored at -70°C, 
and the other half was fixed in 10% neutral buffered formalin for 48 h and then processed 
through to wax using standard methods. Sections 3 µm thick were cut, mounted on 
APES-coated slides and incubated at 56°C for 1 h. For histological assessment, the 
sections were stained with the standard stains of hematoxylin and eosin (H & E) and 
Ziehl-Neelsen (ZN). For immunohistochemical assessment, standard techniques were 
followed using affinity-purified anti-mycosin-1 antiserum as the primary antibody. 
Detection systems used were avidin-biotin (DAB was used as substrate) and FITC-
labelled goat anti-rabbit IgG. To control for non-specific binding, samples were also 
labelled with affinity-purified preimmune serum. 
7.3 RESULTS 
7.3.1 Expression of the mycPl gene during growth of M. tuberculosis in 
macrophages. 
Following a 4-h infection and 15 h of growth in 1774 macrophage-like cells, 
intracellular M tuberculosis bacilli were harvested and the extracted RNA was subjected 
to RT-PCR with mycPl-specific primers. By agarose gel electrophoresis, an expected 
238-bp product was clearly observed for the RNA derived from the intracellular bacteria 
170 
but not for the broth-grown bacteria (Figure 7.lA). The 238-bp product was specific for 
the mycP 1 gene, as determined by Southern blotting, which also revealed faint bands in 
the lanes of broth-grown bacteria (Figure 7.lB). Although these data were suggestive of 
upregulation of mycP 1 expression during intracellular growth, this could not be formally 
concluded as this was not a quantitative RT-PCR assay. 
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Figure. 7.1. Expression of the M. tuberculosis mycPJ gene during growth in macrophages. 
Intracellular bacteria were harvested from infected 1774 macrophages, bacterial RNA was extracted and 
subjected to RT-PCR with my cPJ-specific primers, and the 238-bp products were resolved by agarose gel 
electrophoresis (A) and analyzed by Southern blotting (B) with an ECL-labeled probe. Lanes: 1, RNA 
from intracellular bacteria; 2, RNA from intracellular bacteria, diluted I :2; 3, RNA from broth-grown 
bacteria; 4, RNA from broth-grown bacteria, diluted 1 :2; 5, negative PCR control (no DNA); 6, positive 
PCR control (M tuberculosis genomic DNA); 7, molecular weight marker. 
7.3.2 Detection of mycosin-1 in M. tuberculosis-infected P3889D1 cells 
Equal amounts of protein [ determined using the BioRad protein assay (BioRad 
Laboratories, Richmond, California), as per manufacturer's instructions] from the pellet 
and supernatant samples were resolved by 10% SDS-PAGE, transblotted onto 
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Figure 7.2. Expression of mycosin-1 during growth of M. tuberculosis in macrophages. Lysates of 
infected P3889D1 cells were centrifuged at 100,000 x g and the pellets were resuspended in SDS buffer, 
resolved by 10% SDS-polyacrylamide ge l electrophoresis, and analysed by Western blotting using affinity-
purified anti-mycosin-1 antiserum as the primary antibody. Lanes: Ul , uninfected macrophages; J, infected 
macrophages; +ve, M smegmatis-P1 lysate (positive control); wk6, 6-week M tuberculosis culture filtrate . 
The numbers on the left are molecular weights in kDa. This figure is a composite from two separate 
experiments. 
A 40-kDa immunodominant band was observed in whole cell protein extracts of 
M tuberculosis-infected P3889D 1 cells (Figure 7.2). This corresponded to an 
immunodominant band observed m 6-week M tuberculosis culture filtrates. 
Furthermore, no bands were observed in whole cell extracts of uninfected P3889D 1 cells 
as well as high-speed supernatant samples ( containing intracellular contents) of 
uninfected and infected P3889D, cells. 
7.3.3 Infection of mice with M. tuberculosis GSH-3052 
ZN staining of lung and liver tissue from infected mice revealed numerous acid 
fast bacilli (Figure 7.3B and 7.4B), confirming a significant level of infection. 
Histological examination of the M tuberculosis-infected lung tissue from 14-21 days 
infection showed areas of non-specific inflammation ( data not shown). After 21 days of 






Figure 7.3. Lung tissue sections from control and M. tuberculosis-infected mice. BALB/c mice were 
infected intravenously with M. tuberculosis GSH-3052 and euthenased after 28 days of infection. 
A) Section of lung tissue from a control (uninfected) mouse showing normal tissue morphology. H & E 
stain, 200 x magnification. B) Section of lung tissue from an M. tuberculosis-infected mouse showing an 
ill-defined non-caseating epithelioid granuloma (arrows) containing epithelioid macrophages surrounded 
by lymphocytes and inflammatory cells. H & E stain, 200 x magnification. C) Section of lung tissue from 
an M. tuberculosis-infected mouse showing an ill-defined granuloma containing aggregates of foamy 
macrophages and inflammatory cells. H & E stain, 400 x magnification. D) Section of lung tissue from an 
M. tuberculosis-infected mouse showing numerous acid-fast bacilli (pink) that are scattered through large 





Figure 7.4. Liver tissue sections from control and M. tuberculosis-infected mice. BALB/c mice 
were infected intravenously with M. tuberculosis GSH-3052 and euthenased after 28 days of infection. 
A) Section of liver tissue from a control (uninfected) mouse showing normal tissue morphology. H & E 
stain, 200 x magnification. B) Section of liver tissue from an M. tuberculosis-infected mouse showing 
typical non-caseating epithelioid granulomas (arrows) containing epithelioid macrophages surrounded 
by lymphocytes and inflammatory cells. H & E stain, 200 x magnification. C) Section of liver tissue 
from an M. tuberculosis-infected mouse showing numerous acid-fast bacilli (pink) that appear to be 
localised to discrete lesions. ZN stain, 200 x magnification. 
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epithelioid granulomas (arrows in Figure 7.38). At 60 days of infection numerous 
ill-defined non-caseating epithelioid granulomas were seen containing aggregates of 
foamy macrophages surrounded by numerous lymphocytes and inflammatory cells 
(Figure 7.3C). The formation of ill-defined granulomas 1s typical of 
M tuberculosis-induced lung pathology in mice, especially when infected with an 
intravenous inoculum (North, 1995; Rhoades et al. , 1997). In contrast, the 
M tuberculosis-infected liver tissue revealed typical non-caseating epithelioid 
granulomas (arrows in Figure 7.48). Histological examination showed epithelioid 
macrophages surrounded by numerous lymphocytes and other inflammatory cells. No 
Langhans giant cells were seen. There was no caseous necrosis in any sections of the 
M tuberculosis-infected mice tissue, consistent with the findings presented in the 
literature (North, 1995; Rhoades et al. , 1997). ZN staining of spleen tissue sections from 
each infected mouse revealed numerous acid-fast bacilli and histological examination 
showed typical non-caseating epithelioid granulomas ( data not shown). Thus, the 3 
organs examined showed features of active tuberculous disease. 
7.3.4 Detection of mycosin-1 in M. tuberculosis-infected mice 
Tissue sections as above were probed with anti-mycosin-1 antibodies and binding 
of these antibodies to mycosin-1 was detected using the avidin-biotin detection system or 
FITC-labelled goat anti-rabbit IgG. Faint staining for mycosin-1 was noted in the 
infected tissues, but also in the uninfected tissues (although less than in the infected 
tissues). A variety of antigen retrieval methods, including enzymatic digestion with 
trypsin, heat (HMAR), pressure cooking, etching with hydrochloric acid, and various 




M tuberculosis-infected macrophage-like cells were used to detect the intracellular 
expression of mycosin-1. Initial experiments (performed in collaboration with the 
Molecular Mycobacteriology Research Group, Division of Immunity and Infection, 
University of Birmingham, UK) on RNA isolated from broth-grown M tuberculosis 
H37Rv and 1774 macrophage-like cells infected with M tuberculosis H37Rv revealed 
expression of mycP 1 in broth-grown M tuberculosis H3 7R v bacteria, as well as in the 
infected macrophages. In addition, these data were suggestive of upregulation of mycP 1 
expression during intracellular growth, but these results were not unequivocal as the 
methods used were not quantitative. 
The B. amyloliquefaciens subtilisin is only present as a preproprotein in in vitro 
transcri!Jtion-translation experiments, suggesting that some structural, enzymatic, or 
cofactor function is missing in vitro that is necessary to initiate processing (Power et al. , 
1986). Since it is well documented that intracellular residence of M tuberculosis induces 
protein expression not evident during in vitro growth (Lee et al. , 1995), it is possible that 
a protein only expressed during in vivo growth, or other in vivo factors, may be 
responsible for the activation of mycosin-1 . To address this hypothesis, it was decided to 
look for mycosin-1 expression in M tuberculosis-infected macrophages using anti-
mycosin-1 antibodies. The presence of mycosin-1 with a molecular weight of 38.67 kDa 
would be suggestive of signal peptide and propeptide cleavage (see section 4.2.4.1) and 
may suggest activation. 
Mycosin-1 was only detected in whole cell lysates of M tuberculosis-infected 
P3889D 1 cells and its molecular weight was noted to be - 40 kDa. Interestingly, this size 
corresponds to putative mature mycosin-1 after signal sequence and propeptide cleavage. 
In addition, the 40-kDa form of mycosin-1 was also observed in 6-week M tuberculosis 
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culture filtrates. This smaller form has not been observed in any M smegmatis-Pl 
fractions or in cell lysates of broth-grown M tuberculosis. This likely suggests mycosin-
1 activation (i.e., propeptide cleavage) in vivo, and also in stationary phase culture 
filtrates. 
The presence of a potentially active form of mycosin-1 in stationary phase culture 
filtrates is in agreement with the proteolytic activity described in Chapter 3. Activity 
suggestive of a subtilisin-like protease was detected in low levels after 3 weeks of 
growth. 
The likelihood for the in vivo expression of active mycosin-1 prompted a search for 
the presence of mycosin-1 in tuberculous tissue. To achieve this, and to confirm the 
virulence potential of the M tuberculosis strain selected for use in this study (GSH-
3052), mice were infected with M tuberculosis GSH-3052 by intravenous inoculation 
and euthenased after various time periods of infection. The lungs, liver and spleen were 
harvested, and sections were prepared for histological assessment as well as for the 
detection of mycosin-1 expression in the infected tissues. Using standard staining 
techniques, all three organs were demonstrated to contain the pathological features of 
active tuberculosis, confirming the virulence of M tuberculosis GSH-3052. After 
confirming that each organ contained active disease, it was decided to look for mycosin-1 
in these infected tissues. As described previously (section 7.3.3), standard techniques as 
well as additional antigen retrieval techniques failed to show unequivocal evidence for 
the presence of mycosin-1 in the infected tissues. Altered antigenicity is a potential 
problem with most fixatives, especially formalin. In these experiments formalin was 
selected for its fixative qualities as well as its antimycobacterial effects. In addition, the 
mice organs were exposed to formalin for a lengthy period ( 48 hours). Perhaps the use 
of an alternative fixative with better antigen preservation qualities may improve the 
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detection of mycosin-1 in infected tissues . However, the use of formalin represents one 
of the many factors that may have to be altered in order to detect mycosin-1. The 
numerous technical difficulties inherent to the immunohistochemical techniques used, 
coupled with the difficulties experienced in working with M tuberculosis and 
M tuberculosis-infected tissues, precluded further work in this direction. However, this 
work serves as a foundation for future studies. 
In conclusion, this chapter provides intriguing evidence for the processing and 
possible activation of mycosin-1 in vivo. Although the 40-kDa form of mycosin-1 
detected within macrophages has not been demonstrated to be active, it is tempting to 
suggest that this is indeed the case. In this regard experiments have been planned to 
purify in vivo expressed mycosin-1 for detection and characterisation of activity as well 
as for N-terminal sequencing. It is unfortunate that unequivocal evidence for the 
expression of mycosin-1 in infected tissues could not be presented. However, future 
experiments have been planned to attempt to overcome the problems experienced. 
Although these experiments are potentially difficult and challenging, the unambiguous 
demonstration of active mycosin-1 in infected tissues would allow further speculation on 
the involvement of this protease in the tissue destruction characteristic of active 
tuberculous disease, and would provide a model system in which the effects of 
M tuberculosis strains harboring mutated mycP 1 could be assessed. 
Definitive factors conferring an intracellular survival advantage on M tuberculosis 
have alluded scientists for many years. There is wide consensus that modulation of the 
phagosome is key to the survival and growth of pathogenic mycobacteria in 
macrophages. Maturation of the phagosome to a late compartment competent for fusion 
with lysosomes is inhibited, and hence pathogenic mycobacterial phagosomes do not 
acquire the characteristics of phagolysosomes (Clemens & Horwitz, 1995; De Chastellier 
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& Thilo, 1997; Russell et al. , 1997). It is unknown how this is accomplished, but it is 
presumed to involve both physico-chemical properties of the mycobacterial envelope and 
secreted factors (De Chastellier & Thilo, 1997; Russell et al. , 1997). It is not 
unreasonable to speculate that phagosome manipulation depends in part on proteolytic 
processing of bacterial or host proteins at the interface between the mycobacterial cell 
wall and the phagosome membrane. The mycosins and other M tuberculosis proteases 
may be good candidates for further investigation in this regard. 
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CONCLUDING REMARKS AND FUTURE STUDIES 
This study represents an initial characterisation of the first member of a new family 
of putative exported, membrane-associated, subtilisin-like senne proteases m 
M tuberculosis. Mycosin-1 is an extracellular protein that is membrane and cell wall 
associated, as well as shed into the culture supernatant. The protein is expressed after 
infection of macrophages and is apparently subjected to proteolytic processing. 
Thus far, proteolytically active mycosin-1 could not be produced recombinantly, but 
a serine protease activity consistent with a subtilisin-like enzyme was detected in 
M tuberculosis culture filtrates. However, whether mycosin-1 contributes to the activity 
detected in M tuberculosis culture filtrates remains to be elucidated. Although this study is 
not the first to detect protease activity in M tuberculosis, it does provide the first definitive 
evidence for expression of a protease homologue in vitro and in vivo, and represents the first 
characterisation of a subtilisin homologue in M tuberculosis. 
Proteases are poorly studied in M tuberculosis, which is surprising, considering that 
extracellular proteases frequently serve as virulence factors in bacterial pathogens. 
Moreover, a hallmark of pulmonary tuberculosis is extensive tissue necrosis, to which 
bacterial proteases could make an important contribution. Apart from direct tissue damage, 
M tuberculosis proteases could be involved in a number of activities that are thought to be 
required for intracellular survival, including phagosome membrane modulation, intracellular 
nutrient acquisition, and immune system modulation; additionally, activation of host-derived 
matrix-metalloproteases could also be a mechanism contributing to tissue damage. 
Whether the mycosins or other M tuberculosis proteases are involved in virulence is 
unknown. However, their potential as virulence factors and novel drug targets warrants 
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further investigation. Since M bovis BCG contains a homolgue of mycP 1 that is not 
expressed, it would be interesting to assess whether M bovis BCG harbouring p19K-Pl is 
able to survive intracellularly and whether it would be able to cause disease in mice. In 
addition, future studies on mycosin-1 should include the determination of activation 
conditions, characterisation of the active protease (including substrate preferences), 
assessment of activity and N-terminal sequencing of the in vivo produced 40-kDa form, and 
assessment of the virulence of M tuberculosis bacilli harbouring wild-type versus mutated 
mycPJ. 
Finally, the ability of M tuberculosis to establish disease appears to be 
multifactorial. In addition, many microbes produce proteases that have been shown to be 
intimately involved in the ability of the microbe to establish disease. Hence, it seems likely 
that amongst the diversity of putative protease genes revealed in the M tuberculosis genome 
sequence at least one will be shown to encode a protease that contributes to the pathogenicity 
of M tuberculosis. Since definitive virulence factors have alluded M tuberculosis-
researchers for many years, it would seem that novel and relatively unstudied 
M tuberculosis virulence targets should be sought. Proteases in M tuberculosis are a prime 
example, and it is hoped that this study will trigger enthusiasm for the future study of many 
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The methods used were an adaptation of those described by Sambrook et al 
(1989). Briefly, restriction endonuclease digests were performed in an eppendorf 
containing the appropriate restriction enzyme (3 u/µg DNA), the suggested restriction 
enzyme buffer (Boehringer Mannheim), plasmid DNA, and made up to a total volume of 
20 µl with sdH20. The reactions were incubated at 37°C for 1-3 h. The digested 
products were separated by electrophoresis in a 0.8% agarose gel and then purified using 
NucleoSpin Columns (Macherey Nagel, Germany), as per manufacturer' s instructions. 
A.2 DNA ligation reactions 
Ligation reactions were performed in a total volume of 20 µl per reaction. Each 
reaction contained: 1-2 units T4 DNA ligase (Boehringer Mannheim) per µg purified 
DNA, 10 x ligation buffer (Boehringer Mannheim), vector and insert DNA, and sdH20. 
The total concentration of plasmid DNA was 15 pmol/ml and contained an insert:vector 
ratio of 2:1. The ligation reactions were performed at room temperature for 9-16 h. To 
control for ligase activity, a sample of single-cut plasmid DNA was included as a positive 
control and double-cut (using two different restriction enzymes) plasmid DNA was 
included as a negative control. 
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A.3 Preparation and transformation of competent E. coli cells 
The method used was a modification of the method described by Hanahan (1983). 
Briefly, one viable colony of E. coli XLl -Blue was picked from a freshly streaked agar 
plate, inoculated into 5 ml LB and incubated overnight at 37°C. This starter culture 
(1 ml) was used to inoculate 50 ml pre-warmed LB which was incubated at 37°C until an 
OD600 of 0.5. The bacteria were pelleted by centrifugation at 2,500 x g for 5 min at 4°C. 
To maintain the integrity of the cells all subsequent steps were performed at 4°C. The 
bacterial pellet was resuspended in ice-cold TFB 1 (1 OOmM RbCl, 50 mM Mn Ch, 
30 mM KOAc, 10 mM CaCh, 15% (v/v) glycerol) and incubated on ice for 1-1.5 h. The 
bacteria were again pelleted by centrifugation at 2,500 x g for 5 min at 4°C and 
resuspended in ice-cold TFB 2 (10 mM MOPS, pH 7.0, 10 mM RbCl, 75 mM CaCh, 
15% (v/v) glycerol). This mixture was divided into 100 µl aliquots and stored at -70°C. 
Plasmid DNA (50-200 ng) was added to a 100 µl aliquot of competent cells, 
incubated on ice for 10 min, heat-shocked at 42°C for exactly 2 min and then placed 
directly on ice for 2 min. LB (400 µl) was added and the mixture incubated at 37°C for 
60 min to allow for expression of the selective antibiotic. The transformed cells were 
then plated onto LA plates containing the appropriate selective antibiotic and incubated 
overnight at 37°C. Two additional samples containing competent cells with no added 
plasmid DNA and competent cells with uncut plasmid DNA were included to control for 
spurious transformation results and to monitor transformation efficiency, respectively. 
A.4 Small-scale isolation of E. coli plasmid DNA 
Plasmid DNA was extracted using an adaptation of the Ish-Horowicz and Burke 
method (1981 ). Briefly, one viable colony of transformed E. coli was grown at 3 7°C in 
5 ml LB containing the appropriate selective pressure. Bacteria from 1.5 ml of this 
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culture were pelleted by centrifugation at 12,000 x g for 3 mm. The pellet was 
resuspended in 50 µl TE buffer, 100 µl phenol/chloroform was added and the mixture 
vortexed for 3 min. Proteins were separated from the suspended DNA by centrifugation 
at 12,000 x g for 5 min and 50 µl of the clear top layer was carefully aspirated and 
transferred to a clean eppendorf tube. Eighteen microlitres NaiAc (7.5 M) and 140 µl 
ice-cold ethanol (100%) were added and the mixture incubated at -20°C for 15 min, to 
precipitate the DNA. The DNA was pelleted by centrifugation at 12,000 x g for 10 min, 
washed in 70% ethanol, air-dried for 15 minutes and resuspended in 25 µl TE buffer 
containing 1 µl Rnase (10 mg/ml). 
A.5 SDS-polyacrylamide gel electrophoresis and Western blotting 
SDS-polyacrylarnide gels were prepared and electrophoresed according to the 
method described by Laemrnli (1970), using a mini-gel apparatus (BioRad Laboratories, 
Richmond, California). Equal amounts of protein ( determined using the BioRad Protein 
Determination Kit, as per manufacturers instructions) was added to each lane. 
Electrophoresed proteins were trans blotted (100 V) onto a hybond-C nitrocellulose 
membrane for 1 h at 4 °C. All subsequent steps were performed at room temperature. 
The membrane was incubated in blocking buffer [PBS, 5% (w/v) skim milk, 0.1 % (v/v) 
Tween-20] for 1-2 h, followed by a 1 h incubation with the primary antibody ( diluted in 
blocking buffer). After washing in washing buffer (PBS, 0.1 % (v/v) Tween-20] for 20 
min, the membrane was incubated with peroxidase-conjugated anti-rabbit or anti-mouse 
IgG (ECL Western blotting kit, Amersham; 1 :2,000 dilution in blocking buffer) for lh 
and washed again in washing buffer for 15 min. The washed membranes were then 
treated with ECL detection reagents and exposed to photographic film, as recommended 
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